,words,labels,sentence_id,full sentence
316,The,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
317,genetic,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
318,progress,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
319,is,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
320,then,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
321,transferred,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
322,to,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
323,the,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
324,commercial,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
325,flocks,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
326,through,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
327,artificial,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
328,insemination,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
329,or,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
330,natural,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
331,-,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
332,mating,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
333,rams,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
334,.,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
368,Moreover,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
369,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
370,other,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
371,traits,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
372,are,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
373,gaining,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
374,interest,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
375,for,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
376,selection,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
377,:,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
378,machine,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
379,milking,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
380,ability,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
381,and,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
382,udder,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
383,morphology,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
384,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
385,resistance,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
386,to,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
387,diseases,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
388,(,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
389,mastitis,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
390,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
391,internal,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
392,parasites,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
393,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
394,scrapie,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
395,),O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
396,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
397,and,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
398,traits,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
399,related,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
400,to,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
401,the,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
402,nutritional,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
403,value,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
404,of,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
405,milk,B-AG.01.e,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
406,(,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
407,fatty,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
408,acid,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
409,composition,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
410,),O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
411,.,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
1154,Type,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1155,2,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1156,diabetes,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1157,is,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1158,another,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1159,global,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1160,health,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1161,threat,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1162,closely,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1163,associated,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1164,with,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1165,obesity,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1166,that,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1167,boosts,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1168,the,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1169,risk,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1170,of,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1171,cancer,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1172,driven,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1173,by,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1174,high,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1175,BMI,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1176,.,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1177,Education,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1178,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1179,promote,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1180,positive,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1181,choices,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1182,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1183,physical,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1184,activity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1185,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1186,resolute,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1187,public,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1188,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1189,interventions,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1190,on,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1191,food,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1192,delivery,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1193,are,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1194,requested,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1195,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1196,reduce,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1197,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1198,burden,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1199,of,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1200,obesity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1201,-,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1202,related,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1203,cancer,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1204,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1205,lighten,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1206,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1207,unsustainable,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1208,growing,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1209,expenses,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1210,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1211,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1212,systems,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1213,.,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1230,Numerous,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1231,studies,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1232,have,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1233,documented,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1234,the,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1235,antioxidant,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1236,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1237,anti,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1238,-,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1239,inflammatory,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1240,and,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1241,immunomodulatory,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1242,effects,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1243,of,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1244,spices,B-AG.01.l.03,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1245,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1246,which,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1247,might,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1248,be,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1249,related,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1250,to,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1251,prevention,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1252,and,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1253,treatment,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1254,of,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1255,several,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1256,cancers,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1257,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1258,including,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1259,lung,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1260,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1261,liver,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1262,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1263,breast,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1264,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1265,stomach,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1266,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1267,colorectum,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1268,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1269,cervix,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1270,",",O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1271,and,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1272,prostate,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1273,cancers,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1274,.,O,39.0,"Numerous studies have documented the antioxidant , anti - inflammatory and immunomodulatory effects of spices , which might be related to prevention and treatment of several cancers , including lung , liver , breast , stomach , colorectum , cervix , and prostate cancers ."
1351,The,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1352,main,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1353,mechanisms,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1354,of,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1355,action,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1356,include,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1357,inducing,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1358,apoptosis,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1359,",",O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1360,inhibiting,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1361,proliferation,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1362,",",O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1363,migration,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1364,and,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1365,invasion,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1366,of,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1367,tumors,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1368,",",O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1369,and,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1370,sensitizing,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1371,tumors,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1372,to,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1373,radiotherapy,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1374,and,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1375,chemotherapy,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1376,.,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1429,Levels,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1430,of,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1431,genistein,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1432,and,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1433,its,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1434,beta,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1435,-,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1436,glucoside,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1437,conjugate,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1438,",",O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1439,genistin,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1440,",",O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1441,ingested,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1442,in,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1443,soybeans,B-AG.01.h.02.g,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1444,and,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1445,related,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1446,bean,B-AG.01.n,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1447,products,I-AG.01.n,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1448,by,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1449,the,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1450,Japanese,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1451,were,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1452,quantified,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1453,by,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1454,HPLC,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1455,",",O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1456,to,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1457,estimate,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1458,daily,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1459,intake,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1460,of,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1461,these,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1462,compounds,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1463,.,O,44.0,"Levels of genistein and its beta - glucoside conjugate , genistin , ingested in soybeans and related bean products by the Japanese were quantified by HPLC , to estimate daily intake of these compounds ."
1682,These,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1683,levels,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1684,are,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1685,much,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1686,higher,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1687,than,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1688,those,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1689,for,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1690,Americans,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1691,or,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1692,Western,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1693,Europeans,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1694,",",O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1695,whose,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1696,mortality,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1697,rates,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1698,for,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1699,breast,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1700,",",O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1701,colon,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1702,and,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1703,prostate,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1704,cancers,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1705,are,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1706,greater,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1707,than,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1708,the,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1709,Japanese,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1710,.,O,52.0,"These levels are much higher than those for Americans or Western Europeans , whose mortality rates for breast , colon and prostate cancers are greater than the Japanese ."
1818,We,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1819,found,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1820,an,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1821,inverse,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1822,association,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1823,between,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1824,total,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1825,fruit,B-AG.01.h.01,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1826,and,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1827,vegetable,B-AG.01.h.02,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1828,intake,B-X,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1829,and,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1830,head,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1831,and,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1832,neck,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1833,cancer,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1834,risk,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1835,(,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1836,per,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1837,serving,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1838,/,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1839,"day/1,000",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1840,calories,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1841,",",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1842,Hazard,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1843,Ratio,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1844,",",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1845,95,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1846,%,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1847,Confidence,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1848,interval,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1849,:,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1850,0.94,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1851,",",O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1852,0.89,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1853,-,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1854,0.99,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1855,),O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
1856,.,O,57.0,"We found an inverse association between total fruit and vegetable intake and head and neck cancer risk ( per serving / day/1,000 calories , Hazard Ratio , 95 % Confidence interval : 0.94 , 0.89 - 0.99 ) ."
2332,Indirect,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2333,calorimetry,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2334,showed,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2335,that,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2336,ginger,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2337,administration,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2338,significantly,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2339,increased,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2340,the,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2341,respiratory,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2342,exchange,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2343,ratio,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2344,(,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2345,RER,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2346,),O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2347,and,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2348,heat,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2349,production,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2350,in,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2351,both,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2352,diet,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2353,models,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2354,.,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2550,The,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2551,LP,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2552,trait,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2553,has,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2554,been,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2555,independently,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2556,selected,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2557,at,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2558,least,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2559,4,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2560,times,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2561,and,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2562,is,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2563,under,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2564,rapid,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2565,positive,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2566,selection,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2567,",",O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2568,which,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2569,shows,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2570,that,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2571,dairy,B-AG.01.e,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2572,consumption,B-X,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2573,has,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2574,positive,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2575,survival,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2576,benefits,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2577,.,O,83.0,"The LP trait has been independently selected at least 4 times and is under rapid positive selection , which shows that dairy consumption has positive survival benefits ."
2745,Yogurt,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2746,has,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2747,been,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2748,part,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2749,of,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2750,the,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2751,human,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2752,diet,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2753,for,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2754,thousands,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2755,of,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2756,years,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2757,",",O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2758,and,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2759,during,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2760,that,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2761,time,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2762,a,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2763,number,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2764,of,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2765,health,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2766,benefits,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2767,have,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2768,been,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2769,associated,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2770,with,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2771,its,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2772,consumption,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2773,.,O,87.0,"Yogurt has been part of the human diet for thousands of years , and during that time a number of health benefits have been associated with its consumption ."
2862,When,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2863,assessing,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2864,a,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2865,complex,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2866,food,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2867,matrix,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2868,",",O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2869,rather,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2870,than,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2871,specific,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2872,nutrients,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2873,",",O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2874,scientists,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2875,and,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2876,consumers,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2877,are,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2878,faced,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2879,with,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2880,new,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2881,challenges,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2882,as,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2883,to,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2884,how,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2885,a,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2886,food,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2887,item,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2888,'s,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2889,quality,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2890,or,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2891,necessity,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2892,would,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2893,be,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2894,judged,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2895,as,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2896,part,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2897,of,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2898,an,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2899,individual,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2900,'s,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2901,whole,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2902,diet,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2903,.,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
3294,Trained,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3295,dietitians,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3296,interviewed,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3297,136,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3298,patients,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3299,diagnosed,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3300,with,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3301,GC,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3302,",",O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3303,and,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3304,the,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3305,same,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3306,number,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3307,of,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3308,controls,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3309,were,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3310,selected,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3311,by,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3312,matching,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3313,sex,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3314,",",O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3315,age,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3316,and,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3317,hospital,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3318,.,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3653,Milk,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3654,production,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3655,of,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3656,bST,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3657,cows,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3658,recovered,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3659,better,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3660,than,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3661,that,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3662,of,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3663,placebo,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3664,cows,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3665,.,O,116.0,Milk production of bST cows recovered better than that of placebo cows .
3960,Butter,B-AG.01.e.01,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3961,",",O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3962,relative,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3963,to,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3964,margarine,B-AG.01.f,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3965,",",O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3966,coconut,B-AG.01.f,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3967,and,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3968,soybean,B-AG.01.f,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3969,oils,I-AG.01.f,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3970,",",O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3971,significantly,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3972,increased,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3973,serum,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3974,non,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3975,-,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3976,HDL,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3977,cholesterol,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3978,concentrations,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
3979,.,O,126.0,"Butter , relative to margarine , coconut and soybean oils , significantly increased serum non - HDL cholesterol concentrations ."
4980,About,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4981,25,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4982,days,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4983,after,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4984,diet,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4985,change,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4986,",",O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4987,mice,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4988,that,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4989,consumed,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4990,the,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4991,corn,B-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4992,oil,I-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4993,diet,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4994,stopped,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4995,gaining,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4996,weight,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4997,",",O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4998,whereas,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4999,the,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5000,mice,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5001,that,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5002,consumed,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5003,the,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5004,canola,B-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5005,oil,I-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5006,diet,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5007,continued,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5008,normal,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5009,weight,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5010,gain,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5011,.,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5786,Results,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5787,from,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5788,our,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5789,study,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5790,suggest,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5791,that,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5792,water,B-AG.01.z,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5793,intake,B-X,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5794,may,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5795,be,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5796,associated,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5797,with,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5798,a,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5799,slight,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5800,reduction,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5801,in,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5802,bladder,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5803,cancer,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5804,risk,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5805,.,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
6135,It,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6136,has,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6137,ability,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6138,for,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6139,adenosine,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6140,deaminase,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6141,inhibition,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6142,that,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6143,plays,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6144,important,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6145,role,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6146,in,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6147,the,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6148,regression,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6149,of,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6150,tumor,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6151,.,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6257,Moreover,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6258,",",O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6259,tomato,B-AG.01.h.02.f,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6260,and,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6261,its,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6262,bioactive,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6263,components,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6264,hold,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6265,potential,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6266,to,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6267,become,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6268,effective,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6269,modules,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6270,in,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6271,diet,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6272,-,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6273,based,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6274,regimens,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6275,;,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6276,however,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6277,",",O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6278,integrated,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6279,research,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6280,and,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6281,meta,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6282,-,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6283,analysis,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6284,are,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6285,still,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6286,required,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6287,to,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6288,enhance,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6289,meticulousness,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6290,.,O,205.0,"Moreover , tomato and its bioactive components hold potential to become effective modules in diet - based regimens ; however , integrated research and meta - analysis are still required to enhance meticulousness ."
6353,The,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6354,DGAs,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6355,note,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6356,that,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6357,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6358,are,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6359,consuming,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6360,100,B-AG.01.ab,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6361,%,I-AG.01.ab,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6362,fruit,I-AG.01.ab,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6363,juice,I-AG.01.ab,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6364,within,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6365,recommendations,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6366,(,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6367,that,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6368,is,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6369,",",O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6370,120,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6371,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6372,180,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6373,mL,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6374,/,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6375,d,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6376,for,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6377,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6378,aged,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6379,1,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6380,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6381,6,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6382,y,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6383,and,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6384,236,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6385,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6386,355,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6387,mL,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6388,/,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6389,d,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6390,for,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6391,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6392,aged,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6393,7,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6394,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6395,18,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6396,y,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6397,),O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6398,.,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6703,These,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6704,include,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6705,nutrition,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6706,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6707,particularly,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6708,calcium,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6709,and,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6710,protein,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6711,intake,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6712,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6713,physical,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6714,activity,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6715,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6716,endocrine,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6717,status,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6718,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6719,as,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6720,well,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6721,as,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6722,exposure,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6723,to,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6724,a,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6725,wide,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6726,variety,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6727,of,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6728,risk,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6729,factors,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6730,.,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
7061,The,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7062,purpose,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7063,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7064,this,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7065,study,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7066,was,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7067,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7068,determine,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7069,the,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7070,ideal,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7071,combination,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7072,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7073,coffee,B-AG.01.ad,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7074,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7075,cream,B-AG.01.e,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7076,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7077,and,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7078,sugar,B-AG.01.l.02,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7079,in,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7080,order,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7081,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7082,minimize,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7083,MG,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7084,consumption,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7085,.,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7868,Information,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7869,on,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7870,ingredients,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7871,and,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7872,nutritional,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7873,composition,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7874,was,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7875,retrieved,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7876,from,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7877,food,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7878,package,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7879,labels,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7880,.,O,261.0,Information on ingredients and nutritional composition was retrieved from food package labels .
7902,The,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7903,most,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7904,common,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7905,added,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7906,fat,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7907,was,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7908,sunflower,B-AG.01.f,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7909,oil,I-AG.01.f,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7910,(,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7911,present,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7912,in,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7913,one,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7914,third,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7915,of,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7916,the,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7917,products,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7918,),O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7919,",",O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7920,followed,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7921,by,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7922,palm,B-AG.01.f,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7923,fat,I-AG.01.f,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7924,",",O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7925,olive,B-AG.01.f,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7926,oil,I-AG.01.f,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7927,",",O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7928,and,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7929,cocoa,B-AG.01.f,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
7930,.,O,263.0,"The most common added fat was sunflower oil ( present in one third of the products ) , followed by palm fat , olive oil , and cocoa ."
8307,Under,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8308,the,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8309,realistic,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8310,scenario,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8311,",",O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8312,no,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8313,country,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8314,exceeded,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8315,100,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8316,%,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8317,of,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8318,the,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8319,UL,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8320,for,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8321,any,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8322,nutrient,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8323,.,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
9237,Using,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9238,the,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9239,primary,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9240,data,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9241,",",O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9242,the,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9243,study,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9244,-,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9245,specific,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9246,relative,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9247,risks,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9248,(,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9249,RRs,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9250,),O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9251,were,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9252,calculated,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9253,and,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9254,then,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9255,pooled,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9256,using,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9257,a,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9258,random,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9259,effects,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9260,model,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9261,.,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9871,Whereas,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9872,lingonberry,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9873,fruit,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9874,extract,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9875,did,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9876,not,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9877,provide,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9878,protection,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9879,from,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9880,glutamate,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9881,toxicity,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9882,",",O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9883,blueberry,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9884,fruit,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9885,extracts,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9886,were,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9887,extremely,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9888,protective,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9889,.,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
10147,The,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10148,European,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10149,Commission,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10150,asked,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10151,EFSA,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10152,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10153,a,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10154,scientific,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10155,opinion,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10156,on,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10157,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10158,risks,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10159,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10160,animal,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10161,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10162,human,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10163,health,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10164,related,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10165,to,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10166,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10167,presence,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10168,of,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10169,glycoalkaloids,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10170,(,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10171,GAs,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10172,),O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10173,in,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10174,feed,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10175,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10176,food,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10177,.,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10299,No,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10300,reference,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10301,point,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10302,for,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10303,chronic,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10304,exposure,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10305,could,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10306,be,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10307,identified,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10308,from,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10309,the,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10310,experimental,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10311,animal,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10312,studies,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10313,.,O,346.0,No reference point for chronic exposure could be identified from the experimental animal studies .
10535,The,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10536,plant,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10537,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10538,based,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10539,emulsions,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10540,are,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10541,directed,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10542,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10543,prevent,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10544,diet,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10545,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10546,related,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10547,chronic,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10548,diseases,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10549,including,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10550,diabetes,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10551,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10552,cardiovascular,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10553,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10554,obesity,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10555,and,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10556,other,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10557,disorders,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10558,due,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10559,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10560,the,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10561,presence,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10562,of,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10563,healthy,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10564,long,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10565,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10566,chain,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10567,unsaturated,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10568,fatty,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10569,acids,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10570,as,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10571,compared,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10572,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10573,bovine,B-AG.01.e,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10574,milk,I-AG.01.e,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10575,.,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10958,In,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10959,conclusion,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10960,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10961,glucose,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10962,tolerance,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10963,status,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10964,did,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10965,not,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10966,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10967,in,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10968,general,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10969,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10970,affect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10971,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10972,predictive,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10973,effect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10974,of,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10975,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10976,dietary,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10977,patterns,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10978,.,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10979,The,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10980,study,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10981,suggests,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10982,that,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10983,the,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10984,risk,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10985,of,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10986,worsening,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10987,2h,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10988,-,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10989,PG,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10990,concentrations,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10991,may,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10992,be,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10993,smaller,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10994,for,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10995,individuals,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10996,with,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10997,a,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10998,high,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
10999,modern,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11000,dietary,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11001,pattern,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11002,score,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11003,characterized,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11004,by,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11005,high,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11006,intakes,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11007,of,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11008,vegetables,B-AG.01.h.02,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11009,",",O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11010,fruit,B-AG.01.h.01,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11011,",",O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11012,vegetable,B-AG.01.l.04,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11013,oil,I-AG.01.l.04,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11014,/,I-AG.01.l.04,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11015,vinegar,I-AG.01.l.04,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11016,dressing,I-AG.01.l.04,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11017,",",O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11018,poultry,B-AG.01.d.06,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11019,",",O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11020,pasta,B-AG.01.i,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11021,",",O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11022,rice,B-AG.01.i,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11023,",",O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11024,and,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11025,cereals,B-AG.01.i,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11026,.,O,369.0,"The study suggests that the risk of worsening 2h - PG concentrations may be smaller for individuals with a high modern dietary pattern score characterized by high intakes of vegetables , fruit , vegetable oil / vinegar dressing , poultry , pasta , rice , and cereals ."
11176,The,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11177,outcomes,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11178,were,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11179,average,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11180,change,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11181,in,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11182,body,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11183,weight,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11184,in,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11185,a,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11186,four,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11187,-,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11188,year,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11189,period,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11190,and,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11191,new,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11192,-,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11193,onset,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11194,obesity,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11195,and,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11196,their,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11197,association,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11198,with,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11199,the,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11200,substitution,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11201,of,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11202,one,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11203,serving,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11204,per,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11205,day,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11206,of,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11207,water,B-AG.01.z,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11208,for,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11209,one,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11210,of,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11211,the,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11212,other,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11213,beverages,B-AG.01.y,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11214,.,O,376.0,The outcomes were average change in body weight in a four - year period and new - onset obesity and their association with the substitution of one serving per day of water for one of the other beverages .
11215,During,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11216,the,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11217,follow,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11218,-,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11219,up,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11220,",",O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11221,873,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11222,incident,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11223,cases,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11224,of,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11225,obesity,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11226,were,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11227,identified,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11228,.,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11323,Thus,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11324,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11325,this,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11326,study,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11327,found,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11328,that,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11329,replacing,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11330,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11331,sugar,B-AG.01.y,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11332,-,I-AG.01.y,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11333,sweetened,I-AG.01.y,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11334,soda,I-AG.01.y,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11335,beverage,I-AG.01.y,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11336,or,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11337,beer,B-AG.01.y.01.b,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11338,with,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11339,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11340,serving,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11341,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11342,water,B-AG.01.z,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11343,per,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11344,day,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11345,at,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11346,baseline,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11347,was,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11348,related,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11349,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11350,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11351,lower,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11352,incidence,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11353,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11354,obesity,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11355,and,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11356,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11357,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11358,higher,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11359,weight,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11360,loss,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11361,over,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11362,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11363,four,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11364,-,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11365,year,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11366,period,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11367,time,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11368,in,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11369,the,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11370,case,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11371,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11372,beer,B-AG.01.y.01.b,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11373,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11374,based,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11375,on,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11376,mathematical,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11377,models,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11378,.,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11394,Components,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11395,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11396,the,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11397,Mediterranean,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11398,diet,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11399,associated,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11400,with,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11401,better,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11402,cardiovascular,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11403,health,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11404,include,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11405,low,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11406,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11407,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11408,meat,B-AG.01.d,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11409,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11410,meat,B-AG.01.d,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11411,products,I-AG.01.d,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11412,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11413,moderate,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11414,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11415,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11416,ethanol,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11417,(,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11418,mostly,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11419,from,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11420,wine,B-AG.01.y.01.a,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11421,),O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11422,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11423,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11424,high,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11425,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11426,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11427,vegetables,B-AG.01.h.02,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11428,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11429,fruits,B-AG.01.h.01,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11430,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11431,nuts,B-AG.01.h.01.f,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11432,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11433,legumes,B-AG.01.h.02.g,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11434,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11435,fish,B-AG.01.d.07,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11436,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11437,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11438,olive,B-AG.01.f,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11439,oil,I-AG.01.f,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11440,.,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11541,Immunological,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11542,and,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11543,respiratory,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11544,findings,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11545,were,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11546,studied,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11547,in,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11548,a,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11549,group,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11550,of,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11551,45,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11552,female,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11553,spice,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11554,-,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11555,factory,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11556,workers,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11557,(,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11558,mean,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11559,age,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11560,:,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11561,39,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11562,years,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11563,;,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11564,mean,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11565,exposure,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11566,:,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11567,17,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11568,years,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11569,),O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11570,.,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
12885,It,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12886,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12887,important,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12888,to,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12889,recognize,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12890,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12891,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12892,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12893,only,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12894,a,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12895,crude,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12896,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12897,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12898,estimates,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12899,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12900,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12901,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12902,proportion,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12903,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12904,cancers,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12905,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12906,might,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12907,be,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12908,preventable,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12909,by,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12910,increasing,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12911,fruit,B-AG.01.h,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12912,and,I-AG.01.h,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12913,vegetable,I-AG.01.h,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12914,intake,B-X,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12915,may,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12916,vary,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12917,beyond,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12918,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12919,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12920,for,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12921,specific,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12922,cancer,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12923,sites,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12924,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12925,across,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12926,different,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12927,regions,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12928,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12929,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12930,world,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12931,.,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
13763,Their,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13764,common,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13765,structural,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13766,features,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13767,",",O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13768,such,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13769,as,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13770,eight,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13771,conserved,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13772,cysteines,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13773,forming,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13774,disulfide,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13775,bridges,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13776,",",O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13777,basic,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13778,isoelectric,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13779,point,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13780,and,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13781,high,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13782,similarity,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13783,in,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13784,amino,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13785,acid,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13786,sequence,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13787,",",O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13788,are,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13789,the,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13790,basis,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13791,of,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13792,allergic,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13793,clinical,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13794,cross,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13795,-,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13796,reactivity,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13797,.,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
14007,These,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14008,ingredients,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14009,should,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14010,be,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14011,avoided,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14012,by,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14013,consumers,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14014,with,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14015,allergies,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14016,to,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14017,the,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14018,source,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14019,material,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14020,if,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14021,the,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14022,ingredient,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14023,contains,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14024,detectable,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14025,protein,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14026,residues,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14027,.,O,467.0,These ingredients should be avoided by consumers with allergies to the source material if the ingredient contains detectable protein residues .
14821,If,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14822,untreated,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14823,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14824,this,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14825,can,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14826,progress,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14827,to,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14828,liver,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14829,inflammation,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14830,(,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14831,nonalcoholic,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14832,steatohepatitis,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14833,),O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14834,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14835,fibrosis,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14836,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14837,cirrhosis,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14838,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14839,and,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14840,hepatocellular,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14841,carcinoma,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14842,.,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
15173,Food,O,504.0,"Food cravings are extremely common , particularly among women ."
15174,cravings,O,504.0,"Food cravings are extremely common , particularly among women ."
15175,are,O,504.0,"Food cravings are extremely common , particularly among women ."
15176,extremely,O,504.0,"Food cravings are extremely common , particularly among women ."
15177,common,O,504.0,"Food cravings are extremely common , particularly among women ."
15178,",",O,504.0,"Food cravings are extremely common , particularly among women ."
15179,particularly,O,504.0,"Food cravings are extremely common , particularly among women ."
15180,among,O,504.0,"Food cravings are extremely common , particularly among women ."
15181,women,O,504.0,"Food cravings are extremely common , particularly among women ."
15182,.,O,504.0,"Food cravings are extremely common , particularly among women ."
15473,When,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15474,sterculic,B-AG.01.f,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15475,oil,I-AG.01.f,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15476,was,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15477,included,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15478,",",O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15479,some,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15480,parameters,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15481,were,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15482,further,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15483,ameliorated,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15484,(,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15485,reduction,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15486,of,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15487,insulin,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15488,",",O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15489,increase,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15490,of,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15491,adiponectin,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15492,),O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15493,.,O,516.0,"When sterculic oil was included , some parameters were further ameliorated ( reduction of insulin , increase of adiponectin ) ."
15792,This,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15793,study,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15794,aimed,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15795,to,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15796,explore,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15797,the,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15798,effects,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15799,of,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15800,casein,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15801,",",O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15802,pork,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15803,",",O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15804,and,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15805,chicken,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15806,proteins,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15807,at,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15808,different,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15809,protein,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15810,levels,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15811,(,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15812,40,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15813,%,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15814,E,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15815,vs,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15816,20,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15817,%,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15818,E,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15819,),O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15820,on,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15821,body,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15822,weight,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15823,regulation,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15824,",",O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15825,body,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15826,fat,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15827,accumulation,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15828,",",O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15829,serum,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15830,hormone,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15831,levels,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15832,",",O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15833,and,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15834,inflammatory,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15835,factors,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15836,/,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15837,metabolites,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15838,in,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15839,rats,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15840,maintained,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15841,on,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15842,high,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15843,-,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15844,fat,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15845,(,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15846,45,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15847,%,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15848,E,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15849,fat,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15850,),O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15851,diets,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15852,for,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15853,84,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15854,d.,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15855,Increased,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15856,protein,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15857,levels,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15858,resulted,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15859,in,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15860,a,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15861,significant,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15862,reduction,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15863,in,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15864,body,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15865,fat,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15866,mass,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15867,and,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15868,an,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15869,increase,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15870,in,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15871,the,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15872,serum,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15873,levels,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15874,of,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15875,the,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15876,anti,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15877,-,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15878,inflammatory,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15879,cytokine,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15880,IL-10,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15881,",",O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15882,independent,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15883,of,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15884,protein,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15885,source,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
15886,.,O,529.0,"This study aimed to explore the effects of casein , pork , and chicken proteins at different protein levels ( 40 % E vs 20 % E ) on body weight regulation , body fat accumulation , serum hormone levels , and inflammatory factors / metabolites in rats maintained on high - fat ( 45 % E fat ) diets for 84 d. Increased protein levels resulted in a significant reduction in body fat mass and an increase in the serum levels of the anti - inflammatory cytokine IL-10 , independent of protein source ."
16135,The,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16136,D,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16137,pattern,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16138,had,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16139,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16140,lowest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16141,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16142,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16143,maize,B-AG.01.i,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16144,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16145,15.5,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16146,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16147,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16148,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16149,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16150,highest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16151,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16152,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16153,whole,B-AG.01.e,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16154,-,I-AG.01.e,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16155,fat,I-AG.01.e,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16156,dairy,I-AG.01.e,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16157,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16158,8.0,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16159,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16160,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16161,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16162,rice,B-AG.01.i,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16163,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16164,pasta,B-AG.01.i,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16165,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16166,meat,B-AG.01.d,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16167,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16168,poultry,B-AG.01.d.06,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16169,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16170,eggs,B-AG.01.g,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16171,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16172,saturated,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16173,fat,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16174,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16175,fruits,B-AG.01.h.01,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16176,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16177,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16178,vegetables,B-AG.01.h.02,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16179,.,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16298,Metabolic,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16299,adaptations,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16300,of,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16301,the,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16302,liver,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16303,are,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16304,critical,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16305,for,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16306,successful,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16307,transition,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16308,",",O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16309,yet,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16310,it,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16311,is,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16312,unclear,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16313,how,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16314,heat,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16315,stress,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16316,affects,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16317,metabolic,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16318,pathways,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16319,within,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16320,the,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16321,liver,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16322,at,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16323,the,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16324,proteomic,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16325,level,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
16326,.,O,543.0,"Metabolic adaptations of the liver are critical for successful transition , yet it is unclear how heat stress affects metabolic pathways within the liver at the proteomic level ."
17083,Two,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17084,PCR,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17085,methods,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17086,were,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17087,developed,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17088,for,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17089,specific,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17090,detection,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17091,of,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17092,the,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17093,trnS,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17094,-,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17095,trnG,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17096,intergenic,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17097,spacer,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17098,region,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17099,of,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17100, ,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17101,Prunus,B-AG.01.h.01.e,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17102,persica,I-AG.01.h.01.e,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17103, ,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17104,(,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17105,peach,B-AG.01.h.01.e,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17106,),O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17107,and,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17108,the,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17109,internal,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17110,transcribed,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17111,spacer,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17112,region,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17113,of,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17114, ,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17115,Malus,B-AG.01.h.01.c,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17116,domestica,I-AG.01.h.01.c,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17117, ,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17118,(,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17119,apple,B-AG.01.h.01.c,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17120,),O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17121,.,O,572.0,Two PCR methods were developed for specific detection of the trnS - trnG intergenic spacer region of   Prunus persica   ( peach ) and the internal transcribed spacer region of   Malus domestica   ( apple ) .
17122,The,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17123,peach,B-AG.01.h.01.e,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17124,PCR,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17125,amplified,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17126,a,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17127,target,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17128,-,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17129,size,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17130,product,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17131,from,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17132,the,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17133,DNA,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17134,of,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17135,6,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17136,P.,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17137,persica,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17138,cultivars,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17139,including,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17140,2,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17141,nectarine,B-AG.01.h.01.e,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17142,and,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17143,1,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17144,flat,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17145,peach,B-AG.01.h.01.e,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17146,cultivar,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17147,",",O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17148,but,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17149,not,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17150,from,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17151,those,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17152,of,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17153,36,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17154,nontarget,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17155,species,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17156,including,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17157,6,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17158,Prunus,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17159,and,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17160,5,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17161,other,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17162,Rosaceae,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17163,species,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17164,.,O,573.0,"The peach PCR amplified a target - size product from the DNA of 6 P. persica cultivars including 2 nectarine and 1 flat peach cultivar , but not from those of 36 nontarget species including 6 Prunus and 5 other Rosaceae species ."
17526,In,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17527,contrast,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17528,",",O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17529,in,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17530,study,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17531,2,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17532,there,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17533,were,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17534,no,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17535,significant,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17536,differences,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17537,in,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17538,serum,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17539,lipid,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17540,levels,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17541,between,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17542,control,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17543,and,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17544,coffee,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17545,lipid,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17546,-,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17547,treated,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17548,groups,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17549,across,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17550,time,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17551,.,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17640,Excess,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17641,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17642,fat,B-AG.01.f,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17643,intake,B-X,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17644,leads,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17645,to,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17646,obesity,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17647,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17648,causes,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17649,a,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17650,variety,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17651,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17652,metabolic,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17653,diseases,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17654,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17655,cancer,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17656,.,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17872,A,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17873,growing,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17874,interest,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17875,has,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17876,emerged,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17877,in,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17878,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17879,beneficial,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17880,effects,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17881,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17882,plant,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17883,-,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17884,based,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17885,diets,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17886,for,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17887,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17888,prevention,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17889,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17890,cardiovascular,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17891,disease,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17892,",",O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17893,diabetes,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17894,and,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17895,obesity,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17896,.,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
18435,In,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18436,Wistar,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18437,rats,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18438,",",O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18439,a,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18440,daily,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18441,piece,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18442,of,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18443,chocolate,B-AG.01.n.17.a,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18444,coupled,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18445,to,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18446,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18447,onset,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18448,of,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18449,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18450,active,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18451,phase,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18452,(,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18453,breakfast,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18454,),O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18455,accelerated,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18456,re,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18457,-,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18458,entrainment,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18459,in,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18460,a,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18461,jet,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18462,-,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18463,lag,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18464,model,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18465,by,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18466,setting,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18467,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18468,activity,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18469,of,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18470,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18471,suprachiasmatic,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18472,nucleus,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18473,(,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18474,SCN,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18475,),O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18476,to,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18477,the,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18478,new,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18479,cycle,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18480,.,O,617.0,"In Wistar rats , a daily piece of chocolate coupled to the onset of the active phase ( breakfast ) accelerated re - entrainment in a jet - lag model by setting the activity of the suprachiasmatic nucleus ( SCN ) to the new cycle ."
18481,Furthermore,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18482,",",O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18483,in,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18484,a,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18485,rat,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18486,model,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18487,of,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18488,shift,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18489,-,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18490,work,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18491,",",O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18492,a,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18493,piece,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18494,of,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18495,chocolate,B-AG.01.n.17.a,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18496,for,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18497,breakfast,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18498,prevented,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18499,circadian,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18500,desynchrony,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18501,",",O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18502,by,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18503,increasing,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18504,the,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18505,amplitude,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18506,of,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18507,the,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18508,day,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18509,-,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18510,night,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18511,c,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18512,-,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18513,Fos,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18514,activation,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18515,in,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18516,the,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18517,SCN,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18518,.,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18587,Beer,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18588,is,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18589,the,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18590,most,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18591,widely,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18592,consumed,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18593,alcoholic,B-AG.01.y.01,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18594,drink,I-AG.01.y.01,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18595,in,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18596,the,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18597,world,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18598,",",O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18599,but,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18600,it,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18601,is,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18602,not,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18603,suitable,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18604,for,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18605,patients,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18606,who,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18607,suffer,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18608,from,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18609,celiac,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18610,disease,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18611,(,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18612,CD,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18613,),O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18614,because,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18615,its,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18616,main,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18617,ingresdients,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18618,",",O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18619,barley,B-AG.01.i,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18620,or,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18621,wheat,B-AG.01.i,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18622,",",O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18623,contain,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18624,gluten,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18625,.,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18733,Accordingly,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18734,",",O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18735,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18736,influential,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18737,factors,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18738,are,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18739,discussed,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18740,in,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18741,terms,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18742,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18743,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18744,total,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18745,substitution,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18746,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18747,malt,B-AG.01.ae,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18748,with,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18749,other,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18750,grains,B-AG.01.i,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18751,in,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18752,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18753,production,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18754,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18755,beer,B-AG.01.y.01.b,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18756,.,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18870,Ferulic,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18871,acid,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18872,(,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18873,FA,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18874,),O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18875,is,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18876,the,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18877,major,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18878,phenolic,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18879,compound,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18880,found,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18881,in,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18882,rice,B-AG.01.f,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18883,oil,I-AG.01.f,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18884,and,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18885,various,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18886,fruits,B-AG.01.h.01,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18887,and,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18888,vegetables,B-AG.01.h.02,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
18889,.,O,629.0,Ferulic acid ( FA ) is the major phenolic compound found in rice oil and various fruits and vegetables .
19111,Our,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19112,results,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19113,suggest,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19114,that,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19115,supplementation,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19116,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19117,FA,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19118,may,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19119,have,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19120,health,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19121,benefits,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19122,by,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19123,minimizing,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19124,the,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19125,cardiovascular,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19126,complications,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19127,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19128,MS,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19129,and,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19130,alleviating,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19131,its,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19132,symptoms,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19133,.,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19145,As,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19146,of,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19147,1991,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19148,-,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19149,1992,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19150,in,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19151,Seoul,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19152,",",O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19153,the,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19154,cumulative,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19155,rates,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19156,reported,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19157,for,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19158,the,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19159,age,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19160,span,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19161,0,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19162,-,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19163,74,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19164,were,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19165,7.6,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19166,%,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19167,in,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19168,males,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19169,and,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19170,3.1,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19171,%,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19172,in,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19173,females,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19174,.,O,638.0,"As of 1991 - 1992 in Seoul , the cumulative rates reported for the age span 0 - 74 were 7.6 % in males and 3.1 % in females ."
19302,Pickled,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19303,vegetables,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19304,increased,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19305,the,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19306,risk,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19307,",",O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19308,whereas,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19309,fresh,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19310,vegetables,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19311,did,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19312,not,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19313,.,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19355,Although,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19356,several,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19357,studies,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19358,have,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19359,assessed,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19360,the,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19361,association,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19362,between,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19363,total,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19364,fluid,B-AG.01.y,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19365,intake,B-X,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19366,",",O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19367,specific,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19368,drinks,B-AG.01.y,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19369,and,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19370,bladder,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19371,cancer,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19372,",",O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19373,no,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19374,firm,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19375,conclusions,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19376,can,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19377,yet,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19378,be,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19379,drawn,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19380,.,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19381,Four,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19382,hundred,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19383,thirty,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19384,two,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19385,bladder,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19386,cancer,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19387,cases,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19388,and,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19389,392,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19390,frequency,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19391,matched,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19392,hospital,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19393,-,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19394,based,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19395,controls,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19396,recruited,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19397,in,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19398,the,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19399,South,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19400,and,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19401,East,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19402,of,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19403,China,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19404,between,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19405,October,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19406,2005,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19407,and,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19408,June,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19409,2008,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19410,were,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19411,interviewed,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19412,on,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19413,their,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19414,intake,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19415,of,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19416,6,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19417,nonalcoholic,B-AG.01.y,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19418,and,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19419,3,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19420,alcoholic,B-AG.01.y.01,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19421,drinks,I-AG.01.y.01,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19422,.,O,648.0,Four hundred thirty two bladder cancer cases and 392 frequency matched hospital - based controls recruited in the South and East of China between October 2005 and June 2008 were interviewed on their intake of 6 nonalcoholic and 3 alcoholic drinks .
19461,For,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19462,381,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19463,cases,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19464,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19465,81.9,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19466,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19467,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19468,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19469,and,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19470,371,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19471,controls,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19472,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19473,76.3,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19474,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19475,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19476,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19477,",",O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19478,total,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19479,fluid,B-AG.01.y,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19480,intake,B-X,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19481,could,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19482,be,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19483,calculated,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19484,.,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19485,In,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19486,men,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19487,",",O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19488,an,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19489,increase,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19490,in,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19491,total,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19492,fluid,B-AG.01.y,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19493,intake,B-X,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19494,was,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19495,associated,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19496,with,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19497,a,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19498,significantly,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19499,decreased,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19500,bladder,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19501,cancer,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19502,risk,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19503,(,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19504,OR,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19505,0.93,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19506,",",O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19507,95,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19508,%,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19509,CI,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19510,:,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19511,0.88,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19512,-,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19513,0.99,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19514,",",O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19515,per,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19516,cup,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19517,fluid,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19518,consumed,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19519,),O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19520,.,O,651.0,"In men , an increase in total fluid intake was associated with a significantly decreased bladder cancer risk ( OR 0.93 , 95 % CI : 0.88 - 0.99 , per cup fluid consumed ) ."
19533,Daily,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19534,consumption,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19535,of,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19536,milk,B-AG.01.e,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19537,significantly,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19538,reduced,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19539,the,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19540,risk,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19541,of,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19542,bladder,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19543,cancer,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19544,by,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19545,a,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19546,half,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19547,(,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19548,OR,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19549,0.49,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19550,",",O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19551,95,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19552,%,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19553,CI,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19554,:,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19555,0.32,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19556,-,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19557,0.76,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19558,),O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19559,",",O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19560,which,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19561,strengthens,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19562,earlier,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19563,suggestions,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19564,that,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19565,milk,B-AG.01.e,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19566,is,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19567,probably,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19568,associated,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19569,with,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19570,a,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19571,decreased,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19572,bladder,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19573,cancer,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19574,risk,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19575,.,O,653.0,"Daily consumption of milk significantly reduced the risk of bladder cancer by a half ( OR 0.49 , 95 % CI : 0.32 - 0.76 ) , which strengthens earlier suggestions that milk is probably associated with a decreased bladder cancer risk ."
19576,Consumption,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19577,of,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19578,wine,B-AG.01.y.01.a,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19579,(,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19580,OR,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19581,0.49,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19582,",",O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19583,95,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19584,%,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19585,CI,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19586,:,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19587,0.34,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19588,-,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19589,0.70,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19590,),O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19591,and,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19592,liquor,B-AG.01.y.01,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19593,/,I-AG.01.y.01,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19594,spirits,I-AG.01.y.01,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19595,(,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19596,OR,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19597,0.65,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19598,",",O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19599,95,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19600,%,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19601,CI,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19602,:,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19603,0.47,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19604,-,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19605,0.92,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19606,),O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19607,were,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19608,associated,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19609,with,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19610,a,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19611,significantly,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19612,reduced,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19613,risk,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19614,.,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19630,There,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19631,is,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19632,no,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19633,clear,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19634,indication,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19635,that,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19636,the,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19637,risks,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19638,observed,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19639,in,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19640,this,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19641,Chinese,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19642,population,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19643,are,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19644,substantially,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19645,different,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19646,from,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19647,those,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19648,observed,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19649,in,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19650,Caucasian,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19651,populations,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19652,.,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19666,Uncontrolled,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19667,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19668,blood,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19669,pressure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19670,may,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19671,lead,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19672,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19673,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19674,shortened,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19675,life,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19676,expectancy,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19677,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19678,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19679,higher,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19680,morbidity,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19681,due,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19682,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19683,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19684,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19685,risk,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19686,of,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19687,cardiovascular,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19688,complications,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19689,such,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19690,as,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19691,coronary,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19692,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19693,disease,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19694,(,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19695,which,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19696,leads,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19697,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19698,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19699,attack,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19700,),O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19701,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19702,stroke,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19703,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19704,congestive,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19705,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19706,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19707,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19708,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19709,rhythm,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19710,irregularities,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19711,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19712,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19713,kidney,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19714,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19715,etc,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19716,.,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19966,Moreover,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19967,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19968,substantial,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19969,experimental,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19970,studies,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19971,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19972,supported,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19973,the,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19974,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19975,role,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19976,of,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19977,fruits,B-AG.01.h.01,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19978,against,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19979,CVDs,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19980,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19981,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19982,several,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19983,fruits,B-AG.01.h.01,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19984,(,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19985,grape,B-AG.01.h.01.b,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19986,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19987,blueberry,B-AG.01.h.01.b,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19988,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19989,pomegranate,B-AG.01.h.01,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19990,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19991,apple,B-AG.01.h.01.c,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19992,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19993,hawthorn,B-AG.01.h.01.b,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19994,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19995,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19996,avocado,B-AG.01.h.01.e,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19997,),O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19998,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19999,been,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20000,widely,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20001,studied,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20002,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20003,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20004,shown,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20005,potent,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20006,cardiovascular,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20007,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20008,action,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20009,.,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20523,Moreover,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20524,",",O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20525,subjects,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20526,who,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20527,had,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20528,been,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20529,directly,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20530,weaned,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20531,from,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20532,mother,B-AG.01,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20533,'s,I-AG.01,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20534,milk,I-AG.01,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20535,on,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20536,to,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20537,an,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20538,adult,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20539,diet,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20540,were,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20541,found,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20542,to,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20543,be,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20544,at,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20545,higher,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20546,risk,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20547,for,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20548,NPC,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20549,.,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20574,After,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20575,the,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20576,discovery,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20577,of,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20578,America,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20579,",",O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20580,chocolate,B-AG.01.n.17.a,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20581,was,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20582,introduced,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20583,in,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20584,Europe,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20585,",",O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20586,but,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20587,Christian,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20588,Europe,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20589,looked,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20590,to,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20591,this,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20592,new,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20593,exhilarating,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20594,drink,B-AG.01.y,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20595,with,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20596,extreme,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20597,suspiciousness,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20598,and,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20599,criticism,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20600,.,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
21269,Cows,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21270,with,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21271,chronic,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21272,mastitis,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21273,",",O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21274,measured,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21275,by,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21276,increased,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21277,consecutive,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21278,test,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21279,days,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21280,with,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21281,SCC,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21282,"≥100,000",O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21283,cells,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21284,/,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21285,mL,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21286,",",O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21287,resulted,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21288,in,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21289,higher,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21290,milk,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21291,losses,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21292,than,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21293,cows,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21294,with,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21295,a,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21296,new,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21297,infection,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21298,.,O,706.0,"Cows with chronic mastitis , measured by increased consecutive test days with SCC ≥100,000 cells / mL , resulted in higher milk losses than cows with a new infection ."
21327,Oral,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21328,and,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21329,external,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21330,dosing,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21331,methods,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21332,replicating,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21333,field,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21334,exposure,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21335,were,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21336,developed,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21337,using,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21338,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21339,double,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21340,crested,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21341,cormorant,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21342,(,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21343,DCCO,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21344,),O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21345,to,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21346,test,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21347,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21348,toxicity,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21349,of,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21350,artificially,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21351,weathered,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21352,Deepwater,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21353,Horizon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21354,Mississippi,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21355,Canyon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21356,252,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21357,oil,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21358,.,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21384,However,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21385,",",O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21386,rapid,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21387,gut,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21388,transit,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21389,time,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21390,of,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21391,gavaged,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21392,oil,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21393,likely,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21394,reduces,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21395,oil,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21396,absorption,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21397,.,O,710.0,"However , rapid gut transit time of gavaged oil likely reduces oil absorption ."
21529,Birds,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21530,exposed,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21531,to,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21532,oil,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21533,externally,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21534,consumed,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21535,more,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21536,fish,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21537,than,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21538,control,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21539,birds,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21540,",",O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21541,indicating,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21542,metabolic,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21543,compensation,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21544,for,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21545,thermal,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21546,stress,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21547,.,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21658,Databases,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21659,including,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21660,Medline,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21661,",",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21662,Scopus,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21663,",",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21664,Science,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21665,Direct,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21666,",",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21667,Embase,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21668,",",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21669,PubMed,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21670,Central,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21671,and,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21672,Google,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21673,scholar,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21674,were,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21675,searched,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21676,using,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21677,the,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21678,key,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21679,words,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21680,"""",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21681,cinnamon,B-AG.01.l.03,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21682,"""",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21683,or,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21684,"""",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21685,cinnamomum,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21686,"""",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21687,for,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21688,clinical,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21689,trials,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21690,",",O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21691,case,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21692,reports,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21693,and,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21694,case,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21695,series,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21696,.,O,720.0,"Databases including Medline , Scopus , Science Direct , Embase , PubMed Central and Google scholar were searched using the key words "" cinnamon "" or "" cinnamomum "" for clinical trials , case reports and case series ."
21774,The,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21775,available,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21776,data,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21777,suggests,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21778,that,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21779,despite,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21780,the,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21781,safety,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21782,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21783,cinnamon,B-AG.01.l.03,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21784,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21785,as,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21786,a,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21787,spice,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21788,and/or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21789,flavoring,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21790,agent,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21791,",",O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21792,its,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21793,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21794,may,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21795,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21796,associated,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21797,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21798,significant,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21799,adverse,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21800,effects,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21801,in,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21802,medicinal,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21803,uses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21804,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21805,larger,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21806,doses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21807,or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21808,longer,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21809,duration,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21810,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21811,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21812,and,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21813,should,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21814,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21815,clinically,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21816,monitored,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21817,.,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21818,Biogenic,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21819,amines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21820,have,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21821,been,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21822,reported,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21823,in,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21824,a,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21825,variety,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21826,of,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21827,foods,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21828,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21829,such,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21830,as,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21831,fish,B-AG.01.d.07,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21832,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21833,meat,B-AG.01.d,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21834,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21835,cheese,B-AG.01.e.02,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21836,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21837,vegetables,B-AG.01.h.02,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21838,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21839,and,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21840,wines,B-AG.01.y.01.a,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21841,.,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21860,The,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21861,most,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21862,common,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21863,biogenic,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21864,amines,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21865,found,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21866,in,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21867,foods,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21868,are,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21869,histamine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21870,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21871,tyramine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21872,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21873,cadaverine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21874,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21875,2,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21876,-,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21877,phenylethylamine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21878,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21879,spermine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21880,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21881,spermidine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21882,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21883,putrescine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21884,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21885,tryptamine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21886,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21887,and,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21888,agmatine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21889,.,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
22031,Histamine,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22032,may,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22033,potentially,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22034,be,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22035,degraded,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22036,by,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22037,the,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22038,use,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22039,of,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22040,bacterial,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22041,amine,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22042,oxidase,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22043,or,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22044,amine,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22045,-,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22046,negative,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22047,bacteria,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22048,.,O,735.0,Histamine may potentially be degraded by the use of bacterial amine oxidase or amine - negative bacteria .
22077,Biological,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22078,activities,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22079,associated,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22080,with,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22081,mango,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22082,fractions,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22083,were,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22084,assessed,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22085,in,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22086,cell,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22087,-,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22088,based,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22089,assays,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22090,to,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22091,develop,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22092,effective,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22093,extraction,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22094,and,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22095,fractionation,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22096,methodologies,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22097,and,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22098,to,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22099,define,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22100,sources,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22101,of,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22102,variability,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22103,.,O,738.0,Biological activities associated with mango fractions were assessed in cell - based assays to develop effective extraction and fractionation methodologies and to define sources of variability .
22104,Two,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22105,techniques,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22106,were,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22107,developed,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22108,for,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22109,extraction,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22110,and,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22111,fractionation,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22112,of,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22113,mango,B-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22114,fruit,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22115,peel,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22116,and,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22117,flesh,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22118,.,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22119,Liquid,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22120,chromatography,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22121,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22122,mass,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22123,spectrometry,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22124,(,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22125,LC,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22126,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22127,MS,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22128,),O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22129,was,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22130,used,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22131,to,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22132,assess,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22133,compositional,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22134,differences,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22135,between,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22136,mango,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22137,fractions,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22138,in,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22139,flesh,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22140,extracts,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22141,.,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22766,Slices,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22767,were,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22768,fried,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22769,using,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22770,equivalent,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22771,thermal,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22772,driving,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22773,forces,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22774,",",O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22775,maintaining,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22776,a,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22777,constant,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22778,difference,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22779,between,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22780,oil,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22781,temperature,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22782,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22783,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22784,boiling,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22785,point,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22786,of,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22787,water,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22788,at,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22789,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22790,working,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22791,pressure,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22792,(,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22793,ΔT,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22794,=,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22795,60,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22796,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22797,80,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22798,°,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22799,C,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22800,),O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22801,.,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
23081,LDL,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23082,vitamin,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23083,E,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23084,levels,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23085,were,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23086,highest,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23087,in,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23088,rabbits,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23089,fed,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23090,corn,B-AG.01.f,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23091,oil,I-AG.01.f,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23092,with,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23093,added,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23094,cholesterol,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23095,.,O,772.0,LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol .
23721,Changes,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23722,in,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23723,our,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23724,understanding,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23725,of,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23726,diet,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23727,and,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23728,health,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23729,drive,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23730,changes,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23731,in,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23732,the,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23733,way,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23734,foods,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23735,are,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23736,processed,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23737,.,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
24067,Here,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24068,",",O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24069,disruption,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24070,was,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24071,not,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24072,a,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24073,chemical,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24074,disruption,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24075,",",O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24076,rather,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24077,a,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24078,physical,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24079,disruption,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24080,of,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24081,protein,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24082,curds,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24083,.,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24348,In,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24349,childhood,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24350,calcium,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24351,",",O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24352,phosphorous,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24353,",",O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24354,and,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24355,growth,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24356,factors,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24357,are,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24358,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24359,important,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24360,components,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24361,to,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24362,support,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24363,bone,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24364,growth,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24365,but,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24366,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24367,adults,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24368,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24369,positive,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24370,influence,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24371,on,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24372,bone,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24373,density,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24374,/,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24375,maintenance,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24376,may,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24377,also,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24378,be,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24379,due,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24380,to,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24381,other,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24382,bioactive,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24383,proteins,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24384,/,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24385,peptides,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24386,or,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24387,lipids,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24388,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24389,milk,B-AG.01.e,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24390,acting,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24391,directly,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24392,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24393,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24394,gastrointestinal,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24395,tract,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24396,(,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24397,GIT,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24398,),O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24399,.,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24573,Salt,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24574,tea,B-AG.01.ac,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24575,is,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24576,the,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24577,most,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24578,commonly,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24579,used,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24580,beverage,B-AG.01.y,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24581,in,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24582,Kashmir,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24583,",",O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24584,India,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24585,",",O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24586,where,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24587,esophageal,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24588,squamous,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24589,cell,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24590,carcinoma,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24591,(,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24592,ESCC,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24593,),O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24594,is,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24595,the,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24596,most,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24597,common,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24598,cancer,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
24599,.,O,829.0,"Salt tea is the most commonly used beverage in Kashmir , India , where esophageal squamous cell carcinoma ( ESCC ) is the most common cancer ."
25461,Asthma,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25462,induced,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25463,by,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25464,cereal,B-AG.01.k,857.0,Asthma induced by cereal flour is a long recognized entity .
25465,flour,I-AG.01.k,857.0,Asthma induced by cereal flour is a long recognized entity .
25466,is,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25467,a,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25468,long,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25469,recognized,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25470,entity,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25471,.,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25541,Bronchial,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25542,provocation,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25543,tests,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25544,(,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25545,BPT,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25546,),O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25547,with,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25548,wheat,B-AG.01.k,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25549,flour,I-AG.01.k,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25550,(,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25551,patients,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25552,1,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25553,and,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25554,2,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25555,),O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25556,and,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25557,barley,B-AG.01.k,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25558,flour,I-AG.01.k,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25559,(,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25560,patient,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25561,3,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25562,),O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25563,all,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25564,showed,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25565,immediate,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25566,responses,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25567,.,O,861.0,Bronchial provocation tests ( BPT ) with wheat flour ( patients 1 and 2 ) and barley flour ( patient 3 ) all showed immediate responses .
25856,Olive,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25857,fruit,B-AG.01.h.01.e,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25858,is,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25859,a,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25860,significant,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25861,and,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25862,promising,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25863,source,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25864,of,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25865,potential,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25866,bioactive,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25867,compounds,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25868,such,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25869,as,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25870,oleuropein,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25871,and,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25872,hydroxytyrosol,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25873,.,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25970,Hydroxytyrosol,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25971,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25972,oleuropein,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25973,inhibited,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25974,the,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25975,multiple,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25976,stages,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25977,in,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25978,colon,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25979,carcinogenesis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25980,;,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25981,initiation,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25982,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25983,promotion,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25984,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25985,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25986,metastasis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25987,.,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
26236,Moderate,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26237,beer,B-AG.01.y.01.b,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26238,consumption,B-X,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26239,has,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26240,also,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26241,been,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26242,associated,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26243,with,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26244,these,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26245,effects,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26246,",",O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26247,but,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26248,to,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26249,a,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26250,lesser,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26251,degree,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26252,",",O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26253,probably,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26254,because,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26255,of,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26256,beer,B-AG.01.y.01.b,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26257,'s,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26258,lower,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26259,phenolic,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26260,content,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26261,.,O,888.0,"Moderate beer consumption has also been associated with these effects , but to a lesser degree , probably because of beer 's lower phenolic content ."
26468,The,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26469,literature,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26470,reviews,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26471,revealed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26472,similar,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26473,aspects,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26474,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26475,the,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26476,challenges,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26477,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26478,smallholder,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26479,crop,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26480,-,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26481,livestock,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26482,mixed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26483,farming,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26484,systems,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26485,in,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26486,both,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26487,countries,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26488,.,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26784,The,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26785,experiment,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26786,was,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26787,conducted,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26788,in,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26789,the,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26790,summer,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26791,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26792,2006,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26793,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26794,involved,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26795,24,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26796,Friesian,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26797,cows,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26798,that,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26799,were,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26800,divided,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26801,into,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26802,3,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26803,groups,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26804,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26805,8,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26806,animals,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26807,according,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26808,to,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26809,different,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26810,type,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26811,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26812,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26813,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26814,:,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26815,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26816,traditional,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26817,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26818,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26819,no,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26820,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26821,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26822,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26823,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26824,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26825,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26826,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26827,whole,B-AG.01,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26828,flaxseed,I-AG.01,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26829,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26830,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26831,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26832,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26833,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26834,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26835,fish,B-AG.01.f,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26836,oil,I-AG.01.f,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26837,.,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
27004,In,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27005,conclusion,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27006,",",O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27007,flaxseed,B-AG.01,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27008,supplementation,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27009,improves,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27010,composition,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27011,and,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27012,nutritional,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27013,properties,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27014,of,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27015,milk,B-AG.01.e,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27016,from,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27017,cows,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27018,milked,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27019,during,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27020,times,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27021,of,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27022,high,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27023,ambient,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27024,temperature,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27025,.,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27148,Fish,B-AG.01.f,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27149,oil,I-AG.01.f,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27150,intensified,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27151,oxidation,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27152,associated,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27153,with,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27154,age,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27155,",",O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27156,lowered,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27157,electron,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27158,transport,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27159,chain,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27160,activity,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27161,and,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27162,enhanced,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27163,the,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27164,relative,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27165,telomere,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27166,length,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27167,.,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27203,Sunflower,B-AG.01.f,924.0,Sunflower oil avoided gene expression changes related to age .
27204,oil,I-AG.01.f,924.0,Sunflower oil avoided gene expression changes related to age .
27205,avoided,O,924.0,Sunflower oil avoided gene expression changes related to age .
27206,gene,O,924.0,Sunflower oil avoided gene expression changes related to age .
27207,expression,O,924.0,Sunflower oil avoided gene expression changes related to age .
27208,changes,O,924.0,Sunflower oil avoided gene expression changes related to age .
27209,related,O,924.0,Sunflower oil avoided gene expression changes related to age .
27210,to,O,924.0,Sunflower oil avoided gene expression changes related to age .
27211,age,O,924.0,Sunflower oil avoided gene expression changes related to age .
27212,.,O,924.0,Sunflower oil avoided gene expression changes related to age .
28303,Consumption,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28304,of,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28305,other,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28306,very,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28307,hot,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28308,beverages,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28309,",",O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28310,such,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28311,as,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28312,tea,B-AG.01.ac,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28313,and,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28314,coffee,B-AG.01.ad,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28315,with,I-AG.01.ad,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28316,milk,I-AG.01.ad,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28317,but,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28318,not,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28319,coffee,B-AG.01.ad,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28320,alone,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28321,",",O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28322,was,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28323,also,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28324,significantly,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28325,associated,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28326,with,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28327,an,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28328,increased,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28329,risk,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28330,",",O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28331,in,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28332,the,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28333,2-,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28334,to,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28335,4,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28336,-,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28337,fold,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28338,range,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28339,.,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28500,The,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28501,importance,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28502,of,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28503,β,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28504,-,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28505,glucans,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28506,in,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28507,food,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28508,processing,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28509,industries,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28510,such,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28511,as,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28512,bread,B-AG.01.n.11,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28513,preparation,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28514,",",O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28515,yogurt,B-AG.01.e,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28516,and,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28517,pasta,B-AG.01.i,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28518,have,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28519,been,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28520,well,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28521,elucidated,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28522,.,O,966.0,"The importance of β - glucans in food processing industries such as bread preparation , yogurt and pasta have been well elucidated ."
28523,In,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28524,recent,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28525,findings,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28526,on,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28527,food,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28528,science,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28529,research,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28530,gut,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28531,microbiota,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28532,plays,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28533,a,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28534,significant,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28535,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28536,and,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28537,vastly,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28538,studied,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28539,for,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28540,its,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28541,intermediate,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28542,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28543,in,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28544,regulating,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28545,health,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28546,.,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
29088,Mixed,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29089,findings,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29090,were,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29091,observed,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29092,for,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29093,breast,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29094,",",O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29095,esophageal,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29096,",",O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29097,gastric,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29098,",",O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29099,liver,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29100,and,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29101,a,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29102,mostly,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29103,nan,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29104,association,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29105,for,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29106,colorectal,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29107,",",O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29108,pancreatic,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29109,",",O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29110,and,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29111,prostate,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29112,cancer,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29113,.,O,985.0,"Mixed findings were observed for breast , esophageal , gastric , liver and a mostly nan association for colorectal , pancreatic , and prostate cancer ."
29402,Adults,O,997.0,Adults often consume more fat than is recommended .
29403,often,O,997.0,Adults often consume more fat than is recommended .
29404,consume,O,997.0,Adults often consume more fat than is recommended .
29405,more,O,997.0,Adults often consume more fat than is recommended .
29406,fat,O,997.0,Adults often consume more fat than is recommended .
29407,than,O,997.0,Adults often consume more fat than is recommended .
29408,is,O,997.0,Adults often consume more fat than is recommended .
29409,recommended,O,997.0,Adults often consume more fat than is recommended .
29410,.,O,997.0,Adults often consume more fat than is recommended .
29603,FF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29604,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29605,RFS,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29606,conditions,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29607,were,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29608,liked,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29609,more,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29610,than,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29611,RF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29612,for,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29613,the,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29614,breakfast,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29615,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29616,lunch,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29617,meals,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29618,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29619,French,B-AG.01.n,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29620,toast,I-AG.01.n,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29621,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29622,chicken,B-AG.01.d.06,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29623,entrée,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29624,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29625,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29626,vegetables,B-AG.01.h.02,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29627,.,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29628,Liking,O,1004.0,Liking of all 3 sausage conditions was similar .
29629,of,O,1004.0,Liking of all 3 sausage conditions was similar .
29630,all,O,1004.0,Liking of all 3 sausage conditions was similar .
29631,3,O,1004.0,Liking of all 3 sausage conditions was similar .
29632,sausage,O,1004.0,Liking of all 3 sausage conditions was similar .
29633,conditions,O,1004.0,Liking of all 3 sausage conditions was similar .
29634,was,O,1004.0,Liking of all 3 sausage conditions was similar .
29635,similar,O,1004.0,Liking of all 3 sausage conditions was similar .
29636,.,O,1004.0,Liking of all 3 sausage conditions was similar .
29705,Herbs,B-AG.01.h.02.i,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29706,and,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29707,spices,B-AG.01.l.03,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29708,may,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29709,be,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29710,useful,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29711,for,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29712,improving,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29713,the,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29714,liking,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29715,of,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29716,lower,B-AG.01,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29717,fat,I-AG.01,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29718,foods,I-AG.01,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29719,and,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29720,helping,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29721,Americans,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29722,maintain,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29723,a,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29724,diet,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29725,consistent,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29726,with,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29727,the,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29728,U.S.,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29729,Dietary,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29730,Guidelines,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29731,.,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29851,Although,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29852,the,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29853,H,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29854,diet,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29855,provoked,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29856,dislipemia,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29857,related,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29858,to,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29859,steatosis,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29860,",",O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29861,no,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29862,changes,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29863,in,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29864,isoprostanes,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29865,or,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29866,liver,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29867,malondialdehyde,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29868,(,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29869,MDA,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29870,),O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29871,were,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29872,observed,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29873,.,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29976,Immunoblot,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29977,results,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29978,revealed,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29979,two,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29980,major,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29981,allergens,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29982,of,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29983,28,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29984,and,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29985,60,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29986,kDa,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29987,in,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29988,pepper,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29989,and,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29990,a,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29991,23,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29992,-,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29993,kDa,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29994,allergen,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29995,together,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29996,with,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29997,allergens,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29998,of,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29999,higher,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30000,molecular,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30001,weight,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30002,in,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30003,paprika,B-AG.01.l.03,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30004,.,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30277,This,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30278,longitudinal,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30279,study,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30280,of,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30281,503,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30282,households,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30283,with,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30284,a,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30285,child,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30286,under,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30287,24,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30288,months,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30289,at,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30290,enrolment,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30291,was,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30292,conducted,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30293,in,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30294,villages,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30295,of,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30296,Manyoni,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30297,District,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30298,",",O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30299,Tanzania,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30300,between,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30301,May,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30302,2014,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30303,",",O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30304,and,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30305,May,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30306,2016,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30307,.,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30996,For,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
30997,7,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
30998,of,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
30999,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31000,genes,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31001,",",O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31002,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31003,modulation,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31004,by,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31005,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31006,mixture,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31007,was,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31008,due,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31009,to,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31010,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31011,effect,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31012,of,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31013,a,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31014,particular,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31015,vegetable,B-AG.01.h.02,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31016,.,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31273,In,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31274,this,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31275,study,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31276,",",O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31277,total,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31278,lipids,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31279,(,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31280,TL,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31281,),O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31282,of,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31283,Greek,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31284,olive,B-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31285,oils,I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31286,and,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31287,seed,B-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31288,oils,I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31289,of,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31290,four,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31291,kinds,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31292,",",O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31293,namely,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31294,",",O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31295,soybean,B-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31296,",",I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31297,corn,I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31298,",",I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31299,sunflower,I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31300,",",I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31301,and,I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31302,sesame,I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31303,oil,I-AG.01.f,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31304,",",O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31305,were,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31306,separated,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31307,into,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31308,total,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31309,polar,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31310,lipids,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31311,(,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31312,TPL,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31313,),O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31314,and,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31315,total,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31316,neutral,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31317,lipids,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31318,(,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31319,TNL,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31320,),O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31321,via,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31322,a,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31323,novel,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31324,extraction,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31325,procedure,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31326,.,O,1058.0,"In this study , total lipids ( TL ) of Greek olive oils and seed oils of four kinds , namely , soybean , corn , sunflower , and sesame oil , were separated into total polar lipids ( TPL ) and total neutral lipids ( TNL ) via a novel extraction procedure ."
31327,TPL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31328,and,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31329,TNL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31330,of,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31331,olive,B-AG.01.f,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31332,oil,I-AG.01.f,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31333,were,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31334,fractionated,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31335,by,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31336,HPLC,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31337,for,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31338,further,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31339,study,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31340,.,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31429,Because,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31430,it,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31431,has,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31432,already,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31433,been,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31434,reported,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31435,that,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31436,PAF,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31437,plays,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31438,a,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31439,pivotal,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31440,role,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31441,in,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31442,atherogenesis,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31443,",",O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31444,the,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31445,existence,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31446,of,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31447,PAF,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31448,agonists,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31449,and,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31450,antagonists,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31451,in,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31452,vegetable,B-AG.01.f,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31453,oils,I-AG.01.f,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31454,may,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31455,explain,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31456,their,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31457,protective,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31458,role,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31459,against,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31460,atherosclerosis,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
31461,.,O,1063.0,"Because it has already been reported that PAF plays a pivotal role in atherogenesis , the existence of PAF agonists and antagonists in vegetable oils may explain their protective role against atherosclerosis ."
32336,A,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32337,lot,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32338,of,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32339,research,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32340,has,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32341,be,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32342,conducted,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32343,in,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32344,the,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32345,functionalities,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32346,and,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32347,properties,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32348,of,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32349,buckwheat,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32350,proteins,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32351,",",O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32352,flavonoids,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32353,",",O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32354,flavones,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32355,",",O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32356,phytosterols,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32357,",",O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32358,thiamin,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32359,-,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32360,binding,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32361,proteins,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32362,",",O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32363,and,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32364,other,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32365,rare,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32366,compounds,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32367,in,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32368,buckwheat,B-AG.01.i,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32369,seeds,I-AG.01.i,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32370,.,O,1100.0,"A lot of research has be conducted in the functionalities and properties of buckwheat proteins , flavonoids , flavones , phytosterols , thiamin - binding proteins , and other rare compounds in buckwheat seeds ."
32466,Some,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32467,possible,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32468,mechanisms,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32469,involved,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32470,in,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32471,these,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32472,effects,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32473,are,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32474,discussed,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32475,in,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32476,this,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32477,review,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32478,.,O,1104.0,Some possible mechanisms involved in these effects are discussed in this review .
32545,The,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32546,authors,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32547,conducted,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32548,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32549,case,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32550,-,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32551,control,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32552,study,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32553,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32554,Hawaii,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32555,and,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32556,Los,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32557,Angeles,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32558,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32559,California,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32560,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32561,to,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32562,examine,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32563,several,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32564,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32565,hypotheses,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32566,regarding,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32567,the,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32568,etiology,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32569,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32570,ovarian,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32571,cancer,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32572,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32573,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32574,population,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32575,with,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32576,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32577,broad,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32578,range,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32579,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32580,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32581,intakes,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32582,.,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
33122,We,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33123,developed,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33124,a,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33125,',O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33126,dietary,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33127,gap,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33128,assessment,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33129,',O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33130,to,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33131,evaluate,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33132,the,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33133,degree,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33134,to,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33135,which,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33136,a,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33137,nation,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33138,'s,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33139,food,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33140,supply,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33141,could,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33142,support,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33143,healthy,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33144,diets,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33145,at,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33146,the,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33147,population,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33148,level,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
33149,.,O,1124.0,We developed a ' dietary gap assessment ' to evaluate the degree to which a nation 's food supply could support healthy diets at the population level .
34102,Stepwise,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34103,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34104,multiple,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34105,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34106,regression,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34107,analysis,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34108,revealed,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34109,that,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34110,milk,B-AG.01.e,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34111,+,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34112,cheese,B-AG.01.e.02,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34113,(,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34114,1961,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34115,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34116,65,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34117,),O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34118,made,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34119,a,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34120,significant,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34121,contribution,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34122,to,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34123,the,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34124,incidence,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34125,of,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34126,testicular,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34127,cancer,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34128,(,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34129,standardized,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34130,regression,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34131,coefficient,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34132,[,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34133,R,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34134,],O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34135,=,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34136,0.654,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34137,),O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34138,.,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
35300,This,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35301,walnut,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35302,ELISA,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35303,can,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35304,be,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35305,used,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35306,to,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35307,detect,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35308,undeclared,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35309,walnut,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35310,residues,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35311,in,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35312,foods,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35313,and,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35314,ingredients,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35315,and,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35316,as,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35317,a,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35318,tool,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35319,to,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35320,validate,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35321,the,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35322,effectiveness,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35323,of,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35324,allergen,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35325,control,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35326,programs,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35327,for,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35328,walnuts,B-AG.01.h.01.f,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35329,.,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35339, ,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35340,Some,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35341,studies,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35342,find,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35343,galactose,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35344,to,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35345,be,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35346,toxic,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35347,to,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35348,oocytes,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35349,which,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35350,renders,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35351,ovaries,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35352,susceptible,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35353,to,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35354,cancer,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35355,.,O,1205.0,  Some studies find galactose to be toxic to oocytes which renders ovaries susceptible to cancer .
35781,The,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35782,influence,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35783,of,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35784,mastitis,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35785,on,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35786,milk,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35787,perchlorate,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35788,levels,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35789,",",O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35790,where,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35791,there,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35792,is,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35793,an,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35794,increase,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35795,in,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35796,mammary,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35797,vascular,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35798,permeability,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35799,and,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35800,an,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35801,influx,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35802,of,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35803,blood,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35804,-,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35805,derived,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35806,components,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35807,into,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35808,milk,B-AG.01.e,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35809,",",O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35810,remains,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35811,unknown,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35812,.,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35863,Five,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35864,days,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35865,after,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35866,the,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35867,initiation,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35868,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35869,ruminal,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35870,infusions,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35871,",",O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35872,experimental,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35873,mastitis,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35874,was,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35875,induced,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35876,by,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35877,the,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35878,intramammary,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35879,infusion,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35880,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35881,100,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35882,microg,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35883,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35884,bacterial,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35885,lipopolysaccharide,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35886,(,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35887,LPS,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35888,),O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35889,.,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
36076,To,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36077,address,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36078,this,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36079,issue,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36080,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36081,five,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36082,common,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36083,cereal,B-AG.01.i,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36084,brans,I-AG.01.i,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36085,(,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36086,barley,B-AG.01.i,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36087,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36088,corn,B-AG.01.i,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36089,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36090,oat,B-AG.01.i,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36091,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36092,rice,B-AG.01.i,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36093,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36094,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36095,wheat,B-AG.01.i,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36096,),O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36097,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36098,five,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36099,vegetable,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36100,fiber,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36101,isolates,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36102,(,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36103,broccoli,B-AG.01.h.02.d,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36104,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36105,cabbage,B-AG.01.h.02.d,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36106,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36107,carrot,B-AG.01.h.02.a,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36108,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36109,cauliflower,B-AG.01.h.02.d,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36110,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36111,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36112,lettuce,B-AG.01.h.02.c,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36113,),O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36114,were,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36115,fermented,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36116,in,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36117,vitro,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36118,with,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36119,human,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36120,fecal,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36121,microbiota,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36122,for,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36123,4,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36124,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36125,8,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36126,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36127,12,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36128,",",O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36129,and,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36130,24,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36131,hours,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36132,.,O,1236.0,"To address this issue , five common cereal brans ( barley , corn , oat , rice , and wheat ) and five vegetable fiber isolates ( broccoli , cabbage , carrot , cauliflower , and lettuce ) were fermented in vitro with human fecal microbiota for 4 , 8 , 12 , and 24 hours ."
36405,There,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36406,were,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36407,significant,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36408,reductions,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36409,in,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36410,the,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36411,intake,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36412,of,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36413,table,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36414,fat,B-AG.01.f,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36415,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36416,high,B-AG.01.e,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36417,-,I-AG.01.e,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36418,fat,I-AG.01.e,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36419,milk,I-AG.01.e,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36420,products,I-AG.01.e,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36421,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36422,pork,B-AG.01.d.05,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36423,and,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36424,sausages,B-AG.01.n.05,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36425,(,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36426,containing,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36427,greater,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36428,than,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36429,11,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36430,%,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36431,fat,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36432,),O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36433,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36434,eggs,B-AG.01.g,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36435,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36436,rice,B-AG.01.i,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36437,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36438,pasta,B-AG.01.i,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36439,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36440,cakes,B-AG.01.n.13,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36441,and,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36442,chocolate,B-AG.01.n.17.a,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36443,for,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36444,the,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36445,intervention,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36446,group,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36447,.,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36612,Patterns,O,1252.0,Patterns of cancer are also changing .
36613,of,O,1252.0,Patterns of cancer are also changing .
36614,cancer,O,1252.0,Patterns of cancer are also changing .
36615,are,O,1252.0,Patterns of cancer are also changing .
36616,also,O,1252.0,Patterns of cancer are also changing .
36617,changing,O,1252.0,Patterns of cancer are also changing .
36618,.,O,1252.0,Patterns of cancer are also changing .
36755,Such,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36756,a,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36757,nutritional,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36758,state,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36759,reflects,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36760,avoiding,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36761,excess,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36762,adiposity,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36763,through,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36764,healthy,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36765,dietary,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36766,patterns,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36767,rich,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36768,in,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36769,plant,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36770,foods,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36771,(,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36772,legumes,B-AG.01.h.02.g,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36773,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36774,wholegrains,B-AG.01.i,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36775,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36776,pulses,B-AG.01.h.02.g,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36777,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36778,vegetables,B-AG.01.h.02,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36779,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36780,fruits,B-AG.01.h.01,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36781,),O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36782,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36783,with,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36784,modest,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36785,meat,B-AG.01.d,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36786,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36787,fish,B-AG.01.d.07,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36788,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36789,dairy,B-AG.01.e,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36790,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36791,low,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36792,in,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36793,alcohol,B-AG.01.y.01,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36794,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36795,salt,B-AG.01,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36796,preserved,I-AG.01,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36797,foods,I-AG.01,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36798,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36799,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36800,an,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36801,active,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36802,way,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36803,of,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36804,life,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36805,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36806,avoiding,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36807,sedentary,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36808,behaviours,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36809,.,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36974,Many,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36975,herbal,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36976,medicines,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36977,are,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36978,used,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36979,in,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36980,traditional,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36981,medicine,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36982,for,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36983,their,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36984,protective,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36985,and,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36986,therapeutic,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36987,properties,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36988,against,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36989,liver,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36990,diseases,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36991,.,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
37083,This,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37084,review,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37085,aims,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37086,to,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37087,critically,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37088,analyze,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37089,the,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37090,available,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37091,literature,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37092,regarding,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37093,the,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37094,hepatoprotective,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37095,effects,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37096,of,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37097,QE,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37098,with,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37099,special,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37100,emphasis,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37101,on,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37102,its,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37103,mechanisms,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37104,of,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37105,actions,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37106,.,O,1268.0,This review aims to critically analyze the available literature regarding the hepatoprotective effects of QE with special emphasis on its mechanisms of actions .
37126,Overall,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37127,",",O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37128,data,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37129,in,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37130,literature,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37131,shows,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37132,that,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37133,QE,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37134,appears,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37135,to,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37136,be,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37137,a,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37138,promising,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37139,hepatoprotective,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37140,compound,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37141,.,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37476,Data,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37477,from,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37478,balance,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37479,studies,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37480,of,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37481,healthy,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37482,white,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37483,women,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37484,at,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37485,midlife,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37486,were,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37487,reviewed,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37488,to,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37489,assess,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37490,the,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37491,effect,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37492,of,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37493,diet,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37494,potassium,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37495,on,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37496,the,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37497,calcium,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37498,economy,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37499,under,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37500,steady,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37501,-,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37502,state,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37503,conditions,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37504,.,O,1283.0,Data from balance studies of healthy white women at midlife were reviewed to assess the effect of diet potassium on the calcium economy under steady - state conditions .
37864,In,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37865,bacon,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37866,-,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37867,fed,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37868,rats,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37869,",",O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37870,the,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37871,amount,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37872,of,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37873,NOC,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37874,input,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37875,(,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37876,diet,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37877,),O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37878,and,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37879,output,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37880,(,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37881,feces,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37882,),O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37883,was,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37884,similar,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37885,.,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
38060,The,O,1306.0,The molecular mechanism is still unresolved .
38061,molecular,O,1306.0,The molecular mechanism is still unresolved .
38062,mechanism,O,1306.0,The molecular mechanism is still unresolved .
38063,is,O,1306.0,The molecular mechanism is still unresolved .
38064,still,O,1306.0,The molecular mechanism is still unresolved .
38065,unresolved,O,1306.0,The molecular mechanism is still unresolved .
38066,.,O,1306.0,The molecular mechanism is still unresolved .
38107,Recent,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38108,studies,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38109,have,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38110,identified,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38111,a,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38112,health,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38113,promoting,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38114,mechanism,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38115,common,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38116,to,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38117,coffee,B-AG.01.ad,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38118,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38119,vegetables,B-AG.01.h.02,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38120,and,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38121,fruits,B-AG.01.h.01,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38122,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38123,i.e.,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38124,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38125,the,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38126,activation,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38127,of,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38128,an,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38129,adaptive,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38130,cellular,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38131,response,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38132,characterized,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38133,by,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38134,the,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38135,upregulation,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38136,of,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38137,proteins,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38138,involved,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38139,in,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38140,cell,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38141,protection,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38142,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38143,notably,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38144,antioxidant,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38145,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38146,detoxifying,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38147,and,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38148,repair,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38149,enzymes,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38150,.,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38810,Associations,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38811,by,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38812,type,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38813,of,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38814,alcohol,B-AG.01.y.01,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38815,consumed,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38816,(,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38817,wine,B-AG.01.y.01.a,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38818,",",O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38819,beer,B-AG.01.y.01.b,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38820,and,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38821,liquor,B-AG.01.y.01,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38822,),O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38823,were,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38824,also,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38825,investigated,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38826,.,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
39005,Confounding,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39006,in,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39007,relation,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39008,to,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39009,the,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39010,non,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39011,-,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39012,drinker,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39013,reference,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39014,category,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39015,may,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39016,be,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39017,of,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39018,particular,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39019,importance,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39020,.,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39135,In,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39136,crossed,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39137,radioimmunoelectrophoresis,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39138,(,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39139,CRIE,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39140,),O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39141,none,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39142,of,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39143,the,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39144,precipitates,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39145,could,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39146,be,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39147,shown,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39148,to,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39149,act,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39150,as,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39151,an,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39152,allergen,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39153,.,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39219,Only,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39220,with,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39221,comprehensive,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39222,food,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39223,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39224,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39225,strategies,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39226,based,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39227,on,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39228,fiscal,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39229,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39230,regulatory,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39231,measures,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39232,(,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39233,including,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39234,a,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39235,minimum,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39236,unit,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39237,price,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39238,for,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39239,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39240,",",O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39241,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39242,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39243,duty,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39244,escalator,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39245,",",O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39246,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39247,an,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39248,extension,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39249,of,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39250,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39251,sugar,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39252,levy,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39253,on,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39254,food,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39255,content,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39256,),O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39257,can,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39258,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39259,disease,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39260,burden,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39261,be,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39262,curtailed,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39263,.,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39495,Understanding,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39496,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39497,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39498,harm,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39499,to,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39500,health,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39501,from,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39502,lifestyle,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39503,causes,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39504,among,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39505,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39506,general,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39507,population,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39508,is,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39509,low,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39510,",",O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39511,with,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39512,a,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39513,poor,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39514,knowledge,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39515,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39516,alcohol,B-AG.01.y.01,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39517,consumption,B-X,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39518,and,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39519,dietary,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39520,guidelines,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39521,.,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
40309,A,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40310,food,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40311,-,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40312,frequency,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40313,questionnaire,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40314,was,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40315,used,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40316,to,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40317,evaluate,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40318,nut,B-AG.01.h.01.f,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40319,and,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40320,peanut,B-AG.01.h.01.f,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40321,butter,I-AG.01.h.01.f,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40322,consumption,B-X,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40323,.,O,1382.0,A food - frequency questionnaire was used to evaluate nut and peanut butter consumption .
40751,In,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40752,rats,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40753,fed,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40754,the,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40755,low,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40756,and,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40757,high,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40758,calcium,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40759,phosphate,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40760,diets,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40761,",",O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40762,fecal,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40763,excretion,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40764,of,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40765,fatty,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40766,acids,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40767,diminished,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40768,in,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40769,the,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40770,order,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40771,palm,B-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40772,oil,I-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40773,>,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40774,milk,B-AG.01.e,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40775,fat,I-AG.01.e,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40776,>,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40777,corn,B-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40778,oil,I-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40779,.,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
41107,There,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41108,was,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41109,a,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41110,marked,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41111,positive,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41112,dose,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41113,-,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41114,response,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41115,relation,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41116,between,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41117,coffee,B-AG.01.ad,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41118,consumption,B-X,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41119,and,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41120,plasma,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41121,tHcy,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41122,",",O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41123,which,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41124,was,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41125,stronger,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41126,than,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41127,the,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41128,relation,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41129,between,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41130,coffee,B-AG.01.ad,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41131,and,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41132,total,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41133,serum,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41134,cholesterol,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41135,.,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41194,Although,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41195,coffee,B-AG.01.ad,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41196,drinking,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41197,was,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41198,associated,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41199,with,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41200,smoking,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41201,and,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41202,lower,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41203,intake,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41204,of,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41205,vitamin,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41206,supplements,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41207,and,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41208,fruit,B-AG.01.h.01,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41209,and,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41210,vegetables,B-AG.01.h.02,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41211,",",O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41212,the,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41213,coffee,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41214,-,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41215,tHcy,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41216,association,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41217,was,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41218,only,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41219,moderately,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41220,reduced,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41221,after,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41222,these,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41223,variables,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41224,were,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41225,adjusted,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41226,for,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41227,.,O,1412.0,"Although coffee drinking was associated with smoking and lower intake of vitamin supplements and fruit and vegetables , the coffee - tHcy association was only moderately reduced after these variables were adjusted for ."
41404,Glycemic,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41405,indices,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41406,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41407,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41408,rice,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41409,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41410,38,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41411,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41412,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41413,6,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41414,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41415,and,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41416,almond,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41417,meals,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41418,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41419,55,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41420,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41421,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41422,7,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41423,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41424,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41425,less,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41426,than,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41427,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41428,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41429,potato,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41430,meal,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41431,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41432,94,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41433,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41434,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41435,11,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41436,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41437,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41438,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41439,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41440,0.003,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41441,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41442,",",O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41443,as,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41444,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41445,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41446,postprandial,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41447,areas,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41448,under,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41449,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41450,insulin,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41451,concentration,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41452,time,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41453,curve,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41454,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41455,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41456,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41457,0.001,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41458,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41459,.,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41535,The,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41536,change,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41537,in,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41538,protein,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41539,thiols,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41540,was,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41541,also,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41542,negatively,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41543,related,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41544,to,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41545,the,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41546,postprandial,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41547,incremental,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41548,peak,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41549,glucose,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41550,(,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41551,r,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41552,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41553,-0.29,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41554,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41555,n,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41556,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41557,60,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41558,observations,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41559,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41560,P,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41561,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41562,0.026,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41563,),O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41564,and,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41565,peak,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41566,insulin,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41567,responses,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41568,(,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41569,r,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41570,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41571,-0.26,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41572,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41573,n,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41574,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41575,60,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41576,observations,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41577,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41578,P,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41579,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41580,0.046,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41581,),O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41582,.,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41812,Although,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41813,other,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41814,flavonoid,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41815,-,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41816,rich,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41817,foods,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41818,and,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41819,beverages,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41820,were,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41821,not,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41822,associated,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41823,",",O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41824,red,B-AG.01.y.01.a,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41825,wine,I-AG.01.y.01.a,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41826,was,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41827,inversely,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41828,associated,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41829,with,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41830,diabetes,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41831,.,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
42377,Results,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42378,showed,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42379,that,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42380,garlic,B-AG.01.h.02.e,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42381,significantly,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42382,reduced,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42383,total,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42384,cholesterol,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42385,(,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42386,TC,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42387,),O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42388,",",O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42389,plasma,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42390,triglyceride,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42391,(,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42392,TG,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42393,),O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42394,",",O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42395,LDL,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42396,-,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42397,C,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42398,",",O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42399,VLDL,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42400,-,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42401,C,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42402,",",O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42403,liver,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42404,triglyceride,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42405,",",O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42406,plasma,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42407,malondialdehyde,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42408,(,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42409,MDA,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42410,),O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42411,and,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42412,elevated,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42413,plasma,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42414,antioxidant,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42415,in,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42416,garlic,B-AG.01.h.02.e,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42417,treated,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42418,rats,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42419,(,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42420,groups,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42421,II,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42422,and,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42423,III,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42424,),O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42425,compared,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42426,to,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42427,group,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42428,IV,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42429,(,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42430,lipogenic,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42431,diet,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42432,group,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42433,),O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42434,.,O,1452.0,"Results showed that garlic significantly reduced total cholesterol ( TC ) , plasma triglyceride ( TG ) , LDL - C , VLDL - C , liver triglyceride , plasma malondialdehyde ( MDA ) and elevated plasma antioxidant in garlic treated rats ( groups II and III ) compared to group IV ( lipogenic diet group ) ."
42602,With,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42603,respect,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42604,to,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42605,habitual,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42606,diet,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42607,",",O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42608,an,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42609,increase,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42610,in,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42611,risk,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42612,was,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42613,associated,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42614,with,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42615,consumption,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42616,of,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42617,preserved,B-AG.01.n.07,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42618,fish,I-AG.01.n.07,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42619,",",O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42620,cold,B-AG.01.d,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42621,cuts,I-AG.01.d,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42622,and,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42623,oleaginous,B-AG.01.h.01,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42624,fruits,I-AG.01.h.01,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42625,.,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42690,With,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42691,reference,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42692,to,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42693,past,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42694,diet,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42695,",",O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42696,a,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42697,possible,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42698,protective,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42699,effect,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42700,was,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42701,observed,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42702,for,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42703,daily,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42704,consumption,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42705,of,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42706,fresh,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42707,fruit,B-AG.01.h.01,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42708,and,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42709,green,B-AG.01.h.02,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42710,vegetables,I-AG.01.h.02,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42711,.,O,1464.0,"With reference to past diet , a possible protective effect was observed for daily consumption of fresh fruit and green vegetables ."
42805,Overall,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42806,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42807,we,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42808,recommend,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42809,breast,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42810,cancer,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42811,patients,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42812,consume,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42813,a,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42814,diet,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42815,naturally,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42816,high,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42817,in,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42818,flavonol,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42819,polyphenols,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42820,including,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42821,tea,B-AG.01.ac,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42822,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42823,vegetables,B-AG.01.h.02,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42824,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42825,onion,B-AG.01.h.02.e,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42826,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42827,broccoli,B-AG.01.h.02.d,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42828,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42829,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42830,and,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42831,fruit,B-AG.01.h.01,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42832,(,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42833,apples,B-AG.01.h.01.c,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42834,",",O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42835,citrus,B-AG.01.h.01.a,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42836,),O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42837,.,O,1468.0,"Overall , we recommend breast cancer patients consume a diet naturally high in flavonol polyphenols including tea , vegetables ( onion , broccoli ) , and fruit ( apples , citrus ) ."
42850,Moderate,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42851,soy,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42852,protein,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42853,consumption,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42854,(,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42855,5,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42856,-,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42857,10,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42858,g,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42859,daily,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42860,),O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42861,and,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42862,the,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42863,Mediterranean,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42864,dietary,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42865,pattern,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42866,show,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42867,the,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42868,most,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42869,promise,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42870,for,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42871,breast,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42872,cancer,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42873,patients,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
42874,.,O,1470.0,Moderate soy protein consumption ( 5 - 10 g daily ) and the Mediterranean dietary pattern show the most promise for breast cancer patients .
43241,The,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43242,energy,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43243,-,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43244,dense,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43245,formulations,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43246,of,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43247,many,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43248,cocoa,B-AG.01,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43249,and,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43250,chocolate,B-AG.01.n.17.a,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43251,products,I-AG.01.n.17.a,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43252,",",O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43253,which,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43254,can,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43255,be,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43256,up,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43257,to,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43258,50,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43259,%,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43260,sugar,B-AG.01.l.02,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43261,by,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43262,weight,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43263,",",O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43264,have,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43265,given,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43266,the,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43267,perception,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43268,that,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43269,chocolate,B-AG.01.n.17.a,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43270,may,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43271,be,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43272,harmful,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43273,through,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43274,its,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43275,contribution,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43276,to,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43277,obesity,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43278,.,O,1485.0,"The energy - dense formulations of many cocoa and chocolate products , which can be up to 50 % sugar by weight , have given the perception that chocolate may be harmful through its contribution to obesity ."
43929,These,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43930,data,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43931,are,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43932,in,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43933,accordance,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43934,with,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43935,our,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43936,present,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43937,extended,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43938,analysis,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43939,of,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43940,an,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43941,earlier,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43942,report,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43943,on,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43944,nut,B-AG.01.h.01.f,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43945,intake,B-X,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43946,and,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43947,death,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43948,attributed,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43949,to,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43950,various,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43951,diseases,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43952,in,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43953,the,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43954,Iowa,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43955,Women,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43956,'s,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43957,Health,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43958,Study,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
43959,.,O,1513.0,These data are in accordance with our present extended analysis of an earlier report on nut intake and death attributed to various diseases in the Iowa Women 's Health Study .
44622,No,O,1538.0,No bands were detected from paprika extract .
44623,bands,O,1538.0,No bands were detected from paprika extract .
44624,were,O,1538.0,No bands were detected from paprika extract .
44625,detected,O,1538.0,No bands were detected from paprika extract .
44626,from,O,1538.0,No bands were detected from paprika extract .
44627,paprika,O,1538.0,No bands were detected from paprika extract .
44628,extract,O,1538.0,No bands were detected from paprika extract .
44629,.,O,1538.0,No bands were detected from paprika extract .
44838,Fat,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44839,and,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44840,protein,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44841,were,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44842,supplied,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44843,by,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44844,1,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44845,),O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44846,lard,B-AG.01.f,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44847,and,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44848,casein,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44849,",",O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44850,2,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44851,),O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44852,olive,B-AG.01.f,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44853,oil,I-AG.01.f,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44854,and,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44855,casein,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44856,",",O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44857,3,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44858,),O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44859,beef,B-AG.01.d.03,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44860,",",O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44861,4,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44862,),O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44863,chicken,B-AG.01.d.06,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44864,with,I-AG.01.d.06,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44865,skin,I-AG.01.d.06,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44866,",",O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44867,and,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44868,5,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44869,),O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44870,bacon,B-AG.01.d.05,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44871,.,O,1548.0,"Fat and protein were supplied by 1 ) lard and casein , 2 ) olive oil and casein , 3 ) beef , 4 ) chicken with skin , and 5 ) bacon ."
44872,Meat,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44873,diets,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44874,contained,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44875,30,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44876,%,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44877,or,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44878,60,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44879,%,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44880,freeze,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44881,-,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44882,dried,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44883,fried,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44884,meat,B-AG.01.d,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44885,.,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
45382,Dietary,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45383,habits,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45384,were,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45385,established,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45386,through,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45387,a,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45388,self,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45389,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45390,administered,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45391,semi,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45392,-,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45393,quantitative,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45394,food,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45395,frequency,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45396,questionnaire,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
45397,.,O,1570.0,Dietary habits were established through a self - administered semi - quantitative food frequency questionnaire .
46481,Also,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46482,",",O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46483,high,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46484,dairy,B-AG.01.e,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46485,product,I-AG.01.e,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46486,consumption,B-X,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46487,has,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46488,been,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46489,associated,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46490,with,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46491,risk,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46492,of,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46493,prostate,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46494,and,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46495,ovarian,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46496,cancers,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46497,in,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46498,some,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46499,but,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46500,not,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46501,all,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46502,studies,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46503,.,O,1607.0,"Also , high dairy product consumption has been associated with risk of prostate and ovarian cancers in some but not all studies ."
46580,We,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46581,examined,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46582,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46583,Barilla,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46584,Center,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46585,for,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46586,Food,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46587,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46588,Nutrition,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46589,'s,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46590,double,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46591,pyramid,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46592,to,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46593,describe,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46594,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46595,carbon,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46596,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46597,water,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46598,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46599,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46600,ecological,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46601,footprints,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46602,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46603,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46604,components,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46605,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46606,a,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46607,cardio,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46608,-,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46609,protective,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46610,diet,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46611,.,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46715,Detailed,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46716,knowledge,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46717,of,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46718,food,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46719,oxalate,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46720,content,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46721,is,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46722,of,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46723,essential,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46724,importance,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46725,for,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46726,dietary,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46727,treatment,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46728,of,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46729,recurrent,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46730,calcium,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46731,oxalate,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46732,urolithiasis,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
46733,.,O,1615.0,Detailed knowledge of food oxalate content is of essential importance for dietary treatment of recurrent calcium oxalate urolithiasis .
47394,Phytochemicals,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47395,are,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47396,present,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47397,in,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47398,fruits,B-AG.01.h.01,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47399,",",O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47400,vegetables,B-AG.01.h.02,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47401,and,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47402,various,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47403,plants,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47404,",",O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47405,and,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47406,constitute,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47407,nonessential,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47408,nutrients,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47409,such,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47410,as,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47411,vitamins,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47412,or,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47413,minerals,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47414,",",O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47415,many,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47416,of,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47417,them,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47418,being,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47419,consumed,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47420,in,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47421,a,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47422,popular,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47423,way,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47424,or,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47425,used,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47426,as,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47427,herbal,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47428,remedies,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47429,or,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47430,dietary,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47431,supplements,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47432,.,O,1640.0,"Phytochemicals are present in fruits , vegetables and various plants , and constitute nonessential nutrients such as vitamins or minerals , many of them being consumed in a popular way or used as herbal remedies or dietary supplements ."
47682,During,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47683,11,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47684,years,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47685,of,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47686,follow,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47687,-,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47688,up,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47689,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47690,899,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47691,deaths,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47692,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47693,316,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47694,CVD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47695,-,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47696,related,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47697,deaths,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47698,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47699,569,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47700,CVD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47701,events,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47702,and,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47703,301,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47704,CHD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47705,events,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47706,occurred,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47707,.,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47878,The,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47879,glucose,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47880,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47881,insulin,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47882,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47883,C,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47884,-,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47885,peptide,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47886,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47887,alpha,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47888,amino,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47889,nitrogen,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47890,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47891,AAN,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47892,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47893,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47894,glucagon,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47895,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47896,plasma,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47897,urea,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47898,nitrogen,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47899,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47900,PUN,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47901,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47902,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47903,nonesterified,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47904,fatty,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47905,acid,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47906,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47907,NEFA,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47908,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47909,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47910,and,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47911,triglyceride,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47912,area,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47913,responses,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47914,were,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47915,determined,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47916,using,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47917,the,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47918,water,B-AG.01.z,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47919,meal,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47920,as,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47921,a,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47922,baseline,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47923,.,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
48271,After,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48272,proper,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48273,adjustment,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48274,for,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48275,drinking,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48276,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48277,smoking,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48278,",",O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48279,high,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48280,consumption,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48281,of,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48282,butter,B-AG.01.e.01,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48283,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48284,low,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48285,consumption,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48286,of,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48287,fresh,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48288,fish,B-AG.01.d.07,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48289,",",O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48290,vegetables,B-AG.01.h.02,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48291,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48292,fruits,B-AG.01.h.01,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48293,were,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48294,associated,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48295,strongly,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48296,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48297,independently,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48298,with,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48299,an,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48300,increase,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48301,in,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48302,oesophageal,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48303,-,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48304,cancer,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48305,risk,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48306,.,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
49048,Diet,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49049,plays,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49050,a,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49051,key,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49052,role,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49053,in,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49054,the,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49055,maintenance,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49056,and,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49057,optimal,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49058,functioning,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49059,of,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49060,immune,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49061,cells,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49062,.,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49330,In,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49331,total,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49332,",",O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49333,324,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49334,quarters,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49335,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49336,82,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49337,Holstein,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49338,Friesian,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49339,heifers,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49340,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49341,3,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49342,commercial,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49343,dairy,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49344,herds,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49345,equipped,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49346,with,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49347,an,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49348,automatic,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49349,milking,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49350,system,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49351,were,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49352,included,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49353,and,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49354,followed,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49355,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49356,calving,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49357,up,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49358,to,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49359,4,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49360,mo,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49361,in,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49362,lactation,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49363,.,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49507,Our,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49508,data,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49509,suggest,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49510,that,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49511,IMI,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49512,with,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49513,NAS,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49514,(,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49515,as,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49516,a,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49517,group,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49518,),O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49519,present,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49520,shortly,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49521,after,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49522,calving,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49523,do,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49524,not,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49525,have,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49526,an,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49527,adverse,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49528,effect,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49529,on,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49530,later,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49531,production,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49532,.,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49711,The,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49712,PEF,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49713,was,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49714,tested,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49715,on,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49716,three,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49717,Italian,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49718,olive,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49719,cultivars,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49720,(,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49721,Carolea,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49722,",",O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49723,Coratina,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49724,",",O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49725,and,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49726,Ottobratica,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49727,),O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49728,.,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49847,The,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49848,cardiovascular,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49849,effects,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49850,of,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49851,the,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49852,nonlipid,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49853,portion,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49854,of,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49855,peanuts,B-AG.01.h.01.f,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49856,has,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49857,not,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49858,been,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49859,evaluated,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49860,even,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49861,though,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49862,that,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49863,fraction,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49864,contains,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49865,arginine,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49866,",",O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49867,flavonoids,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49868,",",O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49869,folates,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49870,",",O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49871,and,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49872,other,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49873,compounds,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49874,that,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49875,have,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49876,been,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49877,linked,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49878,to,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49879,cardiovascular,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49880,health,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49881,.,O,1719.0,"The cardiovascular effects of the nonlipid portion of peanuts has not been evaluated even though that fraction contains arginine , flavonoids , folates , and other compounds that have been linked to cardiovascular health ."
49925,Each,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49926,experimental,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49927,diet,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49928,group,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49929,was,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49930,fed,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49931,a,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49932,high,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49933,fat,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49934,",",O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49935,high,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49936,cholesterol,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49937,diet,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49938,with,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49939,various,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49940,peanut,B-AG.01.h.01.f,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49941,components,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49942,(,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49943,FFPF,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49944,",",O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49945,peanut,B-AG.01.f,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49946,oil,I-AG.01.f,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49947,",",O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49948,or,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49949,peanuts,B-AG.01.h.01.f,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49950,),O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49951,substituted,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49952,for,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49953,similar,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49954,metabolic,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49955,components,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49956,in,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49957,the,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49958,control,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49959,diet,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
49960,.,O,1721.0,"Each experimental diet group was fed a high fat , high cholesterol diet with various peanut components ( FFPF , peanut oil , or peanuts ) substituted for similar metabolic components in the control diet ."
50247,In,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50248,addition,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50249,",",O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50250,many,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50251,clinical,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50252,observational,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50253,studies,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50254,have,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50255,demonstrated,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50256,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50257,absence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50258,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50259,a,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50260,relationship,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50261,between,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50262,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50263,frequency,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50264,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50265,miso,B-AG.01.n.02,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50266,soup,I-AG.01.n.02,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50267,intake,B-X,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50268,and,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50269,blood,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50270,pressure,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50271,levels,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50272,or,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50273,hypertension,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50274,incidence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50275,.,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50357,The,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50358,present,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50359,analysis,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50360,aimed,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50361,to,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50362,investigate,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50363,the,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50364,changes,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50365,in,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50366,the,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50367,reported,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50368,portion,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50369,sizes,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50370,(,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50371,PS,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50372,),O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50373,of,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50374,foods,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50375,and,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50376,beverages,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50377,commonly,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50378,consumed,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50379,by,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50380,Irish,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50381,adults,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50382,(,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50383,18,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50384,-,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50385,64,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50386,years,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50387,),O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50388,from,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50389,the,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50390,North,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50391,South,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50392,Ireland,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50393,Food,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50394,Consumption,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50395,Survey,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50396,(,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50397,NSIFCS,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50398,),O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50399,(,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50400,1997,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50401,-,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50402,2001,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50403,),O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50404,and,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50405,the,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50406,National,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50407,Adult,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50408,Nutrition,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50409,Survey,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50410,(,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50411,NANS,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50412,),O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50413,(,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50414,2008,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50415,-,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50416,10,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50417,),O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50418,.,O,1738.0,The present analysis aimed to investigate the changes in the reported portion sizes ( PS ) of foods and beverages commonly consumed by Irish adults ( 18 - 64 years ) from the North South Ireland Food Consumption Survey ( NSIFCS ) ( 1997 - 2001 ) and the National Adult Nutrition Survey ( NANS ) ( 2008 - 10 ) .
50502,The,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50503,analysis,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50504,demonstrated,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50505,that,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50506,PS,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50507,significantly,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50508,increased,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50509,for,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50510,five,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50511,foods,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50512,(,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50513,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50514,white,B-AG.01.n.11,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50515,sliced,I-AG.01.n.11,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50516,bread,I-AG.01.n.11,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50517,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50518,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50519,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50520,brown,B-AG.01.n.11,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50521,/,I-AG.01.n.11,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50522,wholemeal,I-AG.01.n.11,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50523,breads,I-AG.01.n.11,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50524,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50525,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50526,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50527,all,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50528,meat,B-AG.01.d,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50529,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50530,cooked,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50531,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50532,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50533,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50534,poultry,B-AG.01.d.06,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50535,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50536,roasted,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50537,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50538,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50539,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50540,milk,B-AG.01.e,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50541,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50542,),O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50543,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50544,significantly,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50545,decreased,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50546,for,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50547,three,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50548,(,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50549,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50550,potatoes,B-AG.01.h.02.a,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50551,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50552,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50553,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50554,chips,B-AG.01.n.09,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50555,/,I-AG.01.n.09,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50556,wedges,I-AG.01.n.09,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50557,',I-AG.01.n.09,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50558,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50559,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50560,ham,B-AG.01.d,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50561,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50562,sliced,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50563,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50564,),O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50565,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50566,did,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50567,not,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50568,significantly,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50569,change,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50570,for,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50571,five,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50572,foods,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50573,(,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50574,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50575,processed,B-AG.01.n.09,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50576,potato,I-AG.01.n.09,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50577,products,I-AG.01.n.09,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50578,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50579,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50580,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50581,bacon,B-AG.01.d.05,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50582,/,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50583,ham,B-AG.01.d,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50584,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50585,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50586,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50587,cheese,B-AG.01.e.02,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50588,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50589,",",O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50590,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50591,yogurt,B-AG.01.e,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50592,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50593,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50594,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50595,butter,B-AG.01.e.01,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50596,/,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50597,spreads,B-AG.01,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50598,',O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50599,),O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50600,between,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50601,the,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50602,NSIFCS,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50603,and,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50604,the,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50605,NANS,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
50606,.,O,1742.0,"The analysis demonstrated that PS significantly increased for five foods ( ' white sliced bread ' , ' brown / wholemeal breads ' , ' all meat , cooked ' , ' poultry , roasted ' and ' milk ' ) , significantly decreased for three ( ' potatoes ' , ' chips / wedges ' and ' ham , sliced ' ) and did not significantly change for five foods ( ' processed potato products ' , ' bacon / ham ' , ' cheese ' , ' yogurt ' and ' butter / spreads ' ) between the NSIFCS and the NANS ."
51569,The,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51570,effect,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51571,of,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51572,four,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51573,species,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51574,of,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51575,legume,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51576,seeds,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51577,on,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51578,plasma,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51579,cholesterol,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51580,levels,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51581,and,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51582,faecal,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51583,steroid,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51584,excretion,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51585,was,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51586,studied,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51587,in,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51588,pigs,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51589,.,O,1770.0,The effect of four species of legume seeds on plasma cholesterol levels and faecal steroid excretion was studied in pigs .
51590,Thirty,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51591,-,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51592,six,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51593,growing,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51594,boars,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51595,were,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51596,randomly,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51597,allocated,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51598,in,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51599,groups,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51600,of,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51601,six,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51602,to,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51603,six,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51604,diets,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51605,which,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51606,they,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51607,ate,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51608,continuously,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51609,for,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51610,42,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51611,d.,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51612,The,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51613,diets,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51614,fed,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51615,were,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51616,:,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51617,1,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51618,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51619,a,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51620,semi,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51621,-,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51622,purified,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51623,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51624,SP,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51625,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51626,control,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51627,group,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51628,1,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51629,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51630,diet,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51631,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51632,2,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51633,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51634,SP,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51635,+,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51636,10,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51637,g,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51638,cholesterol,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51639,/,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51640,kg,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51641,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51642,control,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51643,group,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51644,2,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51645,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51646,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51647,3,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51648,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51649,4,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51650,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51651,5,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51652,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51653,6,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51654,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51655,SP,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51656,+,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51657,cooked,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51658,legumes,B-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51659,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51660,70:30,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51661,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51662,w,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51663,/,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51664,w,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51665,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51666,respectively,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51667,baked,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51668,beans,B-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51669,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51670,Phaseolus,B-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51671,vulgaris,I-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51672,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51673,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51674,peas,B-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51675,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51676,Pisum,B-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51677,sativum,I-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51678,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51679,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51680,lentils,B-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51681,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51682,Lens,B-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51683,culinaris,I-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51684,Medik,I-AG.01.h.02.g,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51685,.,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
52050,Before,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52051,fortification,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52052,the,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52053,mean,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52054,serum,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52055,and,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52056,red,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52057,blood,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52058,cell,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52059,folate,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52060,concentrations,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52061,were,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52062,9.7,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52063,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52064,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52065,4.3,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52066,and,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52067,290,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52068,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52069,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52070,102,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52071,nmol,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52072,/,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52073,L,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52074,",",O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52075,respectively,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52076,",",O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52077,compared,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52078,with,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52079,37.2,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52080,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52081,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52082,9.5,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52083,and,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52084,707,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52085,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52086,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52087,179,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52088,nmol,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52089,/,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52090,L,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52091,postfortification,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52092,",",O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52093,respectively,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52094,.,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52095,The,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52096,mean,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52097,FA,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52098,content,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52099,of,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52100,bread,B-AG.01.n.11,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52101,was,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52102,2020,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52103,+,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52104,/-,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52105,940,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52106,micro,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52107,g,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52108,/,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52109,kg,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52110,.,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52195,This,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52196,manuscript,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52197,provides,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52198,a,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52199,brief,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52200,synopsis,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52201,of,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52202,30,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52203,studies,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52204,aimed,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52205,at,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52206,examining,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52207,tea,B-AG.01.ac,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52208,consumption,B-X,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52209,as,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52210,a,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52211,factor,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52212,in,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52213,the,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52214,incidence,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52215,of,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52216,colon,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52217,and,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52218,rectal,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52219,cancers,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52220,.,O,1790.0,This manuscript provides a brief synopsis of 30 studies aimed at examining tea consumption as a factor in the incidence of colon and rectal cancers .
52241,These,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52242,studies,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52243,do,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52244,not,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52245,provide,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52246,consistent,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52247,evidence,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52248,to,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52249,support,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52250,the,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52251,theory,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52252,from,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52253,animal,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52254,studies,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52255,and,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52256,basic,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52257,research,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52258,that,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52259,tea,B-AG.01.ac,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52260,is,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52261,a,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52262,potent,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52263,chemopreventive,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52264,agent,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52265,.,O,1792.0,These studies do not provide consistent evidence to support the theory from animal studies and basic research that tea is a potent chemopreventive agent .
52436,The,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52437,Mediterranean,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52438,diet,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52439,is,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52440,a,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52441,healthy,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52442,eating,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52443,pattern,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52444,with,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52445,protective,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52446,effects,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52447,on,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52448,chronic,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52449,diseases,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52450,.,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52843,A,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52844,total,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52845,of,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52846,14,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52847,phenolic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52848,compounds,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52849,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52850,a,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52851,piperine,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52852,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52853,cinnamic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52854,acid,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52855,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52856,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52857,cinnamaldehyde,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52858,were,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52859,identified,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52860,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52861,quantitated,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52862,.,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52900,All,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52901,spices,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52902,exhibited,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52903,inhibitory,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52904,activity,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52905,against,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52906,selected,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52907,Ruminococcus,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52908,species,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52909,.,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
53308,Furthermore,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53309,",",O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53310,the,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53311,estimation,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53312,of,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53313,the,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53314,GI,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53315,of,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53316,a,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53317,mixed,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53318,meal,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53319,by,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53320,calculation,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53321,is,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53322,imprecise,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53323,.,O,1834.0,"Furthermore , the estimation of the GI of a mixed meal by calculation is imprecise ."
53788,Based,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53789,on,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53790,available,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53791,evidence,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53792,",",O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53793,a,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53794,well,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53795,-,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53796,formulated,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53797,ketogenic,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53798,diet,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53799,does,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53800,not,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53801,appear,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53802,to,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53803,have,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53804,major,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53805,safety,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53806,concerns,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53807,for,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53808,the,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53809,general,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53810,public,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53811,and,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53812,can,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53813,be,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53814,considered,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53815,a,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53816,first,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53817,-,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53818,line,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53819,approach,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53820,for,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53821,obesity,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53822,and,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53823,diabetes,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53824,.,O,1853.0,"Based on available evidence , a well - formulated ketogenic diet does not appear to have major safety concerns for the general public and can be considered a first - line approach for obesity and diabetes ."
53875,To,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53876,cope,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53877,with,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53878,this,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53879,issue,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53880,",",O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53881,researchers,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53882,in,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53883,the,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53884,agricultural,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53885,sector,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53886,have,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53887,implemented,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53888,deficit,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53889,irrigation,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53890,strategies,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53891,intended,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53892,to,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53893,reduce,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53894,water,B-AG.01.z,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53895,consumption,B-X,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53896,by,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53897,increasing,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53898,fruit,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53899,quality,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53900,.,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53901,Almond,B-AG.01.h.01.f,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53902,is,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53903,among,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53904,the,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53905,most,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53906,popular,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53907,tree,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53908,nuts,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53909,worldwide,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53910,and,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53911,also,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53912,the,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53913,most,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53914,nut,B-AG.01.h.01.f,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53915,cultivated,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53916,in,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53917,Spain,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53918,.,O,1857.0,Almond is among the most popular tree nuts worldwide and also the most nut cultivated in Spain .
53919,Almond,B-AG.01.h.01.f,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53920,consumption,B-X,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53921,",",O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53922,together,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53923,with,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53924,other,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53925,nuts,B-AG.01.h.01.f,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53926,",",O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53927,has,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53928,been,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53929,widely,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53930,associated,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53931,with,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53932,improvements,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53933,in,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53934,cardiovascular,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53935,health,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53936,",",O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53937,metabolic,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53938,syndrome,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53939,and,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53940,diabetes,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53941,owing,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53942,to,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53943,their,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53944,bioactive,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53945,compounds,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53946,such,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53947,as,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53948,polyphenols,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53949,.,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
54222,It,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54223,is,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54224,known,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54225,that,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54226,patients,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54227,with,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54228,pollinosis,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54229,may,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54230,display,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54231,clinical,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54232,characteristics,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54233,caused,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54234,by,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54235,allergy,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54236,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54237,certain,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54238,fruits,B-AG.01.h.01,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54239,and,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54240,vegetables,B-AG.01.h.02,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54241,",",O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54242,but,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54243,subjects,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54244,allergic,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54245,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54246,Artemisia,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54247,seem,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54248,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54249,show,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54250,particularly,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54251,peculiar,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54252,characteristics,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54253,.,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54617,For,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54618,colon,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54619,cancer,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54620,",",O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54621,no,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54622,statistically,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54623,significant,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54624,associations,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54625,with,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54626,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54627,vegetable,B-AG.01.h.02,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54628,intake,B-X,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54629,or,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54630,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54631,fruit,B-AG.01.h.01,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54632,intake,B-X,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54633,were,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54634,found,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54635,.,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54677,Brassica,B-AG.01.h.02.d,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54678,vegetables,I-AG.01.h.02.d,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54679,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54680,cooked,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54681,leafy,B-AG.01.h.02.c,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54682,vegetables,I-AG.01.h.02.c,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54683,showed,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54684,inverse,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54685,associations,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54686,for,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54687,both,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54688,men,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54689,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54690,women,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54691,.,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54692,Among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54693,women,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54694,and,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54695,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54696,to,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54697,a,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54698,lesser,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54699,extent,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54700,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54701,among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54702,men,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54703,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54704,inverse,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54705,associations,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54706,were,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54707,stronger,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54708,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54709,distal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54710,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54711,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54712,than,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54713,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54714,proximal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54715,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54716,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54717,.,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54902,In,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54903,a,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54904,limited,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54905,number,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54906,of,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54907,studies,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54908,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54909,cumin,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54910,seeds,I-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54911,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54912,Cuminum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54913,cyminum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54914,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54915,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54916,ginger,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54917,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54918,Zingiber,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54919,officinale,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54920,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54921,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54922,mustard,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54923,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54924,Brassica,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54925,nigra,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54926,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54927,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54928,curry,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54929,leaves,I-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54930,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54931,Murraya,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54932,koenigii,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54933,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54934,and,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54935,coriander,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54936,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54937,Coriandrum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54938,sativum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54939,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54940,have,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54941,been,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54942,reported,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54943,to,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54944,be,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54945,hypoglycaemic,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54946,.,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
55415,No,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55416,such,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55417,relationship,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55418,was,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55419,found,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55420,between,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55421,choice,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55422,of,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55423,spread,B-AG.01,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55424,and,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55425,family,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55426,history,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55427,of,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55428,heart,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55429,disease,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55430,or,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55431,hypertension,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55432,.,O,1916.0,No such relationship was found between choice of spread and family history of heart disease or hypertension .
55616,We,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55617,hypothesised,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55618,that,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55619,the,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55620,ameliorating,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55621,effect,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55622,of,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55623,Yukihikari,B-AG.01.i,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55624,on,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55625,atopic,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55626,dermatitis,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55627,is,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55628,associated,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55629,with,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55630,the,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55631,gut,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55632,microbiota,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55633,.,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55801,Additionally,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55802,",",O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55803,the,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55804,translocation,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55805,of,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55806,horseradish,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55807,peroxidase,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55808,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55809,isolated,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55810,segments,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55811,of,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55812,ileum,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55813,and,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55814,colon,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55815,tended,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55816,to,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55817,be,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55818,lower,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55819,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55820,mice,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55821,fed,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55822,Yukihikari,B-AG.01.i,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55823,",",O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55824,suggesting,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55825,a,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55826,reduction,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55827,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55828,gut,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55829,permeability,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55830,in,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55831,mice,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55832,fed,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55833,Yukihikari,B-AG.01.i,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
55834,.,O,1929.0,"Additionally , the translocation of horseradish peroxidase in isolated segments of ileum and colon tended to be lower in mice fed Yukihikari , suggesting a reduction in gut permeability in mice fed Yukihikari ."
56101,Pomegranate,O,1937.0,Pomegranate is a rich source of polyphenols .
56102,is,O,1937.0,Pomegranate is a rich source of polyphenols .
56103,a,O,1937.0,Pomegranate is a rich source of polyphenols .
56104,rich,O,1937.0,Pomegranate is a rich source of polyphenols .
56105,source,O,1937.0,Pomegranate is a rich source of polyphenols .
56106,of,O,1937.0,Pomegranate is a rich source of polyphenols .
56107,polyphenols,O,1937.0,Pomegranate is a rich source of polyphenols .
56108,.,O,1937.0,Pomegranate is a rich source of polyphenols .
56470,All,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56471,nuggets,B-AG.01.n.06,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56472,were,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56473,analyzed,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56474,for,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56475,hardness,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56476,by,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56477,a,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56478,textural,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56479,analyzer,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56480,",",O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56481,crispness,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56482,by,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56483,an,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56484,acoustic,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56485,sound,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56486,",",O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56487,and,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56488,sensory,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56489,characteristics,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56490,by,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56491,a,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56492,trained,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56493,panel,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
56494,.,O,1951.0,"All nuggets were analyzed for hardness by a textural analyzer , crispness by an acoustic sound , and sensory characteristics by a trained panel ."
57003,In,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57004,contrast,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57005,",",O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57006,others,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57007,have,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57008,shown,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57009,no,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57010,association,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57011,of,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57012,red,B-AG.01.d,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57013,meat,I-AG.01.d,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57014,intake,B-X,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57015,with,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57016,CVD,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57017,.,O,1968.0,"In contrast , others have shown no association of red meat intake with CVD ."
57042,Many,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57043,observational,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57044,and,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57045,interventional,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57046,studies,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57047,confirmed,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57048,that,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57049,increasing,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57050,protein,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57051,intake,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57052,",",O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57053,especially,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57054,plant,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57055,-,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57056,based,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57057,proteins,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57058,and,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57059,certain,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57060,animal,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57061,-,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57062,based,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57063,proteins,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57064,(,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57065,poultry,B-AG.01.d.06,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57066,",",O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57067,fish,B-AG.01.d.07,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57068,",",O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57069,unprocessed,B-AG.01.d,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57070,red,I-AG.01.d,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57071,meat,I-AG.01.d,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57072,low,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57073,in,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57074,saturated,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57075,fats,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57076,and,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57077,low,B-AG.01.e,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57078,-,I-AG.01.e,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57079,fat,I-AG.01.e,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57080,dairy,I-AG.01.e,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57081,products,I-AG.01.e,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57082,),O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57083,have,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57084,a,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57085,positive,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57086,effect,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57087,in,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57088,modifying,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57089,cardiometabolic,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57090,risk,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57091,factors,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57092,.,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57668,Women,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57669,in,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57670,the,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57671,higher,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57672,tertile,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57673,of,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57674,adherence,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57675,to,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57676,the,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57677,unhealthy,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57678,dietary,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57679,pattern,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57680,had,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57681,a,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57682,higher,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57683,homeostatic,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57684,model,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57685,assessment,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57686,for,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57687,insulin,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57688,resistance,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57689,(,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57690,HOMA,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57691,),O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57692,index,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57693,(,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57694,b,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57695,=,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57696,2.49,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57697,;,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57698,95,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57699,%,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57700,CI,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57701,:,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57702,0.41,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57703,-,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57704,4.57,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57705,;,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57706,While,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57707,differences,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57708,in,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57709,glucose,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57710,and,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57711,insulin,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57712,responses,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57713,to,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57714,specific,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57715,carbohydrate,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57716,foods,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57717,have,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57718,been,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57719,reported,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57720,",",O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57721,few,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57722,data,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57723,are,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57724,available,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57725,for,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57726,mixed,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57727,meals,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57728,incorporating,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57729,such,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57730,foods,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
57731,.,O,1997.0,"Women in the higher tertile of adherence to the unhealthy dietary pattern had a higher homeostatic model assessment for insulin resistance ( HOMA ) index ( b = 2.49 ; 95 % CI : 0.41 - 4.57 ; While differences in glucose and insulin responses to specific carbohydrate foods have been reported , few data are available for mixed meals incorporating such foods ."
58733,These,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58734,include,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58735,oligosaccharides,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58736,",",O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58737,fucosylated,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58738,oligosaccharides,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58739,",",O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58740,hormones,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58741,",",O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58742,growth,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58743,factors,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58744,",",O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58745,mucin,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58746,",",O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58747,gangliosides,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58748,",",O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58749,and,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58750,endogenous,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58751,peptides,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58752,",",O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58753,which,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58754,are,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58755,present,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58756,in,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58757,milk,B-AG.01.e,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58758,at,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58759,secretion,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58760,.,O,2030.0,"These include oligosaccharides , fucosylated oligosaccharides , hormones , growth factors , mucin , gangliosides , and endogenous peptides , which are present in milk at secretion ."
58894,We,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58895,tested,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58896,the,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58897,GI,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58898,of,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58899,beer,B-AG.01.y.01.b,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58900,and,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58901,estimated,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58902,its,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58903,contribution,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58904,to,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58905,dietary,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58906,GI,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58907,and,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58908,GL,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58909,in,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58910,the,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58911,Netherlands,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58912,.,O,2036.0,We tested the GI of beer and estimated its contribution to dietary GI and GL in the Netherlands .
58941,Subsequently,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58942,",",O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58943,GI,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58944,and,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58945,GL,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58946,values,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58947,were,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58948,assigned,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58949,to,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58950,2556,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58951,food,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58952,items,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58953,in,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58954,the,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58955,2011,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58956,Dutch,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58957,food,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58958,composition,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58959,table,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58960,using,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58961,a,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58962,six,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58963,-,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58964,step,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58965,methodology,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58966,and,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58967,consulting,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58968,four,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58969,databases,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
58970,.,O,2038.0,"Subsequently , GI and GL values were assigned to 2556 food items in the 2011 Dutch food composition table using a six - step methodology and consulting four databases ."
59039,Other,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59040,foods,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59041,that,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59042,contributed,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59043,to,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59044,the,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59045,inter,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59046,-,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59047,individual,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59048,variation,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59049,in,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59050,GI,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59051,and,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59052,GL,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59053,included,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59054,potatoes,B-AG.01.h.02.a,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59055,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59056,bread,B-AG.01.n.11,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59057,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59058,soft,B-AG.01.y,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59059,drinks,I-AG.01.y,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59060,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59061,sugar,B-AG.01.l.02,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59062,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59063,candy,B-AG.01.n.17.a,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59064,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59065,wine,B-AG.01.y.01.a,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59066,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59067,coffee,B-AG.01.ad,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59068,and,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59069,tea,B-AG.01.ac,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59070,.,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59381,In,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59382,conclusion,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59383,",",O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59384,personalized,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59385,diets,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59386,with,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59387,supplemented,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59388,functional,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59389,ingredients,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59390,improved,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59391,antioxidant,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59392,status,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59393,and/or,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59394,anticoagulant,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59395,activity,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59396,in,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59397,cancer,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59398,patients,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59399,undergoing,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59400,chemotherapy,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59401,and,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59402,in,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59403,remission,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59404,.,O,2055.0,"In conclusion , personalized diets with supplemented functional ingredients improved antioxidant status and/or anticoagulant activity in cancer patients undergoing chemotherapy and in remission ."
59553,The,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59554,aim,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59555,of,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59556,this,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59557,paper,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59558,is,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59559,to,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59560,define,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59561,the,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59562,historical,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59563,development,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59564,and,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59565,nutritional,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59566,importance,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59567,of,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59568,olive,B-AG.01.h.01.e,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59569,and,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59570,olive,B-AG.01.f,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59571,oil,I-AG.01.f,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59572,constituted,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59573,an,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59574,important,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59575,part,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59576,of,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59577,the,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59578,Mediterranean,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59579,diet,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59580,.,O,2062.0,The aim of this paper is to define the historical development and nutritional importance of olive and olive oil constituted an important part of the Mediterranean diet .
59628,With,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59629,increasing,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59630,content,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59631,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59632,iron,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59633,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59634,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59635,up,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59636,to,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59637,25,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59638,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59639,fold,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59640,higher,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59641,concentrations,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59642,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59643,the,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59644,toxic,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59645,lipid,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59646,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59647,products,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59648,malondialdehyde,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59649,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59650,4,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59651,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59652,hydroxy-2,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59653,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59654,nonenal,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59655,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59656,and,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59657,other,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59658,volatile,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59659,aldehydes,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59660,were,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59661,formed,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59662,during,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59663,digestion,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59664,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59665,together,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59666,with,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59667,increased,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59668,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59669,carbonyl,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59670,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59671,as,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59672,measurement,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59673,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59674,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59675,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59676,.,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59940,Similar,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59941,risk,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59942,reductions,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59943,were,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59944,associated,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59945,with,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59946,red,B-AG.01.y.01.a,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59947,wine,I-AG.01.y.01.a,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59948,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59949,white,B-AG.01.y.01.a,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59950,wine,I-AG.01.y.01.a,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59951,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59952,other,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59953,types,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59954,of,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59955,wine,B-AG.01.y.01.a,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59956,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59957,and,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59958,combinations,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59959,of,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59960,wine,B-AG.01.y.01.a,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59961,types,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59962,.,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
60059,In,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60060,the,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60061,process,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60062,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60063,consumption,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60064,of,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60065,animal,B-AG.01.d,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60066,products,I-AG.01.d,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60067,increases,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60068,the,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60069,risk,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60070,for,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60071,cardiovascular,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60072,disease,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60073,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60074,cancer,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60075,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60076,diabetes,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60077,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60078,obesity,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60079,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60080,and,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60081,other,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60082,disorders,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60083,.,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60162,However,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60163,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60164,a,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60165,diet,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60166,based,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60167,on,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60168,vegetables,B-AG.01.h.02,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60169,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60170,fruits,B-AG.01.h.01,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60171,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60172,whole,B-AG.01.i,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60173,grains,I-AG.01.i,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60174,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60175,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60176,legumes,B-AG.01.h.02.g,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60177,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60178,supplemented,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60179,with,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60180,vitamin,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60181,B-12,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60182,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60183,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60184,nutritionally,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60185,superior,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60186,to,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60187,diets,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60188,including,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60189,animal,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60190,products,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60191,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60192,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60193,healthful,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60194,for,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60195,children,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60196,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60197,adults,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60198,.,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60449,In,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60450,addition,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60451,",",O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60452,we,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60453,also,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60454,did,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60455,not,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60456,observe,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60457,any,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60458,association,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60459,with,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60460,prostate,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60461,cancer,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60462,for,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60463,beer,B-AG.01.y.01.b,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60464,",",O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60465,white,B-AG.01.y.01.a,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60466,wine,I-AG.01.y.01.a,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60467,",",O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60468,liquor,B-AG.01.y.01,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60469,or,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60470,combined,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60471,alcoholic,B-AG.01.y.01,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60472,beverage,I-AG.01.y.01,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60473,intake,B-X,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60474,(,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60475,HR,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60476,for,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60477,combined,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60478,alcoholic,B-AG.01.y.01,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60479,beverage,I-AG.01.y.01,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60480,intake,B-X,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60481,of,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60482,>,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60483,or,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60484,=,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60485,5,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60486,drinks,B-AG.01.y,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60487,/,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60488,day,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60489,=,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60490,1.16,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60491,(,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60492,0.83,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60493,-,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60494,1.63,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60495,),O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60496,.,O,2094.0,"In addition , we also did not observe any association with prostate cancer for beer , white wine , liquor or combined alcoholic beverage intake ( HR for combined alcoholic beverage intake of > or = 5 drinks / day = 1.16 ( 0.83 - 1.63 ) ."
60718,Consumers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60719,who,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60720,are,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60721,predominately,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60722,beer,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60723,drinkers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60724,were,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60725,more,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60726,heavily,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60727,influenced,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60728,by,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60729,nutritional,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60730,information,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60731,than,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60732,consumers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60733,who,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60734,were,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60735,predominately,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60736,wine,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60737,drinkers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60738,.,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
61304,Moreover,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61305,",",O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61306,cocoa,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61307,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61308,rich,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61309,diet,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61310,suppressed,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61311,c,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61312,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61313,Jun,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61314,N,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61315,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61316,terminal,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61317,kinase,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61318,and,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61319,p38,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61320,activation,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61321,caused,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61322,by,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61323,insulin,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61324,resistance,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61325,.,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61349,Many,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61350,countries,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61351,set,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61352,quantitative,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61353,targets,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61354,for,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61355,added,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61356,sugars,B-AG.01.l.02,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61357,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61358,justifying,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61359,this,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61360,by,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61361,expressing,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61362,concern,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61363,about,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61364,the,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61365,likely,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61366,impact,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61367,of,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61368,sugar,B-AG.01.l.02,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61369,on,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61370,weight,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61371,control,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61372,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61373,dental,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61374,health,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61375,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61376,diet,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61377,quality,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61378,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61379,or,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61380,metabolic,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61381,syndrome,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61382,.,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61992,This,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61993,review,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61994,summarizes,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61995,the,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61996,potential,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61997,role,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61998,of,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
61999,dietary,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62000,natural,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62001,products,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62002,and,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62003,their,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62004,major,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62005,bioactive,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62006,components,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62007,in,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62008,prevention,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62009,and,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62010,treatment,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62011,of,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62012,breast,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62013,cancer,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62014,",",O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62015,and,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62016,special,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62017,attention,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62018,was,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62019,paid,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62020,to,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62021,the,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62022,mechanisms,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62023,of,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62024,action,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62025,.,O,2150.0,"This review summarizes the potential role of dietary natural products and their major bioactive components in prevention and treatment of breast cancer , and special attention was paid to the mechanisms of action ."
62100,Fruit,B-AG.01.h,2153.0,Fruit and vegetable consumption was assessed at baseline .
62101,and,I-AG.01.h,2153.0,Fruit and vegetable consumption was assessed at baseline .
62102,vegetable,I-AG.01.h,2153.0,Fruit and vegetable consumption was assessed at baseline .
62103,consumption,B-X,2153.0,Fruit and vegetable consumption was assessed at baseline .
62104,was,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62105,assessed,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62106,at,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62107,baseline,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62108,.,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62295,Attenuation,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62296,of,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62297,the,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62298,risk,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62299,estimates,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62300,from,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62301,dietary,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62302,changes,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62303,over,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62304,time,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62305,can,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62306,not,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62307,be,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62308,excluded,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62309,",",O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62310,but,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62311,appears,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62312,unlikely,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62313,.,O,2161.0,"Attenuation of the risk estimates from dietary changes over time can not be excluded , but appears unlikely ."
62500,This,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62501,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62502,confirmed,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62503,by,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62504,bronchial,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62505,challenge,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62506,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62507,",",O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62508,but,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62509,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62510,comparison,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62511,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62512,not,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62513,obviously,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62514,consistent,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62515,with,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62516,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62517,results,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62518,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62519,prick,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62520,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62521,or,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62522,estimation,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62523,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62524,histamine,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62525,released,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62526,from,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62527,his,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62528,leucocytes,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62529,.,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62626,Heating,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62627,of,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62628,the,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62629,food,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62630,remarkably,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62631,reduced,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62632,the,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62633,activity,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62634,of,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62635,apple,B-AG.01.h.01.c,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62636,",",O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62637,hazelnut,B-AG.01.h.01.f,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62638,",",O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62639,and,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62640,celeriac,B-AG.01.h.02.a,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62641,",",O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62642,but,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62643,had,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62644,little,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62645,effect,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62646,on,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62647,peanut,B-AG.01.h.01.f,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62648,.,O,2174.0,"Heating of the food remarkably reduced the activity of apple , hazelnut , and celeriac , but had little effect on peanut ."
62716,Variation,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62717,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62718,extraction,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62719,conditions,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62720,had,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62721,little,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62722,effect,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62723,on,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62724,the,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62725,composition,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62726,and,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62727,activity,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62728,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62729,extracts,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62730,from,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62731,hazelnut,B-AG.01.h.01.f,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62732,.,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62898,The,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62899,purpose,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62900,of,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62901,this,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62902,research,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62903,was,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62904,to,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62905,optimize,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62906,the,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62907,production,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62908,of,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62909,wheat,B-AG.01.n.11,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62910,-,I-AG.01.n.11,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62911,free,I-AG.01.n.11,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62912,bread,I-AG.01.n.11,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62913,containing,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62914,carob,B-AG.01.k,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62915,germ,I-AG.01.k,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62916,flour,I-AG.01.k,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62917,",",O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62918,corn,B-AG.01.l,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62919,starch,I-AG.01.l,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62920,",",O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62921,NaCl,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62922,",",O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62923,sucrose,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62924,",",O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62925,hydroxypropyl,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62926,methylcellulose,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62927,(,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62928,HPMC,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62929,),O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62930,",",O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62931,and,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62932,H₂O.,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62933,A,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62934,key,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62935,criterion,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62936,was,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62937,to,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62938,formulate,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62939,viscoelastic,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62940,dough,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62941,similar,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62942,to,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62943,wheat,B-AG.01.n,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62944,dough,I-AG.01.n,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
62945,.,O,2184.0,"The purpose of this research was to optimize the production of wheat - free bread containing carob germ flour , corn starch , NaCl , sucrose , hydroxypropyl methylcellulose ( HPMC ) , and H₂O. A key criterion was to formulate viscoelastic dough similar to wheat dough ."
63125,Carob,B-AG.01.k,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63126,germ,I-AG.01.k,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63127,flour,I-AG.01.k,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63128,may,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63129,be,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63130,used,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63131,as,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63132,an,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63133,alternative,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63134,to,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63135,wheat,B-AG.01.k,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63136,flour,I-AG.01.k,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63137,in,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63138,formulating,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63139,viscoelastic,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63140,dough,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63141,and,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63142,high,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63143,quality,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63144,gluten,B-AG.01.n.11,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63145,-,I-AG.01.n.11,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63146,free,I-AG.01.n.11,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63147,bread,I-AG.01.n.11,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63148,.,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63149,Changing,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63150,patterns,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63151,of,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63152,esophageal,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63153,squamous,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63154,cell,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63155,carcinoma,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63156,(,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63157,ESCC,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63158,),O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63159,and,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63160,esophageal,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63161,adenocarcinoma,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63162,(,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63163,EAC,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63164,),O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63165,incidence,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63166,worldwide,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63167,suggest,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63168,distinct,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63169,etiologies,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63170,.,O,2192.0,Changing patterns of esophageal squamous cell carcinoma ( ESCC ) and esophageal adenocarcinoma ( EAC ) incidence worldwide suggest distinct etiologies .
63592,The,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63593,rapidly,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63594,digestible,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63595,starch,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63596,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63597,RDS,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63598,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63599,content,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63600,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63601,estimated,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63602,glycemic,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63603,index,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63604,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63605,eGI,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63606,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63607,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63608,as,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63609,cooking,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63610,temperature,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63611,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63612,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63613,the,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63614,ratio,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63615,of,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63616,water,B-AG.01.z,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63617,to,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63618,rice,B-AG.01.i,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63619,increased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63620,.,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63878,The,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63879,Bland,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63880,Altman,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63881,plots,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63882,were,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63883,used,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63884,as,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63885,an,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63886,alternative,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63887,and,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63888,new,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63889,method,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63890,.,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63891,Two,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63892,factors,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63893,were,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63894,retained,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63895,for,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63896,both,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63897,women,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63898,and,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63899,men,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63900,",",O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63901,which,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63902,accounted,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63903,for,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63904,15.1,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63905,-,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63906,17.4,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63907,%,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63908,of,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63909,the,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63910,total,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63911,variation,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63912,.,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63913,The,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63914,',O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63915,Traditional,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63916,',O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63917,pattern,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63918,was,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63919,characterised,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63920,by,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63921,high,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63922,loadings,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63923,(,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63924,>,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63925,or,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63926,=,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63927,0.40,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63928,),O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63929,on,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63930,paté,B-AG.01.n.06,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63931,or,I-AG.01.n.06,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63932,high,I-AG.01.n.06,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63933,-,I-AG.01.n.06,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63934,fat,I-AG.01.n.06,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63935,meat,I-AG.01.n.06,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63936,for,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63937,sandwiches,B-AG.01.n.11,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63938,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63939,mayonnaise,B-AG.01.n,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63940,salads,I-AG.01.n,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63941,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63942,red,B-AG.01.d,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63943,meat,I-AG.01.d,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63944,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63945,potatoes,B-AG.01.h.02.a,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63946,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63947,butter,B-AG.01.e.01,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63948,and,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63949,lard,B-AG.01.f,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63950,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63951,low,B-AG.01.d.07,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63952,-,I-AG.01.d.07,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63953,fat,I-AG.01.d.07,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63954,fish,I-AG.01.d.07,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63955,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63956,low,B-AG.01.d,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63957,-,I-AG.01.d,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63958,fat,I-AG.01.d,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63959,meat,I-AG.01.d,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63960,for,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63961,sandwiches,B-AG.01.n.11,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63962,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63963,and,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63964,sauces,B-AG.01.l.04,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63965,.,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
64799,The,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64800,application,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64801,of,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64802,ISWs,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64803,caused,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64804,an,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64805,increase,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64806,in,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64807,heavy,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64808,metal,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64809,contents,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64810,of,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64811,tomato,B-AG.01.h.02.f,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64812,plants,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64813,.,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
65329,We,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65330,conclude,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65331,that,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65332,ethanol,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65333,",",O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65334,particularly,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65335,wine,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65336,ethanol,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65337,",",O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65338,is,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65339,inversely,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65340,related,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65341,to,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65342,CHD,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65343,but,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65344,not,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65345,to,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65346,longevity,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65347,in,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65348,populations,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65349,.,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65980,While,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65981,Plenish,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65982,induced,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65983,less,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65984,insulin,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65985,resistance,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65986,than,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65987,conventional,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65988,soybean,B-AG.01.f,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65989,oil,I-AG.01.f,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65990,",",O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65991,it,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65992,resulted,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65993,in,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65994,hepatomegaly,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65995,and,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65996,liver,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65997,dysfunction,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65998,as,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
65999,did,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66000,olive,B-AG.01.f,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66001,oil,I-AG.01.f,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66002,",",O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66003,which,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66004,has,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66005,a,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66006,similar,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66007,fatty,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66008,acid,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66009,composition,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66010,.,O,2301.0,"While Plenish induced less insulin resistance than conventional soybean oil , it resulted in hepatomegaly and liver dysfunction as did olive oil , which has a similar fatty acid composition ."
66031,Increasing,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66032,evidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66033,suggest,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66034,that,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66035,low,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66036,-,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66037,dose,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66038,alcohol,B-AG.01.y.01,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66039,consumption,B-X,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66040,(,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66041,LAC,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66042,),O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66043,reduces,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66044,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66045,incidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66046,and,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66047,improves,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66048,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66049,functional,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66050,outcome,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66051,of,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66052,ischemic,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66053,stroke,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66054,.,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66496,Cancer,O,2322.0,Cancer is one of the leading causes of death worldwide .
66497,is,O,2322.0,Cancer is one of the leading causes of death worldwide .
66498,one,O,2322.0,Cancer is one of the leading causes of death worldwide .
66499,of,O,2322.0,Cancer is one of the leading causes of death worldwide .
66500,the,O,2322.0,Cancer is one of the leading causes of death worldwide .
66501,leading,O,2322.0,Cancer is one of the leading causes of death worldwide .
66502,causes,O,2322.0,Cancer is one of the leading causes of death worldwide .
66503,of,O,2322.0,Cancer is one of the leading causes of death worldwide .
66504,death,O,2322.0,Cancer is one of the leading causes of death worldwide .
66505,worldwide,O,2322.0,Cancer is one of the leading causes of death worldwide .
66506,.,O,2322.0,Cancer is one of the leading causes of death worldwide .
66611,In,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66612,this,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66613,review,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66614,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66615,Part,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66616,2,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66617,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66618,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66619,we,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66620,present,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66621,a,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66622,research,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66623,overview,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66624,conducted,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66625,on,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66626,some,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66627,plants,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66628,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66629,vegetables,B-AG.01.h.02,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66630,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66631,spirulina,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66632,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66633,broccoli,B-AG.01.h.02.d,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66634,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66635,chamomile,B-AG.01.h.02.i,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66636,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66637,cocoa,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66638,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66639,ginger,B-AG.01.l.03,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66640,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66641,laurel,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66642,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66643,marigold,B-AG.01.h.02,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66644,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66645,roselle,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66646,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66647,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66648,rosemary,B-AG.01.h.02.i,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66649,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66650,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66651,which,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66652,are,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66653,frequently,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66654,consumed,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66655,by,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66656,humans,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66657,.,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66709,An,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66710,association,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66711,between,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66712,alcohol,B-AG.01.y.01,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66713,consumption,B-X,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66714,and,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66715,prostate,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66716,cancer,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66717,risk,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66718,remains,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66719,uncertain,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66720,.,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66797,Incident,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66798,prostate,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66799,cancers,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66800,(,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66801,n,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66802,=,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66803,816,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66804,),O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66805,as,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66806,of,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66807,December,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66808,31,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66809,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66810,2004,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66811,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66812,were,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66813,identified,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66814,through,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66815,the,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66816,Surveillance,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66817,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66818,Epidemiology,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66819,",",O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66820,and,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66821,End,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66822,Results,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66823,cancer,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66824,registry,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
66825,.,O,2333.0,"Incident prostate cancers ( n = 816 ) as of December 31 , 2004 , were identified through the Surveillance , Epidemiology , and End Results cancer registry ."
67206,Boiling,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67207,red,B-AG.01.i,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67208,rice,I-AG.01.i,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67209,with,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67210,ghee,B-AG.01.e.01,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67211,or,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67212,cooking,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67213,red,B-AG.01.i,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67214,rice,I-AG.01.i,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67215,with,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67216,ghee,B-AG.01.e.01,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67217,pilaf,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67218,-,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67219,style,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67220,may,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67221,provide,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67222,beneficial,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67223,effects,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67224,on,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67225,postprandial,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67226,blood,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67227,glucose,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67228,and,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67229,insulin,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67230,concentrations,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67231,",",O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67232,and,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67233,improve,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67234,colonic,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67235,health,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67236,.,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67758,One,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67759,of,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67760,the,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67761,greatest,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67762,challenges,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67763,is,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67764,to,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67765,reduce,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67766,malnutrition,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67767,worldwide,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67768,while,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67769,promoting,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67770,sustainable,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67771,agricultural,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67772,and,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67773,food,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67774,systems,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
67775,.,O,2367.0,One of the greatest challenges is to reduce malnutrition worldwide while promoting sustainable agricultural and food systems .
68163,The,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68164,literature,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68165,on,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68166,wheat,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68167,gluten,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68168,is,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68169,vast,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68170,and,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68171,extends,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68172,back,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68173,over,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68174,two,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68175,centuries,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68176,",",O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68177,with,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68178,most,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68179,studies,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68180,focusing,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68181,on,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68182,the,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68183,structures,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68184,of,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68185,gluten,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68186,proteins,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68187,and,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68188,their,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68189,role,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68190,in,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68191,determining,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68192,the,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68193,functional,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68194,properties,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68195,of,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68196,wheat,B-AG.01.k,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68197,flour,I-AG.01.k,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68198,and,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68199,dough,B-AG.01.n,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68200,.,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68702,This,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68703,study,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68704,estimated,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68705,the,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68706,potential,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68707,reductions,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68708,in,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68709,body,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68710,weight,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68711,",",O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68712,obesity,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68713,-,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68714,related,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68715,disease,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68716,incidence,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68717,",",O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68718,and,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68719,healthcare,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68720,cost,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68721,savings,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68722,associated,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68723,with,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68724,consumption,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68725,of,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68726,one,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68727,less,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68728,serving,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68729,per,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68730,week,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68731,of,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68732,different,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68733,discretionary,B-AG.01,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68734,foods,I-AG.01,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68735,.,O,2397.0,"This study estimated the potential reductions in body weight , obesity - related disease incidence , and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods ."
68906,A,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68907,decrease,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68908,of,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68909,one,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68910,serving,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68911,of,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68912,sweet,B-AG.01.n.14,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68913,biscuits,I-AG.01.n.14,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68914,had,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68915,the,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68916,second,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68917,largest,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68918,potential,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68919,impact,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68920,on,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68921,weight,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68922,change,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68923,overall,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68924,",",O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68925,with,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68926,healthcare,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68927,cost,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68928,savings,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68929,of,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68930,$,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68931,640.7,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68932,M,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68933,(,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68934,95,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68935,%,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68936,CI,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68937,:,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68938,$,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68939,402.6,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68940,M,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68941,to,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68942,$,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68943,885.8,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68944,M,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68945,),O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68946,and,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68947,the,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68948,largest,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68949,potential,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68950,weight,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68951,reduction,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68952,amongst,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68953,those,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68954,aged,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68955,75,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68956,years,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68957,and,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68958,over,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68959,(,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68960,mean,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68961,0.21,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68962,kg,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68963,",",O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68964,95,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68965,%,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68966,UI,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68967,:,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68968,0.14,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68969,kg,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68970,to,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68971,0.27,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68972,kg,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68973,),O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68974,.,O,2402.0,"A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall , with healthcare cost savings of $ 640.7 M ( 95 % CI : $ 402.6 M to $ 885.8 M ) and the largest potential weight reduction amongst those aged 75 years and over ( mean 0.21 kg , 95 % UI : 0.14 kg to 0.27 kg ) ."
68975,The,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68976,results,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68977,demonstrate,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68978,that,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68979,small,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68980,reductions,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68981,in,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68982,discretionary,B-AG.01,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68983,food,I-AG.01,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68984,consumption,B-X,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68985,are,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68986,likely,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68987,to,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68988,have,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68989,substantial,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68990,health,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68991,benefits,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68992,at,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68993,the,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68994,population,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68995,level,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68996,.,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
69307,Whatever,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69308,the,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69309,tested,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69310,meals,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69311,",",O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69312,foods,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69313,elicited,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69314,a,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69315,growing,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69316,glycemic,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69317,index,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69318,hierarchy,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69319,from,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69320,beans,B-AG.01.h.02.g,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69321,to,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69322,lentils,B-AG.01.h.02.g,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69323,",",O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69324,rice,B-AG.01.i,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69325,",",O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69326,spaghetti,B-AG.01.n,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69327,",",O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69328,potato,B-AG.01.h.02.a,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69329,",",O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69330,and,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69331,bread,B-AG.01.n.11,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69332,(,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69333,mean,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69334,range,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69335,:,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69336,0.21,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69337,+,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69338,/-,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69339,0.12,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69340,-,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69341,92,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69342,+,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69343,/-,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69344,0.12,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69345,",",O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69346,p,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69347,less,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69348,than,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69349,0.001,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69350,),O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69351,.,O,2416.0,"Whatever the tested meals , foods elicited a growing glycemic index hierarchy from beans to lentils , rice , spaghetti , potato , and bread ( mean range : 0.21 + /- 0.12 - 92 + /- 0.12 , p less than 0.001 ) ."
69558,Meat,B-AG.01.d,2424.0,Meat is sometimes added .
69559,is,O,2424.0,Meat is sometimes added .
69560,sometimes,O,2424.0,Meat is sometimes added .
69561,added,O,2424.0,Meat is sometimes added .
69562,.,O,2424.0,Meat is sometimes added .
70041,Roasted,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70042,peanuts,B-AG.01.h.01.f,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70043,contain,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70044,61,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70045,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70046,114,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70047,mg,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70048,PS/100,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70049,g,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70050,depending,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70051,on,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70052,the,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70053,peanut,B-AG.01.h.01.f,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70054,variety,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70055,",",O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70056,78,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70057,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70058,83,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70059,%,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70060,of,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70061,which,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70062,is,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70063,in,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70064,the,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70065,form,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70066,of,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70067,beta,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70068,-,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70069,sitosterol,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70070,.,O,2441.0,"Roasted peanuts contain 61 - 114 mg PS/100 g depending on the peanut variety , 78 - 83 % of which is in the form of beta - sitosterol ."
70455,In,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70456,addition,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70457,",",O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70458,dietary,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70459,EW,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70460,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70461,EWH,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70462,decreased,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70463,stearoyl,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70464,-,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70465,CoA,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70466,desaturase,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70467,(,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70468,SCD,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70469,),O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70470,indices,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70471,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70472,glucose-6,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70473,-,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70474,phosphate,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70475,dehydrogenase,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70476,activity,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70477,of,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70478,the,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70479,liver,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70480,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70481,gastrocnemius,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70482,muscle,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70483,.,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70662,Total,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70663,frequency,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70664,of,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70665,usual,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70666,milk,B-AG.01.e,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70667,intake,B-X,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70668,was,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70669,not,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70670,associated,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70671,with,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70672,increased,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70673,risk,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70674,.,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70916,The,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70917,multivariate,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70918,RR,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70919,(,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70920,95,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70921,%,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70922,CI,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70923,),O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70924,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70925,comparing,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70926,highest,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70927,to,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70928,lowest,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70929,quintiles,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70930,of,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70931,cumulative,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70932,average,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70933,intake,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70934,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70935,was,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70936,1.05,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70937,(,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70938,0.83,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70939,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70940,1.34,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70941,;,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70942,p,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70943,-,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70944,value,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70945,for,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70946,test,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70947,of,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70948,trend=0.96,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70949,),O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70950,for,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70951,the,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70952,sum,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70953,of,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70954,flavonols,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70955,and,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70956,there,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70957,were,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70958,no,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70959,associations,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70960,seen,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70961,between,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70962,individual,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70963,flavonols,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70964,such,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70965,as,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70966,kaempferol,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70967,",",O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70968,quercetin,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70969,and,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70970,myricetin,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70971,and,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70972,breast,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70973,cancer,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70974,risk,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
70975,.,O,2472.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 1.05 ( 0.83 , 1.34 ; p - value for test of trend=0.96 ) for the sum of flavonols and there were no associations seen between individual flavonols such as kaempferol , quercetin and myricetin and breast cancer risk ."
71401,Data,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71402,from,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71403,the,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71404,North,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71405,West,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71406,Adelaide,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71407,Health,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71408,Study,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71409,",",O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71410,a,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71411,population,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71412,-,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71413,based,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71414,cohort,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71415,study,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71416,undertaken,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71417,in,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71418,Australia,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71419,",",O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71420,were,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71421,used,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71422,to,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71423,assess,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71424,this,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71425,association,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71426,among,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71427,adults,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71428,aged,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71429,50,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71430,years,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71431,and,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71432,above,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71433,.,O,2484.0,"Data from the North West Adelaide Health Study , a population - based cohort study undertaken in Australia , were used to assess this association among adults aged 50 years and above ."
71698,The,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71699,aim,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71700,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71701,this,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71702,study,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71703,was,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71704,to,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71705,test,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71706,the,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71707,effect,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71708,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71709,replacing,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71710,soybean,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71711,hulls,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71712,with,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71713,different,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71714,doses,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71715,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71716,cocoa,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71717,husk,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71718,(,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71719,CH,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71720,),O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71721,on,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71722,milk,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71723,production,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71724,traits,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71725,and,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71726,the,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71727,hematological,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71728,profile,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71729,of,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71730,dairy,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71731,ewes,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71732,.,O,2493.0,The aim of this study was to test the effect of replacing soybean hulls with different doses of cocoa husk ( CH ) on milk production traits and the hematological profile of dairy ewes .
71799,In,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71800,the,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71801,second,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71802,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71803,",",O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71804,soybean,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71805,hulls,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71806,were,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71807,replaced,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71808,with,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71809,50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71810,g,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71811,of,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71812,CH,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71813,/,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71814,d,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71815,(,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71816,CH50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71817,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71818,),O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71819,.,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
72470,A,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72471,"""",O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72472,Western,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72473,"""",O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72474,dietary,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72475,pattern,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72476,after,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72477,surgery,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72478,is,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72479,inversely,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72480,associated,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72481,with,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72482,QoL,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72483,in,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72484,CRC,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72485,patients,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72486,",",O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72487,whereas,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72488,a,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72489,diet,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72490,rich,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72491,in,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72492,fruits,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72493,and,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72494,vegetables,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72495,may,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72496,be,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72497,beneficial,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72498,for,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72499,patients,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72500,',O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72501,QoL,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72502,over,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72503,time,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72504,.,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72673,The,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72674,wild,B-AG.01.h.02,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72675,vegetable,I-AG.01.h.02,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72676,could,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72677,be,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72678,promoted,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72679,as,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72680,a,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72681,protein,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72682,supplement,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72683,for,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72684,cereal,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72685,-,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72686,based,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72687,diets,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72688,in,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72689,poor,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72690,rural,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72691,communities,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72692,",",O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72693,while,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72694,its,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72695,high,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72696,potassium,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72697,content,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72698,could,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72699,be,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72700,utilized,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72701,for,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72702,the,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72703,management,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72704,of,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72705,hypertension,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72706,and,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72707,other,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72708,cardiovascular,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72709,conditions,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72710,.,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72759,We,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72760,sought,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72761,to,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72762,examine,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72763,relationships,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72764,between,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72765,energy,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72766,",",O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72767,protein,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72768,and,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72769,calcium,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72770,consumption,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72771,from,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72772,dairy,B-AG.01.e,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72773,foods,I-AG.01.e,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72774,(,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72775,milk,B-AG.01.e,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72776,",",O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72777,yoghurt,B-AG.01.e,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72778,",",O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72779,cheese,B-AG.01.e.02,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72780,",",O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72781,dairy,B-AG.01.e,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72782,spreads,I-AG.01.e,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72783,",",O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72784,ice,B-AG.01.n.17.b,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72785,-,I-AG.01.n.17.b,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72786,cream,I-AG.01.n.17.b,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72787,),O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72788,and,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72789,adiposity,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72790,including,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72791,body,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72792,mass,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72793,index,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72794,(,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72795,BMI,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72796,),O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72797,",",O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72798,waist,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72799,(,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72800,WC,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72801,),O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72802,and,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72803,hip,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72804,circumference,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72805,(,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72806,HC,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72807,),O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72808,",",O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72809,and,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72810,direct,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72811,measures,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72812,of,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72813,body,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72814,composition,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72815,using,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72816,dual,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72817,energy,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72818,X,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72819,-,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72820,ray,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72821,absorptiometry,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72822,(,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72823,%,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72824,body,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72825,fat,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72826,and,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72827,abdominal,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72828,fat,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72829,),O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72830,in,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72831,an,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72832,opportunistic,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72833,sample,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72834,of,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72835,720,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72836,overweight,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72837,/,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72838,obese,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72839,Australian,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72840,men,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72841,and,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72842,women,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
72843,.,O,2529.0,"We sought to examine relationships between energy , protein and calcium consumption from dairy foods ( milk , yoghurt , cheese , dairy spreads , ice - cream ) and adiposity including body mass index ( BMI ) , waist ( WC ) and hip circumference ( HC ) , and direct measures of body composition using dual energy X - ray absorptiometry ( % body fat and abdominal fat ) in an opportunistic sample of 720 overweight / obese Australian men and women ."
73174,The,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73175,type,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73176,of,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73177,the,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73178,garlic,B-AG.01,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73179,products,I-AG.01,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73180,may,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73181,be,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73182,another,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73183,important,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73184,factor,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73185,responsible,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73186,for,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73187,the,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73188,conflicting,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73189,outcomes,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73190,",",O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73191,as,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73192,different,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73193,garlic,B-AG.01,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73194,products,I-AG.01,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73195,are,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73196,composed,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73197,of,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73198,different,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73199,organosulfur,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73200,compounds,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73201,.,O,2541.0,"The type of the garlic products may be another important factor responsible for the conflicting outcomes , as different garlic products are composed of different organosulfur compounds ."
73415,The,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73416,medians,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73417,of,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73418,milk,B-AG.01.e,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73419,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73420,yogurt,B-AG.01.e,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73421,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73422,cheese,B-AG.01.e.02,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73423,consumption,B-X,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73424,were,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73425,293,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73426,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73427,interquartile,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73428,range,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73429,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73430,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73431,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73432,146,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73433,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73434,439,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73435,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73436,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73437,35·3,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73438,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73439,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73440,8·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73441,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73442,71·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73443,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73444,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73445,14·6,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73446,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73447,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73448,4·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73449,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73450,26·9,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73451,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73452,g,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73453,/,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73454,d,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73455,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73456,respectively,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73457,.,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
74357,Skin,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74358,prick,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74359,tests,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74360,(,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74361,SPT,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74362,),O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74363,for,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74364,the,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74365,more,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74366,important,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74367,inhalant,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74368,allergens,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74369,and,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74370,foods,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74371,were,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74372,performed,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74373,on,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74374,all,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74375,children,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74376,.,O,2582.0,Skin prick tests ( SPT ) for the more important inhalant allergens and foods were performed on all children .
74445,Of,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74446,326,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74447,atopic,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74448,children,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74449,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74450,10,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74451,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74452,3,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74453,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74454,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74455,presented,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74456,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74457,skin,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74458,test,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74459,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74460,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74461,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74462,but,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74463,only,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74464,five,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74465,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74466,1.5,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74467,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74468,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74469,also,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74470,had,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74471,a,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74472,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74473,clinical,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74474,history,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74475,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74476,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74477,exposure,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74478,.,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74628,The,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74629,natural,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74630,history,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74631,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74632,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74633,positive,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74634,-,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74635,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74636,-,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74637,SPT,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74638,children,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74639,without,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74640,clinical,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74641,reactions,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74642,to,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74643,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74644,exposure,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74645,and,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74646,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74647,clinical,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74648,significance,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74649,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74650,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74651,association,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74652,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74653,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74654,and,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74655,fruit,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74656,sensitivity,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74657,require,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74658,further,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74659,studies,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74660,.,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74672,PAs,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74673,have,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74674,been,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74675,reported,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74676,to,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74677,be,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74678,hepatotoxic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74679,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74680,mutagenic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74681,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74682,and,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74683,carcinogenic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74684,;,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74685,they,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74686,are,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74687,a,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74688,significant,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74689,group,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74690,of,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74691,natural,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74692,toxins,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74693,affecting,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74694,livestock,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74695,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74696,wildlife,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74697,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74698,and,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74699,humans,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74700,.,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74906,The,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74907,folic,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74908,acid,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74909,analytical,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74910,values,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74911,together,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74912,with,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74913,national,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74914,food,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74915,consumption,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74916,data,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74917,were,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74918,used,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74919,to,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74920,generate,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74921,estimates,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74922,of,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74923,the,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74924,population,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74925,'s,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74926,folic,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74927,acid,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74928,intake,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74929,from,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74930,fortified,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74931,foods,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
74932,.,O,2603.0,The folic acid analytical values together with national food consumption data were used to generate estimates of the population 's folic acid intake from fortified foods .
75107,Changes,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75108,in,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75109,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75110,chemical,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75111,modification,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75112,of,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75113,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75114,milk,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75115,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75116,were,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75117,monitored,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75118,by,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75119,measuring,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75120,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75121,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75122,-,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75123,bound,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75124,carbonyls,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75125,and,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75126,PAGE,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75127,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75128,profiles,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75129,.,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75356,In,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75357,patients,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75358,with,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75359,excessive,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75360,loss,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75361,of,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75362,salt,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75363,in,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75364,the,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75365,sweat,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75366,or,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75367,poor,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75368,salt,B-AG.01.l.01,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75369,intake,B-X,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75370,",",O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75371,the,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75372,maintenance,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75373,of,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75374,metabolic,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75375,alkalosis,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75376,is,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75377,crucially,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75378,modulated,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75379,by,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75380,the,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75381,chloride,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75382,-,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75383,bicarbonate,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75384,exchanger,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75385,pendrin,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75386,located,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75387,on,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75388,the,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75389,renal,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75390,tubular,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75391,membrane,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75392,of,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75393,type,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75394,B,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75395,intercalated,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75396,cells,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75397,.,O,2620.0,"In patients with excessive loss of salt in the sweat or poor salt intake , the maintenance of metabolic alkalosis is crucially modulated by the chloride - bicarbonate exchanger pendrin located on the renal tubular membrane of type B intercalated cells ."
75508,In,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75509,all,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75510,cases,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75511,",",O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75512,both,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75513,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75514,clinical,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75515,and,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75516,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75517,laboratory,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75518,features,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75519,remitted,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75520,in,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75521,≤7,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75522,days,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75523,when,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75524,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75525,infants,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75526,were,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75527,fed,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75528,on,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75529,formula,B-AG.01,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75530,milk,I-AG.01,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75531,with,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75532,a,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75533,normal,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75534,chloride,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75535,content,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75536,.,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75763,Nevertheless,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75764,",",O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75765,we,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75766,suggest,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75767,dietary,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75768,guidelines,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75769,for,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75770,prevention,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75771,of,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75772,CHD,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75773,in,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75774,Spain,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75775,.,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
76420,Low,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76421,-,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76422,producing,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76423,cows,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76424,had,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76425,a,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76426,greater,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76427,risk,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76428,of,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76429,prolonged,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76430,milk,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76431,residues,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76432,.,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76536,This,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76537,model,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76538,extends,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76539,the,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76540,verification,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76541,of,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76542,a,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76543,simple,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76544,physiologically,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76545,based,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76546,framework,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76547,for,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76548,the,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76549,study,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76550,of,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76551,intramammary,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76552,drugs,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
76553,.,O,2659.0,This model extends the verification of a simple physiologically based framework for the study of intramammary drugs .
77705,Epidemiological,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77706,data,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77707,regarding,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77708,tea,B-AG.01.ac,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77709,and,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77710,coffee,B-AG.01.ad,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77711,consumption,B-X,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77712,and,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77713,risk,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77714,of,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77715,esophageal,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77716,cancer,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77717,(,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77718,EC,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77719,),O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77720,is,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77721,still,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77722,inconclusive,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
77723,.,O,2696.0,Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer ( EC ) is still inconclusive .
78011,Ovarian,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78012,cancer,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78013,is,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78014,commonly,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78015,a,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78016,fatal,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78017,disease,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78018,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78019,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78020,despite,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78021,advances,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78022,in,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78023,screening,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78024,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78025,treatment,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78026,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78027,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78028,lack,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78029,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78030,understanding,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78031,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78032,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78033,underlying,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78034,etiology,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78035,has,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78036,limited,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78037,prevention,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78038,strategies,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78039,.,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78066,We,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78067,identified,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78068,7,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78069,cohort,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78070,studies,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78071,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78072,27,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78073,case,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78074,-,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78075,control,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78076,studies,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78077,of,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78078,consumption,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78079,of,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78080,major,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78081,food,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78082,groups,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78083,(,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78084,fruits,B-AG.01.h.01,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78085,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78086,vegetables,B-AG.01.h.02,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78087,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78088,meats,B-AG.01.d,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78089,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78090,eggs,B-AG.01.g,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78091,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78092,fish,B-AG.01.d.07,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78093,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78094,dairy,B-AG.01.e,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78095,products,I-AG.01.e,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78096,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78097,grains,B-AG.01.i,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78098,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78099,fats,B-AG.01.f,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78100,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78101,oils,B-AG.01.f,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78102,),O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78103,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78104,EOC,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78105,risk,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78106,.,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78107,Vegetable,B-AG.01.h.02,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78108,but,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78109,not,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78110,fruit,B-AG.01.h.01,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78111,consumption,B-X,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78112,was,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78113,found,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78114,to,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78115,possibly,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78116,exhibit,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78117,beneficial,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78118,effects,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78119,on,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78120,the,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78121,risk,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78122,of,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78123,EOC,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78124,",",O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78125,whereas,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78126,high,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78127,meat,B-AG.01.d,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78128,consumption,B-X,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78129,may,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78130,be,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78131,associated,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78132,with,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78133,an,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78134,increased,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78135,risk,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78136,.,O,2709.0,"Vegetable but not fruit consumption was found to possibly exhibit beneficial effects on the risk of EOC , whereas high meat consumption may be associated with an increased risk ."
78517,Although,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78518,the,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78519,inverse,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78520,association,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78521,between,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78522,coffee,B-AG.01.ad,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78523,consumption,B-X,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78524,and,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78525,risk,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78526,of,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78527,diabetes,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78528,has,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78529,been,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78530,reported,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78531,numerous,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78532,times,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78533,",",O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78534,the,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78535,role,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78536,of,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78537,caffeine,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78538,intake,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78539,in,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78540,this,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78541,association,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78542,has,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78543,remained,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78544,unclear,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78545,.,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78546,We,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78547,evaluated,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78548,the,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78549,consumption,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78550,of,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78551,coffee,B-AG.01.ad,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78552,and,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78553,other,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78554,beverages,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78555,and,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78556,food,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78557,containing,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78558,caffeine,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78559,in,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78560,relation,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78561,to,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78562,the,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78563,incidence,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78564,of,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78565,diabetes,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78566,.,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78974,High,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78975,consumption,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78976,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78977,margarine,B-AG.01.f,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78978,exerted,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78979,a,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78980,significant,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78981,protection,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78982,against,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78983,cancer,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78984,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78985,the,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78986,colon,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78987,whereas,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78988,high,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78989,consumption,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78990,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78991,carrot,B-AG.01.h.02.a,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78992,spinach,B-AG.01.h.02.c,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78993,",",O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78994,whole,B-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78995,-,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78996,grain,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78997,bread,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78998,and,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78999,pasta,B-AG.01.i,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79000,(,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79001,favorably,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79002,),O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79003,and,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79004,red,B-AG.01.d,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79005,meat,I-AG.01.d,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79006,(,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79007,unfavorably,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79008,),O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79009,affected,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79010,rectal,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79011,cancer,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79012,risk,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79013,in,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79014,particular,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79015,.,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79016,Thus,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79017,the,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79018,present,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79019,study,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79020,gives,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79021,support,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79022,for,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79023,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79024,protective,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79025,effect,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79026,associated,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79027,with,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79028,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79029,fiber,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79030,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79031,rich,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79032,or,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79033,vegetable,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79034,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79035,rich,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79036,diet,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79037,",",O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79038,while,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79039,it,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79040,indicates,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79041,that,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79042,frequent,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79043,consumption,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79044,of,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79045,refined,B-AG.01,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79046,starchy,I-AG.01,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79047,foods,I-AG.01,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79048,",",O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79049,eggs,B-AG.01.g,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79050,and,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79051,fat,B-AG.01,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79052,-,I-AG.01,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79053,rich,I-AG.01,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79054,foods,I-AG.01,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79055,such,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79056,as,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79057,cheese,B-AG.01.e.02,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79058,and,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79059,red,B-AG.01.d,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79060,meat,I-AG.01.d,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79061,is,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79062,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79063,risk,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79064,factor,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79065,for,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79066,colo,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79067,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79068,rectal,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79069,cancer,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79070,.,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79085,They,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79086,are,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79087,rich,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79088,in,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79089,fiber,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79090,and,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79091,phytochemicals,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79092,such,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79093,as,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79094,phenolic,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79095,compounds,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
79096,.,O,2739.0,They are rich in fiber and phytochemicals such as phenolic compounds .
80058,White,B-AG.01,2774.0,White - green foods in the onion family contain allyl sulfides .
80059,-,I-AG.01,2774.0,White - green foods in the onion family contain allyl sulfides .
80060,green,I-AG.01,2774.0,White - green foods in the onion family contain allyl sulfides .
80061,foods,I-AG.01,2774.0,White - green foods in the onion family contain allyl sulfides .
80062,in,O,2774.0,White - green foods in the onion family contain allyl sulfides .
80063,the,O,2774.0,White - green foods in the onion family contain allyl sulfides .
80064,onion,B-AG.01.h.02.e,2774.0,White - green foods in the onion family contain allyl sulfides .
80065,family,O,2774.0,White - green foods in the onion family contain allyl sulfides .
80066,contain,O,2774.0,White - green foods in the onion family contain allyl sulfides .
80067,allyl,O,2774.0,White - green foods in the onion family contain allyl sulfides .
80068,sulfides,O,2774.0,White - green foods in the onion family contain allyl sulfides .
80069,.,O,2774.0,White - green foods in the onion family contain allyl sulfides .
80271,The,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80272,pyramid,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80273,shows,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80274,that,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80275,carbohydrates,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80276,should,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80277,be,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80278,consumed,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80279,every,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80280,day,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80281,(,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80282,3,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80283,portions,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80284,of,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80285,whole,B-AG.01.i,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80286,grains,I-AG.01.i,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80287,",",O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80288,preferably,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80289,gluten,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80290,free,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80291,),O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80292,",",O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80293,together,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80294,with,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80295,fruits,B-AG.01.h.01,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80296,and,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80297,vegetables,B-AG.01.h.02,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80298,(,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80299,5,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80300,portions,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80301,;,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80302,among,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80303,which,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80304,fruit,B-AG.01.h.01,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80305,",",O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80306,berries,B-AG.01.h.01.b,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80307,and,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80308,citrus,B-AG.01.h.01.a,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80309,fruit,I-AG.01.h.01.a,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80310,are,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80311,to,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80312,be,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80313,preferred,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80314,",",O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80315,and,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80316,among,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80317,the,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80318,vegetables,B-AG.01.h.02,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80319,",",O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80320,green,B-AG.01.h.02.c,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80321,leafy,I-AG.01.h.02.c,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80322,ones,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80323,.,O,2781.0,"The pyramid shows that carbohydrates should be consumed every day ( 3 portions of whole grains , preferably gluten free ) , together with fruits and vegetables ( 5 portions ; among which fruit , berries and citrus fruit are to be preferred , and among the vegetables , green leafy ones ."
80449,The,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80450,food,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80451,pyramid,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80452,allows,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80453,patients,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80454,to,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80455,easily,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80456,figure,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80457,out,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80458,what,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80459,to,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80460,eat,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80461,.,O,2784.0,The food pyramid allows patients to easily figure out what to eat .
80673,An,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80674,increased,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80675,risk,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80676,of,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80677,GBC,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80678,was,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80679,observed,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80680,with,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80681,deep,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80682,frying,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80683,of,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80684,fresh,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80685,fish,B-AG.01.d.07,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80686,in,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80687,mustard,B-AG.01.f,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80688,oil,I-AG.01.f,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80689,(,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80690,OR,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80691,=,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80692,1.57,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80693,",",O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80694,95,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80695,%,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80696,CI,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80697,=,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80698,0.99,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80699,-,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80700,2.47,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80701,",",O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80702,p,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80703,-,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80704,value,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80705,=,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80706,0.052,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80707,),O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80708,.,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80726,No,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80727,association,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80728,was,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80729,observed,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80730,between,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80731,consumption,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80732,of,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80733,meat,B-AG.01.d,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80734,",",O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80735,spicy,B-AG.01,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80736,food,I-AG.01,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80737,",",O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80738,turmeric,B-AG.01.l.03,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80739,",",O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80740,pulses,B-AG.01.h.02.g,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80741,or,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80742,with,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80743,any,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80744,other,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80745,oil,B-AG.01.f,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80746,as,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80747,a,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80748,cooking,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80749,medium,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80750,.,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80780,The,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80781,bioaccessibility,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80782,of,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80783,fat,B-AG.01.f,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80784,has,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80785,implications,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80786,for,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80787,satiety,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80788,and,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80789,postprandial,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80790,lipidaemia,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80791,.,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80970,Microstructural,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80971,examination,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80972,showed,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80973,ruptured,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80974,and,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80975,fissured,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80976,cell,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80977,walls,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80978,that,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80979,would,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80980,allow,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80981,digestion,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80982,of,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80983,cellular,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80984,contents,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80985,",",O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80986,and,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80987,this,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80988,may,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80989,be,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80990,governed,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80991,by,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80992,internal,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80993,cellular,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80994,properties,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80995,such,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80996,as,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80997,oil,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80998,body,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
80999,state,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
81000,.,O,2805.0,"Microstructural examination showed ruptured and fissured cell walls that would allow digestion of cellular contents , and this may be governed by internal cellular properties such as oil body state ."
81116,In,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81117,this,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81118,study,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81119,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81120,a,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81121,new,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81122,approach,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81123,has,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81124,been,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81125,examined,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81126,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81127,based,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81128,on,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81129,previous,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81130,reports,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81131,that,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81132,platelet,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81133,-,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81134,activating,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81135,factor,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81136,(,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81137,PAF,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81138,),O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81139,is,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81140,involved,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81141,in,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81142,atherogenesis,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81143,.,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81385,Every,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81386,other,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81387,week,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81388,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81389,they,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81390,were,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81391,served,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81392,lunches,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81393,composed,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81394,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81395,among,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81396,other,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81397,items,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81398,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81399,of,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81400,green,B-AG.01.h.02.g,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81401,beans,I-AG.01.h.02.g,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81402,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81403,pasta,B-AG.01.i,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81404,with,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81405,varying,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81406,salt,B-AG.01.l.01,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81407,(,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81408,0,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81409,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81410,0·6,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81411,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81412,1·2,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81413, ,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81414,%,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81415,added,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81416,salt,B-AG.01.l.01,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81417,),O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81418,or,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81419,fat,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81420,(,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81421,0,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81422,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81423,2·5,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81424,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81425,5,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81426, ,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81427,%,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81428,added,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81429,butter,B-AG.01.e.01,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81430,),O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81431,levels,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81432,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81433,afternoon,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81434,snacks,B-AG.01,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81435,composed,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81436,of,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81437,fruit,B-AG.01.n.08,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81438,purée,I-AG.01.n.08,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81439,varying,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81440,in,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81441,sugar,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81442,level,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81443,(,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81444,0,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81445,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81446,5,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81447,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81448,10,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81449, ,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81450,%,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81451,added,B-AG.01.l.02,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81452,sugar,I-AG.01.l.02,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81453,),O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81454,.,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81512,This,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81513,implies,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81514,that,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81515,fat,B-AG.01.f,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81516,and,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81517,sugar,B-AG.01.l.02,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81518,addition,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81519,could,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81520,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81521,avoided,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81522,in,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81523,foods,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81524,for,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81525,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81526,without,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81527,having,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81528,an,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81529,impact,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81530,on,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81531,palatability,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81532,",",O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81533,allowing,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81534,the,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81535,energy,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81536,density,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81537,of,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81538,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81539,'s,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81540,diet,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81541,to,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81542,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81543,limited,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81544,.,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81671,Specificities,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81672,and,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81673,positive,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81674,predictive,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81675,accuracies,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81676,were,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81677,low,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81678,for,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81679,all,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81680,allergens,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81681,and,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81682,tests,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81683,.,O,2830.0,Specificities and positive predictive accuracies were low for all allergens and tests .
81966,A,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81967,vegetarian,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81968,diet,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81969,is,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81970,defined,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81971,as,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81972,one,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81973,that,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81974,does,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81975,not,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81976,include,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81977,meat,B-AG.01.d,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81978,(,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81979,including,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81980,fowl,B-AG.01.d.06,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81981,),O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81982,or,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81983,seafood,B-AG.01.d.07,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81984,",",O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81985,or,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81986,products,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81987,containing,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81988,those,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81989,foods,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81990,.,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
82277,Gastric,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82278,pH,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82279,was,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82280,measured,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82281,with,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82282,a,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82283,noninvasive,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82284,intragastric,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82285,probe,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82286,",",O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82287,demonstrating,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82288,that,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82289,administration,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82290,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82291,125,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82292,mL,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82293,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82294,white,B-AG.01.y.01.a,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82295,or,I-AG.01.y.01.a,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82296,red,I-AG.01.y.01.a,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82297,wine,I-AG.01.y.01.a,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82298,to,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82299,healthy,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82300,volunteers,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82301,stimulated,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82302,gastric,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82303,acid,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82304,secretion,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82305,more,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82306,potently,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82307,than,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82308,the,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82309,administration,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82310,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82311,equivalent,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82312,amounts,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82313,of,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82314,ethanol,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82315,.,O,2852.0,"Gastric pH was measured with a noninvasive intragastric probe , demonstrating that administration of 125 mL of white or red wine to healthy volunteers stimulated gastric acid secretion more potently than the administration of equivalent amounts of ethanol ."
82445,However,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82446,",",O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82447,addition,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82448,of,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82449,ethanol,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82450,to,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82451,individual,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82452,organic,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82453,acids,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82454,attenuated,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82455,the,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82456,secretory,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82457,effect,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82458,of,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82459,tartaric,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82460,acid,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82461,",",O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82462,but,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82463,not,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82464,that,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82465,of,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82466,the,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82467,other,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82468,organic,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82469,acids,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82470,.,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
83092,The,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83093,monitoring,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83094,of,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83095,heavy,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83096,metals,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83097,in,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83098,industrialized,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83099,areas,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83100,to,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83101,study,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83102,their,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83103,association,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83104,with,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83105,different,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83106,occupational,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83107,and,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83108,environmental,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83109,factors,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83110,is,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83111,carried,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83112,out,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83113,in,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83114,different,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83115,ways,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83116,.,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83442,In,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83443,the,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83444,current,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83445,study,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83446,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83447,ginger,B-AG.01.l.03,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83448,sequentially,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83449,extracted,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83450,with,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83451,different,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83452,solvents,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83453,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83454,namely,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83455,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83456,hexane,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83457,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83458,ethyl,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83459,acetate,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83460,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83461,methanol,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83462,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83463,70,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83464,%,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83465,methanol,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83466,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83467,water,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83468,and,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83469,water,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83470,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83471,were,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83472,screened,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83473,to,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83474,determine,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83475,the,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83476,variations,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83477,in,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83478,phenolic,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83479,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83480,linked,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83481,active,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83482,constituents,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83483,.,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83617,This,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83618,study,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83619,aimed,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83620,to,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83621,determine,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83622,both,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83623,sensory,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83624,and,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83625,nonsensory,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83626,factors,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83627,that,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83628,might,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83629,affect,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83630,U.S.,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83631,consumers,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83632,',O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83633,acceptability,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83634,of,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83635,Seolgitteok,B-AG.01.n.13,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83636,.,O,2899.0,This study aimed to determine both sensory and nonsensory factors that might affect U.S. consumers ' acceptability of Seolgitteok .
83832,However,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83833,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83834,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83835,removal,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83836,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83837,fat,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83838,often,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83839,impairs,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83840,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83841,sensory,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83842,and,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83843,textural,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83844,properties,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83845,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83846,foods,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83847,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83848,leading,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83849,to,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83850,low,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83851,consumer,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83852,acceptance,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83853,.,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83962,A,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83963,similar,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83964,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83965,was,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83966,also,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83967,shown,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83968,for,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83969,rennet,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83970,casein,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83971,",",O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83972,whereas,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83973,inulin,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83974,and,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83975,polydextrose,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83976,had,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83977,little,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83978,or,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83979,no,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83980,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83981,on,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83982,these,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83983,rheological,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83984,parameters,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83985,.,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
84042,Our,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84043,results,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84044,indicate,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84045,the,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84046,different,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84047,concentrations,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84048,and,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84049,combinations,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84050,of,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84051,fat,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84052,replacers,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84053,and,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84054,rennet,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84055,casein,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84056,that,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84057,can,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84058,be,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84059,included,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84060,in,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84061,reduced,B-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84062,-,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84063,fat,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84064,processed,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84065,cheese,I-AG.01.e.02,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84066,to,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84067,develop,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84068,products,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84069,with,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84070,specific,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84071,rheological,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84072,properties,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84073,",",O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84074,thus,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84075,meeting,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84076,future,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84077,demand,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84078,for,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84079,reduced,B-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84080,-,I-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84081,fat,I-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84082,products,I-AG.01,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84083,with,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84084,attractive,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84085,sensory,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84086,attributes,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84087,.,O,2914.0,"Our results indicate the different concentrations and combinations of fat replacers and rennet casein that can be included in reduced - fat processed cheese to develop products with specific rheological properties , thus meeting future demand for reduced - fat products with attractive sensory attributes ."
84165,According,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84166,to,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84167,national,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84168,and,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84169,European,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84170,reference,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84171,values,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84172,",",O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84173,the,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84174,children,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84175,had,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84176,an,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84177,adequate,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84178,nutrient,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84179,intake,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84180,with,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84181,exception,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84182,of,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84183,low,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84184,intakes,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84185,of,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84186,total,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84187,fat,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84188,",",O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84189,n-3,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84190,fatty,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84191,acids,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84192,from,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84193,fish,B-AG.01.d.07,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84194,and,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84195,possibly,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84196,iron,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84197,.,O,2918.0,"According to national and European reference values , the children had an adequate nutrient intake with exception of low intakes of total fat , n-3 fatty acids from fish and possibly iron ."
84226,Consumption,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84227,of,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84228,fruit,B-AG.01.h.01,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84229,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84230,fats,B-AG.01.f,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84231,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84232,fish,B-AG.01.d.07,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84233,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84234,and,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84235,fluids,B-AG.01.y,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84236,was,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84237,substantially,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84238,less,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84239,than,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84240,recommended,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84241,.,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84426,At,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84427,the,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84428,end,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84429,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84430,each,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84431,study,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84432,period,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84433,",",O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84434,faeces,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84435,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84436,twelve,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84437,volunteers,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84438,were,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84439,collected,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84440,for,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84441,chemical,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84442,analyses,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84443,and,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84444,use,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84445,in,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84446,cell,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84447,-,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84448,culture,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84449,systems,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84450,.,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84564,Faecal,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84565,water,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84566,pH,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84567,decreased,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84568,only,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84569,after,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84570,carrot,B-AG.01.y,2934.0,Faecal water pH decreased only after carrot juice consumption .
84571,juice,I-AG.01.y,2934.0,Faecal water pH decreased only after carrot juice consumption .
84572,consumption,B-X,2934.0,Faecal water pH decreased only after carrot juice consumption .
84573,.,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
85397,There,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85398,are,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85399,two,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85400,at,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85401,-,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85402,risk,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85403,periods,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85404,in,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85405,the,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85406,lives,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85407,of,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85408,children,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85409,when,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85410,nutritional,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85411,education,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85412,procedures,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85413,as,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85414,well,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85415,as,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85416,diabetes,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85417,care,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85418,in,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85419,general,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85420,are,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85421,less,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85422,likely,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85423,to,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85424,be,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85425,effective,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85426,:,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85427,early,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85428,years,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85429,of,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85430,life,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85431,and,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85432,adolescence,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85433,.,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85693,Subsequent,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85694,16th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85695,to,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85696,early,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85697,20th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85698,century,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85699,manuscripts,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85700,produced,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85701,in,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85702,Europe,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85703,and,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85704,New,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85705,Spain,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85706,revealed,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85707,>,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85708,100,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85709,medicinal,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85710,uses,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85711,for,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85712,cacao,B-AG.01,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85713,/,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85714,chocolate,B-AG.01.n.17.a,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85715,.,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85775,Additional,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85776,medical,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85777,complaints,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85778,treated,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85779,with,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85780,chocolate,B-AG.01.n.17.a,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85781,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85782,cacao,B-AG.01,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85783,have,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85784,included,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85785,anemia,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85786,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85787,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85788,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85789,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85790,mental,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85791,fatigue,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85792,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85793,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85794,breast,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85795,milk,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85796,production,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85797,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85798,consumption,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85799,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85800,tuberculosis,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85801,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85802,fever,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85803,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85804,gout,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85805,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85806,kidney,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85807,stones,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85808,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85809,reduced,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85810,longevity,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85811,and,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85812,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85813,sexual,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85814,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85815,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85816,low,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85817,virility,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85818,.,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85894,The,O,2975.0,The proceedings are synthesized in this article .
85895,proceedings,O,2975.0,The proceedings are synthesized in this article .
85896,are,O,2975.0,The proceedings are synthesized in this article .
85897,synthesized,O,2975.0,The proceedings are synthesized in this article .
85898,in,O,2975.0,The proceedings are synthesized in this article .
85899,this,O,2975.0,The proceedings are synthesized in this article .
85900,article,O,2975.0,The proceedings are synthesized in this article .
85901,.,O,2975.0,The proceedings are synthesized in this article .
86053,Preliminary,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86054,evidence,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86055,suggests,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86056,that,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86057,mushrooms,B-AG.01.h.02.h,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86058,may,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86059,support,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86060,healthy,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86061,immune,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86062,and,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86063,inflammatory,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86064,responses,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86065,through,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86066,interaction,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86067,with,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86068,the,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86069,gut,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86070,microbiota,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86071,",",O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86072,enhancing,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86073,development,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86074,of,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86075,adaptive,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86076,immunity,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86077,",",O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86078,and,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86079,improved,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86080,immune,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86081,cell,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86082,functionality,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86083,.,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86209,Therefore,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86210,",",O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86211,we,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86212,considered,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86213,it,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86214,important,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86215,to,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86216,determine,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86217,if,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86218,other,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86219,common,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86220,dietary,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86221,proteins,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86222,also,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86223,strongly,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86224,stimulate,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86225,an,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86226,increase,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86227,in,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86228,insulin,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86229,concentration,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86230,when,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86231,given,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86232,with,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86233,glucose,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86234,.,O,2987.0,"Therefore , we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose ."
86568,After,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86569,adjusting,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86570,for,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86571,these,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86572,effects,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86573,",",O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86574,case,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86575,-,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86576,control,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86577,differences,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86578,were,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86579,found,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86580,for,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86581,several,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86582,dietary,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86583,variables,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86584,",",O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86585,assessed,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86586,by,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86587,asking,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86588,about,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86589,the,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86590,usual,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86591,frequency,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86592,of,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86593,consumption,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86594,of,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86595,146,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86596,food,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86597,items,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86598,and,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86599,beverages,B-AG.01.y,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86600,.,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86814,People,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86815,with,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86816,diabetes,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86817,are,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86818,at,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86819,higher,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86820,risk,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86821,of,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86822,fatal,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86823,thromboembolic,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86824,accidents,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86825,in,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86826,the,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86827,cerebral,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86828,and,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86829,coronary,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86830,circulations,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86831,",",O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86832,especially,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86833,stroke,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86834,and,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86835,ischemic,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86836,heart,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86837,disease,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
86838,.,O,3008.0,"People with diabetes are at higher risk of fatal thromboembolic accidents in the cerebral and coronary circulations , especially stroke and ischemic heart disease ."
87146,To,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87147,compare,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87148,the,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87149,metabolic,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87150,effect,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87151,of,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87152,coingestion,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87153,of,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87154,saturated,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87155,and,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87156,monounsaturated,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87157,fats,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87158,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87159,potato,B-AG.01.h.02.a,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87160,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87161,12,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87162,subjects,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87163,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87164,non,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87165,-,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87166,insulin,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87167,-,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87168,dependent,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87169,diabetes,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87170,mellitus,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87171,(,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87172,NIDDM,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87173,),O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87174,received,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87175,300,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87176,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87177,mashed,B-AG.01.n.09,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87178,potato,I-AG.01.n.09,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87179,alone,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87180,or,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87181,in,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87182,combination,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87183,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87184,40,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87185,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87186,olive,B-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87187,oil,I-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87188,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87189,80,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87190,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87191,olive,B-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87192,oil,I-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87193,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87194,50,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87195,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87196,butter,B-AG.01.e.01,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87197,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87198,or,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87199,100,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87200,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87201,butter,B-AG.01.e.01,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87202,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87203,respectively,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87204,.,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87362,Fatty,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87363,acid,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87364,concentrations,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87365,were,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87366,similar,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87367,to,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87368,those,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87369,found,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87370,for,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87371,the,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87372,other,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87373,meals,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87374,.,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87558,Relative,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87559,to,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87560,baseline,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87561,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87562,the,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87563,proportion,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87564,of,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87565,calories,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87566,from,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87567,milk,B-AG.01.e,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87568,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87569,soup,B-AG.01.n.02,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87570,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87571,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87572,ONS,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87573,significantly,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87574,increased,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87575,at,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87576,post,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87577,-,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87578,treatment,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87579,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87580,while,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87581,grain,B-AG.01.i,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87582,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87583,meat,B-AG.01.d,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87584,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87585,potato,B-AG.01.h.02.a,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87586,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87587,baked,B-AG.01.n,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87588,dessert,I-AG.01.n,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87589,",",O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87590,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87591,oil,B-AG.01.f,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87592,and,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87593,sugar,B-AG.01.l.02,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87594,decreased,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87595,(,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87596,P,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87597,<,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87598,0.03,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87599,),O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
87600,.,O,3031.0,"Relative to baseline , the proportion of calories from milk , soup , and ONS significantly increased at post - treatment , while grain , meat , potato , baked dessert , and oil and sugar decreased ( P < 0.03 ) ."
88024,High,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88025,blood,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88026,pressure,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88027,is,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88028,an,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88029,important,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88030,risk,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88031,factor,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88032,for,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88033,cardiovascular,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88034,disease,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88035,and,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88036,cardiovascular,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88037,events,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88038,worldwide,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88039,.,O,3047.0,High blood pressure is an important risk factor for cardiovascular disease and cardiovascular events worldwide .
88175,Long,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88176,-,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88177,term,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88178,trials,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88179,investigating,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88180,the,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88181,effect,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88182,of,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88183,cocoa,B-AG.01,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88184,products,I-AG.01,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88185,are,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88186,needed,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88187,to,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88188,determine,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88189,whether,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88190,or,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88191,not,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88192,blood,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88193,pressure,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88194,is,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88195,reduced,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88196,on,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88197,a,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88198,chronic,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88199,basis,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88200,by,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88201,daily,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88202,ingestion,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88203,of,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88204,cocoa,B-AG.01,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
88205,.,O,3054.0,Long - term trials investigating the effect of cocoa products are needed to determine whether or not blood pressure is reduced on a chronic basis by daily ingestion of cocoa .
89441,A,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89442,similar,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89443,effect,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89444,was,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89445,also,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89446,seen,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89447,for,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89448,increased,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89449,consumption,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89450,of,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89451,raw,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89452,vegetables,B-AG.01.h.02,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89453,.,O,3095.0,A similar effect was also seen for increased consumption of raw vegetables .
89490,The,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89491,association,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89492,of,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89493,alcoholic,B-AG.01.y.01,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89494,beverages,I-AG.01.y.01,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89495,with,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89496,stomach,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89497,cancer,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89498,risk,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89499,may,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89500,reflect,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89501,a,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89502,particular,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89503,life,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89504,style,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89505,rather,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89506,than,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89507,being,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89508,causally,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89509,related,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89510,to,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89511,risk,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89512,.,O,3098.0,The association of alcoholic beverages with stomach cancer risk may reflect a particular life style rather than being causally related to risk .
89836,Gluten,B-AG.01.n,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89837,-,I-AG.01.n,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89838,free,I-AG.01.n,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89839,dough,I-AG.01.n,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89840,results,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89841,from,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89842,the,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89843,combination,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89844,of,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89845,different,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89846,ingredients,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89847,",",O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89848,additives,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89849,",",O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89850,and,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89851,the,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89852,processing,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89853,aids,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89854,required,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89855,for,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89856,building,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89857,up,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89858,network,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89859,structures,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89860,responsible,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89861,for,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89862,bread,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89863,quality,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89864,.,O,3112.0,"Gluten - free dough results from the combination of different ingredients , additives , and the processing aids required for building up network structures responsible for bread quality ."
89996,Bitterness,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89997,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89998,however,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89999,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90000,is,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90001,an,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90002,integral,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90003,part,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90004,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90005,the,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90006,complex,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90007,flavor,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90008,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90009,chocolate,B-AG.01.n.17.a,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90010,.,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90160,Untrained,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90161,chocolate,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90162,ice,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90163,cream,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90164,consumers,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90165,participated,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90166,in,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90167,a,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90168,large,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90169,-,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90170,scale,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90171,sensory,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90172,test,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90173,by,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90174,indicating,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90175,their,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90176,preferences,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90177,for,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90178,blinded,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90179,pairs,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90180,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90181,unspiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90182,and,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90183,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90184,samples,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90185,",",O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90186,where,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90187,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90188,spiked,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90189,sample,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90190,had,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90191,increasing,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90192,levels,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90193,of,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90194,the,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90195,added,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90196,bitterant,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90197,.,O,3125.0,"Untrained chocolate ice cream consumers participated in a large - scale sensory test by indicating their preferences for blinded pairs of unspiked and spiked samples , where the spiked sample had increasing levels of the added bitterant ."
90654,The,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90655,breaking,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90656,stress,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90657,of,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90658,the,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90659,films,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90660,blended,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90661,with,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90662,sugar,B-AG.01.l.02,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90663,and,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90664,oil,B-AG.01.f,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90665,was,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90666,less,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90667,than,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90668,that,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90669,of,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90670,control,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90671,.,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90756,PRACTICAL,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90757,APPLICATION,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90758,:,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90759,Trehalose,B-AG.01.l.02,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90760,",",O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90761,allose,B-AG.01.l.02,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90762,",",O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90763,canola,B-AG.01.f,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90764,oil,I-AG.01.f,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90765,",",O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90766,and,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90767,coconut,B-AG.01.f,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90768,oil,I-AG.01.f,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90769,could,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90770,be,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90771,used,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90772,as,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90773,a,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90774,plasticizer,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90775,in,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90776,a,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90777,starch,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90778,edible,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90779,/,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90780,biodegradable,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90781,film,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90782,system,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90783,.,O,3145.0,"PRACTICAL APPLICATION : Trehalose , allose , canola oil , and coconut oil could be used as a plasticizer in a starch edible / biodegradable film system ."
90840,The,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90841,authors,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90842,investigated,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90843,the,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90844,association,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90845,of,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90846,dietary,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90847,patterns,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90848,and,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90849,type,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90850,2,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90851,diabetes,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90852,in,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90853,a,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90854,4,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90855,-,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90856,year,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90857,prospective,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90858,study,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90859,of,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90860,"36,787",O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90861,adults,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90862,in,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90863,the,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90864,Melbourne,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90865,Collaborative,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90866,Cohort,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90867,Study,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90868,(,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90869,1990,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90870,-,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90871,1994,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90872,),O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90873,.,O,3148.0,"The authors investigated the association of dietary patterns and type 2 diabetes in a 4 - year prospective study of 36,787 adults in the Melbourne Collaborative Cohort Study ( 1990 - 1994 ) ."
90920,Variables,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90921,with,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90922,factor,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90923,loadings,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90924,having,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90925,absolute,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90926,values,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90927,of,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90928,0.3,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90929,or,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90930,greater,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90931,were,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90932,used,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90933,in,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90934,interpreting,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90935,the,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90936,factors,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90937,.,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
91030,Factor,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91031,3,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91032,",",O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91033,characterized,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91034,by,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91035,meats,B-AG.01.d,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91036,and,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91037,fatty,B-AG.01,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91038,foods,I-AG.01,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91039,",",O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91040,was,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91041,associated,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91042,with,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91043,increased,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91044,diabetes,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91045,risk,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91046,.,O,3155.0,"Factor 3 , characterized by meats and fatty foods , was associated with increased diabetes risk ."
91175,Of,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91176,the,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91177,eleven,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91178,free,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91179,-,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91180,living,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91181,subjects,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91182,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91183,were,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91184,normocholesteremic,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91185,",",O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91186,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91187,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91188,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91189,IIa,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91190,hyperlipidemia,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91191,and,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91192,five,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91193,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91194,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91195,VI,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91196,(,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91197,IIb,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91198,),O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91199,.,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91820,Information,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91821,about,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91822,constituents,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91823,of,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91824,milk,B-AG.01.e,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91825,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91826,visual,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91827,alterations,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91828,can,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91829,be,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91830,used,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91831,for,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91832,management,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91833,support,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91834,in,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91835,improving,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91836,mastitis,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91837,detection,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91838,",",O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91839,monitoring,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91840,fertility,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91841,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91842,reproduction,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91843,",",O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91844,and,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91845,adapting,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91846,individual,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91847,diets,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
91848,.,O,3182.0,"Information about constituents of milk and visual alterations can be used for management support in improving mastitis detection , monitoring fertility and reproduction , and adapting individual diets ."
92527,Obesity,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92528,is,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92529,often,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92530,accompanied,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92531,by,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92532,chronic,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92533,",",O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92534,low,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92535,-,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92536,grade,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92537,inflammation,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92538,perpetuated,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92539,by,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92540,adipose,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92541,tissue,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92542,and,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92543,the,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92544,gut,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92545,.,O,3209.0,"Obesity is often accompanied by chronic , low - grade inflammation perpetuated by adipose tissue and the gut ."
92588,Yogurt,B-AG.01.e,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92589,consumption,B-X,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92590,may,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92591,improve,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92592,gut,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92593,health,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92594,and,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92595,reduce,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92596,chronic,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92597,inflammation,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92598,by,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92599,enhancing,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92600,innate,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92601,and,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92602,adaptive,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92603,immune,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92604,responses,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92605,",",O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92606,intestinal,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92607,barrier,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92608,function,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92609,",",O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92610,lipid,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92611,profiles,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92612,",",O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92613,and,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92614,by,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92615,regulating,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92616,appetite,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92617,.,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
93527,Overnight,O,3244.0,Overnight 12 h urine samples were then collected .
93528,12,O,3244.0,Overnight 12 h urine samples were then collected .
93529,h,O,3244.0,Overnight 12 h urine samples were then collected .
93530,urine,O,3244.0,Overnight 12 h urine samples were then collected .
93531,samples,O,3244.0,Overnight 12 h urine samples were then collected .
93532,were,O,3244.0,Overnight 12 h urine samples were then collected .
93533,then,O,3244.0,Overnight 12 h urine samples were then collected .
93534,collected,O,3244.0,Overnight 12 h urine samples were then collected .
93535,.,O,3244.0,Overnight 12 h urine samples were then collected .
93536,Urine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93537,volume,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93538,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93539,pH,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93540,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93541,oxalate,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93542,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93543,creatinine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93544,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93545,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93546,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93547,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93548,theobromine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93549,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93550,and,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93551,a,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93552,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93553,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93554,crystallization,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93555,test,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93556,were,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93557,determined,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93558,for,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93559,each,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93560,sample,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93561,.,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93562,The,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93563,results,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93564,for,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93565,all,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93566,20,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93567,patients,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93568,show,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93569,that,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93570,uric,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93571,acid,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93572,crystallization,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93573,was,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93574,significantly,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93575,lower,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93576,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93577,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93578,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93579,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93580,chocolate,B-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93581,powder,I-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93582,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93583,dark,B-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93584,chocolate,I-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93585,relative,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93586,to,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93587,baseline,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93588,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93589,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93590,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93591,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93592,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93593,milk,B-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93594,chocolate,I-AG.01.n.17.a,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93595,.,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93655,The,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93656,patient,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93657,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93658,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93659,anaphylactic,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93660,episodes,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93661,after,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93662,accidental,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93663,ingestion,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93664,of,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93665,raw,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93666,carrots,B-AG.01.h.02.a,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93667,",",O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93668,but,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93669,she,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93670,tolerated,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93671,cooked,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93672,carrots,B-AG.01.h.02.a,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93673,.,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93751,Immunoblot,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93752,of,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93753,raw,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93754,carrot,B-AG.01.h.02.a,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93755,showed,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93756,a,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93757,single,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93758,IgE,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93759,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93760,binding,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93761,18,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93762,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93763,kDa,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93764,band,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93765,.,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
94059,Due,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94060,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94061,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94062,lack,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94063,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94064,sufficient,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94065,evidence,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94066,from,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94067,clinical,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94068,studies,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94069,for,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94070,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94071,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94072,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94073,botanicals,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94074,reviewed,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94075,",",O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94076,it,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94077,is,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94078,premature,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94079,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94080,actively,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94081,recommend,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94082,use,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94083,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94084,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94085,particular,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94086,herb,B-AG.01.h.02.i,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94087,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94088,treat,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94089,either,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94090,glucose,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94091,or,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94092,other,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94093,risk,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94094,factors,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94095,.,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94563,Thirty,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94564,-,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94565,nine,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94566,hypertriglyceridemic,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94567,patients,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94568,were,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94569,randomly,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94570,assigned,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94571,to,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94572,1,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94573,of,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94574,2,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94575,experimental,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94576,groups,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94577,.,O,3280.0,Thirty - nine hypertriglyceridemic patients were randomly assigned to 1 of 2 experimental groups .
94873,The,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94874,evidence,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94875,for,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94876,a,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94877,protective,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94878,effect,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94879,of,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94880,greater,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94881,vegetable,B-AG.01.h,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94882,and,I-AG.01.h,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94883,fruit,I-AG.01.h,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94884,consumption,B-X,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94885,is,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94886,consistent,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94887,for,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94888,cancers,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94889,of,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94890,the,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94891,stomach,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94892,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94893,esophagus,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94894,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94895,lung,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94896,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94897,oral,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94898,cavity,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94899,and,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94900,pharynx,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94901,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94902,endometrium,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94903,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94904,pancreas,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94905,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94906,and,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94907,colon,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94908,.,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
95085,Public,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95086,awareness,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95087,and,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95088,misunderstandings,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95089,of,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95090,lactose,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95091,intolerance,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95092,are,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95093,at,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95094,an,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95095,all,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95096,-,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95097,time,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95098,high,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95099,.,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95157,This,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95158,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95159,in,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95160,turn,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95161,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95162,can,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95163,increase,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95164,the,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95165,risk,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95166,of,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95167,major,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95168,chronic,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95169,diseases,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95170,such,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95171,as,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95172,osteoporosis,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95173,(,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95174,porous,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95175,bones,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95176,),O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95177,and,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95178,hypertension,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95179,.,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95375,94,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95376,%,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95377,of,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95378,the,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95379,patients,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95380,showed,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95381,positive,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95382,prick,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95383,tests,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95384,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95385,raw,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95386,celeriac,B-AG.01.h.02.a,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95387,",",O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95388,36,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95389,%,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95390,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95391,cooked,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95392,celeriac,B-AG.01.h.02.b,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95393,and,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95394,8/13,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95395,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95396,cooking,B-AG.01.z,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95397,water,I-AG.01.z,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95398,.,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95984,The,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95985,Western,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95986,blots,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95987,revealed,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95988,varied,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95989,affinity,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95990,of,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95991,ELISA,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95992,antibodies,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95993,to,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95994,gluten,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95995,-,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95996,containing,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95997,grain,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95998,proteins,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
95999,and,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96000,no,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96001,reactivity,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96002,to,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96003,oat,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96004,and,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96005,corn,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96006,proteins,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96007,.,O,3328.0,The Western blots revealed varied affinity of ELISA antibodies to gluten - containing grain proteins and no reactivity to oat and corn proteins .
96488,Intervention,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96489,studies,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96490,provide,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96491,evidence,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96492,that,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96493,dairy,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96494,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96495,have,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96496,more,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96497,potent,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96498,effects,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96499,on,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96500,insulin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96501,and,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96502,incretin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96503,secretion,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96504,compared,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96505,to,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96506,other,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96507,commonly,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96508,consumed,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96509,animal,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96510,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96511,.,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
97163,Many,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97164,lectins,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97165,resist,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97166,digestion,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97167,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97168,survive,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97169,gut,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97170,passage,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97171,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97172,and,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97173,bind,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97174,to,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97175,gastrointestinal,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97176,cells,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97177,and/or,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97178,enter,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97179,the,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97180,circulation,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97181,intact,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97182,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97183,maintaining,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97184,full,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97185,biological,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97186,activity,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97187,.,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97270,They,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97271,also,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97272,affect,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97273,the,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97274,immune,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97275,system,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97276,by,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97277,altering,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97278,the,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97279,production,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97280,of,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97281,various,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97282,interleukins,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97283,",",O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97284,or,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97285,by,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97286,activating,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97287,certain,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97288,protein,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97289,kinases,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97290,.,O,3370.0,"They also affect the immune system by altering the production of various interleukins , or by activating certain protein kinases ."
97675,A,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97676,relationship,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97677,has,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97678,also,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97679,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97680,observed,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97681,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97682,certain,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97683,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97684,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97685,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97686,such,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97687,as,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97688,constituents,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97689,of,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97690,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97691,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97692,Mediterranean,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97693,diet,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97694,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97695,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97696,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97697,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97698,metabolic,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97699,syndrome,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97700,;,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97701,similar,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97702,associations,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97703,have,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97704,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97705,noted,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97706,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97707,these,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97708,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97709,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97710,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97711,dementia,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97712,.,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97771,The,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97772,benefits,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97773,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97774,fruit,B-AG.01.n.08,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97775,products,I-AG.01.n.08,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97776,are,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97777,thought,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97778,to,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97779,be,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97780,a,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97781,result,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97782,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97783,its,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97784,polyphenol,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97785,content,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97786,.,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
98099,Avoidance,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98100,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98101,saturated,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98102,fat,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98103,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98104,cholesterol,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98105,by,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98106,"1,210",O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98107,Mexican,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98108,Americans,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98109,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98110,866,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98111,non,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98112,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98113,Hispanic,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98114,whites,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98115,was,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98116,assessed,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98117,as,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98118,part,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98119,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98120,a,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98121,population,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98122,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98123,based,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98124,survey,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98125,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98126,diabetes,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98127,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98128,cardiovascular,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98129,risk,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98130,factors,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98131,.,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
99081,At,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99082,the,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99083,end,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99084,of,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99085,the,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99086,trial,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99087,",",O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99088,liver,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99089,and,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99090,muscle,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99091,biopsies,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99092,were,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99093,taken,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99094,to,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99095,assess,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99096,triglyceride,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99097,contents,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99098,in,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99099,these,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99100,tissues,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99101,.,O,3436.0,"At the end of the trial , liver and muscle biopsies were taken to assess triglyceride contents in these tissues ."
99268,However,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99269,",",O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99270,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99271,cows,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99272,fed,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99273,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99274,diet,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99275,supplemented,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99276,with,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99277,GSGME,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99278,had,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99279,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99280,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99281,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99282,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99283,and,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99284,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99285,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99286,daily,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99287,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99288,protein,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99289,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99290,.,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99514,Treatments,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99515,continued,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99516,until,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99517,7,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99518,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99519,after,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99520,cows,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99521,received,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99522,an,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99523,infusion,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99524,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99525,10,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99526,microg,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99527,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99528,LPS,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99529,into,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99530,one,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99531,quarter,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99532,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99533,the,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99534,mammary,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99535,gland,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99536,(,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99537,on,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99538,average,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99539,",",O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99540,this,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99541,occurred,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99542,32,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99543,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99544,postcalving,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99545,),O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99546,.,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99547,Supplementation,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99548,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99549,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99550,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99551,increased,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99552,plasma,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99553,concentrations,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99554,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99555,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99556,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99557,at,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99558,calving,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99559,",",O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99560,but,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99561,no,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99562,differences,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99563,were,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99564,observed,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99565,in,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99566,samples,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99567,taken,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99568,24,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99569,h,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99570,postinfusion,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99571,.,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99619,The,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99620,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99621,infusion,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99622,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99623,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99624,alter,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99625,concentrations,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99626,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99627,vitamin,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99628,C,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99629,in,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99630,plasma,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99631,or,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99632,milk,B-AG.01.e,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99633,",",O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99634,suggesting,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99635,that,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99636,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99637,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99638,model,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99639,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99640,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99641,produce,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99642,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99643,same,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99644,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99645,as,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99646,a,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99647,bacterial,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99648,infection,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99649,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99650,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99651,mammary,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99652,gland,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99653,with,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99654,respect,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99655,to,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99656,antioxidant,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99657,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99658,.,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
100164,Despite,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100165,the,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100166,accumulating,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100167,epidemiological,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100168,research,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100169,",",O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100170,there,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100171,is,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100172,still,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100173,a,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100174,lack,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100175,of,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100176,consistent,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100177,results,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100178,from,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100179,high,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100180,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100181,quality,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100182,studies,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100183,for,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100184,many,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100185,health,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100186,outcomes,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100187,(,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100188,i.e.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100189,certain,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100190,cancers,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100191,and,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100192,metabolism,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100193,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100194,related,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100195,disorders,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100196,),O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100197,.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100659,ED05,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100660,estimates,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100661,ranged,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100662,between,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100663,0.4,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100664, ,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100665,mg,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100666,for,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100667,mustard,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100668,protein,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100669,and,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100670,280,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100671, ,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100672,mg,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100673,for,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100674,shrimp,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100675,protein,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100676,.,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100829,Median,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100830,intake,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100831,of,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100832,total,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100833,dairy,B-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100834,products,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100835,was,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100836,four,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100837,servings,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100838,/,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100839,d.,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100840,Low,B-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100841,-,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100842,fat,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100843,yogurt,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100844,substituted,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100845,for,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100846,whole,B-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100847,-,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100848,fat,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100849,yogurt,I-AG.01.e,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100850,was,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100851,associated,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100852,with,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100853,a,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100854,higher,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100855,rate,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100856,of,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100857,ischaemic,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100858,stroke,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100859,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100860,hazard,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100861,ratio,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100862,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100863,HR,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100864,),O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100865,=,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100866,2·58,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100867,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100868,95,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100869,%,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100870,CI,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100871,1·11,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100872,",",O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100873,5·97)/serving,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100874,per,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100875,d,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100876,),O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100877,.,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
101570,Low,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101571,bone,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101572,mass,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101573,is,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101574,related,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101575,to,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101576,increased,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101577,incidence,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101578,of,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101579,osteoporotic,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101580,fractures,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
101581,.,O,3523.0,Low bone mass is related to increased incidence of osteoporotic fractures .
102233,In,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102234,a,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102235,recent,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102236,study,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102237,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102238,fruit,B-AG.01.ab,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102239,juice,I-AG.01.ab,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102240,prepared,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102241,by,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102242,nutrient,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102243,extraction,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102244,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102245,a,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102246,process,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102247,that,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102248,retains,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102249,the,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102250,fiber,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102251,component,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102252,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102253,was,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102254,shown,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102255,to,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102256,elicit,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102257,a,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102258,favorable,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102259,glycemic,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102260,index,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102261,(,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102262,GI,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102263,),O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102264,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102265,compared,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102266,to,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102267,eating,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102268,the,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102269,fruit,B-AG.01.h.01,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102270,whole,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102271,",",O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102272,in,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102273,healthy,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102274,weight,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102275,adults,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102276,.,O,3549.0,"In a recent study , fruit juice prepared by nutrient extraction , a process that retains the fiber component , was shown to elicit a favorable glycemic index ( GI ) , compared to eating the fruit whole , in healthy weight adults ."
102823,Salt,B-AG.01.l.01,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102824,and,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102825,salty,B-AG.01.l,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102826,condiments,I-AG.01.l,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102827,were,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102828,added,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102829,most,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102830,of,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102831,the,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102832,time,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102833,during,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102834,cooking,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102835,(,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102836,92,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102837,%,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102838,and,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102839,64,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102840,%,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102841,",",O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102842,respectively,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102843,),O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102844,but,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102845,rarely,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102846,at,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102847,the,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102848,table,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102849,(,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102850,11,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102851,%,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102852,),O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102853,.,O,3569.0,"Salt and salty condiments were added most of the time during cooking ( 92 % and 64 % , respectively ) but rarely at the table ( 11 % ) ."
102963,We,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102964,also,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102965,identified,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102966,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102967,mid,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102968,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102969,dorsal,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102970,insula,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102971,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102972,well,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102973,as,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102974,the,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102975,primary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102976,and,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102977,secondary,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102978,somatosensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102979,cortex,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102980,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102981,regions,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102982,previously,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102983,assumed,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102984,to,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102985,integrate,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102986,oral,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102987,-,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102988,sensory,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102989,inputs,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102990,.,O,3575.0,We also identified the mid - dorsal insula as well as the primary and secondary somatosensory cortex - regions previously assumed to integrate oral - sensory inputs .
102991,These,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102992,findings,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102993,suggest,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102994,that,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102995,fat,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102996,perception,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102997,involves,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102998,a,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
102999,specific,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103000,set,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103001,of,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103002,brain,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103003,regions,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103004,that,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103005,were,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103006,previously,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103007,reported,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103008,to,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103009,underpin,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103010,gustatory,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103011,processing,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103012,and,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103013,oral,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103014,-,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103015,sensory,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103016,integration,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103017,processes,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103018,.,O,3576.0,These findings suggest that fat perception involves a specific set of brain regions that were previously reported to underpin gustatory processing and oral - sensory integration processes .
103019,Dietary,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103020,intakes,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103021,of,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103022,B,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103023,vitamins,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103024,and,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103025,other,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103026,components,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103027,involved,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103028,in,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103029,one,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103030,-,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103031,carbon,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103032,metabolism,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103033,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103034,which,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103035,is,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103036,necessary,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103037,for,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103038,DNA,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103039,replication,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103040,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103041,DNA,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103042,repair,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103043,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103044,and,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103045,regulation,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103046,of,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103047,gene,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103048,expression,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103049,",",O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103050,may,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103051,be,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103052,associated,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103053,with,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103054,carcinogenesis,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103055,.,O,3577.0,"Dietary intakes of B vitamins and other components involved in one - carbon metabolism , which is necessary for DNA replication , DNA repair , and regulation of gene expression , may be associated with carcinogenesis ."
103096,A,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103097,total,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103098,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103099,159,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103100,incident,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103101,gastric,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103102,cancer,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103103,cases,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103104,were,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103105,identified,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103106,from,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103107,the,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103108,Melbourne,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103109,Collaborative,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103110,Cohort,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103111,Study,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103112,(,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103113,N,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103114, ,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103115,=,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103116, ,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103117,"41,513",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103118,),O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103119,and,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103120,matched,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103121,with,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103122,159,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103123,controls,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103124,on,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103125,year,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103126,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103127,birth,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103128,",",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103129,sex,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103130,",",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103131,and,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103132,country,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103133,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103134,birth,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103135,using,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103136,incidence,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103137,density,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103138,sampling,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103139,.,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103294,Data,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103295,were,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103296,obtained,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103297,by,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103298,means,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103299,of,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103300,a,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103301,standardized,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103302,admissions,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103303,questionnaire,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103304,.,O,3585.0,Data were obtained by means of a standardized admissions questionnaire .
103710,However,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103711,",",O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103712,the,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103713,scientific,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103714,and,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103715,technological,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103716,revolution,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103717,in,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103718,Western,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103719,countries,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103720,made,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103721,fermentation,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103722,turn,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103723,from,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103724,a,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103725,household,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103726,to,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103727,a,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103728,controlled,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103729,process,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103730,suitable,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103731,for,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103732,industrial,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103733,scale,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103734,production,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103735,systems,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103736,intended,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103737,for,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103738,the,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103739,mass,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103740,marketplace,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103741,.,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
104028,CLA,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104029,has,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104030,been,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104031,shown,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104032,to,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104033,inhibit,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104034,chemically,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104035,-,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104036,induced,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104037,skin,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104038,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104039,stomach,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104040,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104041,mammary,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104042,or,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104043,colon,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104044,tumours,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104045,in,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104046,mice,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104047,and,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104048,rats,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104049,.,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104086,When,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104087,young,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104088,animals,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104089,(,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104090,mice,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104091,",",O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104092,pigs,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104093,),O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104094,are,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104095,placed,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104096,on,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104097,CLA,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104098,-,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104099,containing,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104100,diets,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104101,after,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104102,weaning,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104103,they,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104104,accumulate,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104105,more,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104106,body,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104107,protein,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104108,and,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104109,less,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104110,fat,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104111,.,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
105928,This,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105929,position,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105930,paper,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105931,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105932,written,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105933,by,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105934,collaboration,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105935,between,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105936,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105937,Israel,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105938,Heart,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105939,Association,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105940,and,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105941,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105942,Israel,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105943,Dietetic,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105944,Association,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105945,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105946,summarizes,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105947,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105948,current,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105949,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105950,preferably,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105951,latest,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105952,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105953,literature,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105954,on,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105955,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105956,association,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105957,of,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105958,nutrition,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105959,and,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105960,CVD,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105961,with,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105962,emphasis,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105963,on,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105964,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105965,level,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105966,of,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105967,evidence,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105968,and,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105969,practical,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105970,recommendations,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105971,.,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
106227,Serum,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106228,was,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106229,analyzed,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106230,for,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106231,biomarkers,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106232,",",O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106233,and,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106234,nutrient,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106235,intake,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106236,computed,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106237,using,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106238,purpose,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106239,-,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106240,built,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106241,food,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106242,composition,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106243,data,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106244,and,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106245,adjusted,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106246,for,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106247,within,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106248,-,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106249,person,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106250,variation,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106251,.,O,3694.0,"Serum was analyzed for biomarkers , and nutrient intake computed using purpose - built food composition data and adjusted for within - person variation ."
106267,(,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106268,3,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106269,),O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106270,Results,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106271,:,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106272,We,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106273,collected,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106274,1838,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106275,of,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106276,an,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106277,expected,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106278,1986,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106279,diet,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106280,records,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106281,(,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106282,92.5,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106283,%,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106284,),O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106285,",",O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106286,610/658,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106287,serum,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106288,samples,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106289,(,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106290,92.7,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106291,%,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106292,),O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106293,",",O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106294,and,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106295,315/334,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106296,height,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106297,and,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106298,weight,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106299,measurements,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106300,(,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106301,94.3,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106302,%,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106303,),O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106304,.,O,3696.0,"( 3 ) Results : We collected 1838 of an expected 1986 diet records ( 92.5 % ) , 610/658 serum samples ( 92.7 % ) , and 315/334 height and weight measurements ( 94.3 % ) ."
106809,Observational,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106810,studies,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106811,support,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106812,the,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106813,role,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106814,of,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106815,modifying,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106816,lifestyle,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106817,-,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106818,related,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106819,risk,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106820,factors,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106821,such,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106822,as,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106823,diet,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106824,",",O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106825,physical,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106826,activity,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106827,and,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106828,alcohol,B-AG.01.y.01,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106829,use,B-X,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106830,in,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106831,stroke,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106832,prevention,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106833,.,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
107185,Patients,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107186,with,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107187,renal,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107188,impairment,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107189,",",O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107190,including,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107191,the,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107192,elderly,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107193,",",O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107194,should,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107195,limit,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107196,red,B-AG.01.d,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107197,meat,I-AG.01.d,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107198,and,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107199,avoid,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107200,egg,B-AG.01.g,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107201,yolk,I-AG.01.g,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107202,",",O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107203,as,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107204,should,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107205,other,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107206,patients,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107207,at,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107208,high,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107209,risk,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107210,of,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107211,stroke,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107212,.,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107248,It,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107249,now,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107250,clear,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107251,that,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107252,B,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107253,vitamins,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107254,to,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107255,lower,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107256,homocysteine,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107257,reduce,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107258,the,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107259,risk,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107260,of,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107261,stroke,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107262,",",O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107263,but,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107264,we,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107265,should,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107266,probably,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107267,be,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107268,using,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107269,methylcobalamin,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107270,instead,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107271,of,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107272,cyanocobalamin,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107273,.,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107454,Blood,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107455,glucose,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107456,increment,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107457,after,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107458,white,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107459,spaghetti,B-AG.01.n,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107460,and,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107461,bolognese,B-AG.01.n.06,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107462,sauce,I-AG.01.n.06,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107463,was,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107464,only,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107465,approximately,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107466,50,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107467,%,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107468,of,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107469,that,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107470,seen,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107471,in,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107472,response,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107473,to,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107474,potato,B-AG.01.h.02.a,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107475,and,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107476,bolognese,B-AG.01.n.06,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107477,sauce,I-AG.01.n.06,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107478,.,O,3735.0,Blood glucose increment after white spaghetti and bolognese sauce was only approximately 50 % of that seen in response to potato and bolognese sauce .
107844,Age-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107845,",",O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107846,gender-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107847,",",O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107848,education-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107849,and,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107850,total,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107851,energy,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107852,intake,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107853,-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107854,adjusted,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107855,odds,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107856,ratios,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107857,(,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107858,OR,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107859,),O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107860,were,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107861,computed,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107862,.,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
108393,Hepatic,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108394,LDL,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108395,receptor,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108396,activity,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108397,may,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108398,be,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108399,regulated,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108400,by,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108401,the,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108402,messenger,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108403,RNA,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108404,concentration,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108405,of,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108406,the,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108407,LDL,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108408,receptor,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108409,.,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108718,We,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108719,followed,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108720,"29,142",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108721,women,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108722,and,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108723,"26,029",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108724,men,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108725,aged,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108726,50,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108727,-,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108728,64,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108729,years,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108730,in,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108731,the,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108732,Danish,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108733,Diet,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108734,",",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108735,Cancer,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108736,and,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108737,Health,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108738,cohort,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108739,.,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108866,A,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108867,higher,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108868,intake,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108869,of,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108870,cabbage,B-AG.01.h.02.d,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108871,replacing,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108872,other,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108873,vegetable,B-AG.01.h.02,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108874,subgroups,B-X,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108875,was,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108876,associated,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108877,with,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108878,a,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108879,statistically,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108880,non,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108881,-,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108882,significant,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108883,higher,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108884,risk,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108885,of,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108886,MI,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108887,.,O,3785.0,A higher intake of cabbage replacing other vegetable subgroups was associated with a statistically non - significant higher risk of MI .
108941,Cranberries,O,3789.0,Cranberries contain various types of bioactive components .
108942,contain,O,3789.0,Cranberries contain various types of bioactive components .
108943,various,O,3789.0,Cranberries contain various types of bioactive components .
108944,types,O,3789.0,Cranberries contain various types of bioactive components .
108945,of,O,3789.0,Cranberries contain various types of bioactive components .
108946,bioactive,O,3789.0,Cranberries contain various types of bioactive components .
108947,components,O,3789.0,Cranberries contain various types of bioactive components .
108948,.,O,3789.0,Cranberries contain various types of bioactive components .
108966,In,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108967,the,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108968,21st,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108969,century,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108970,",",O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108971,the,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108972,protection,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108973,provided,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108974,by,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108975,cranberry,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108976,phytochemicals,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108977,against,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108978,cancer,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108979,and,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108980,vascular,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108981,diseases,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108982,has,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108983,drawn,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108984,more,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108985,attention,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108986,from,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108987,researchers,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108988,.,O,3791.0,"In the 21st century , the protection provided by cranberry phytochemicals against cancer and vascular diseases has drawn more attention from researchers ."
108989,Anthocyanins,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108990,",",O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108991,procyanidins,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108992,",",O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108993,and,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108994,flavonols,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108995,in,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108996,cranberries,B-AG.01.h.01.b,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108997,were,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108998,all,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
108999,documented,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109000,to,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109001,have,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109002,potential,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109003,effects,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109004,on,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109005,cancer,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109006,prevention,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109007,.,O,3792.0,"Anthocyanins , procyanidins , and flavonols in cranberries were all documented to have potential effects on cancer prevention ."
109336,Suppression,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109337,of,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109338,ovarian,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109339,steroids,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109340,by,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109341,ovariectomy,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109342,resulted,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109343,in,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109344,a,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109345,greater,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109346,persistency,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109347,of,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109348,lactation,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109349,and,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109350,a,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109351,decrease,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109352,in,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109353,MEC,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109354,exfoliation,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109355,.,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109395,In,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109396,most,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109397,of,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109398,these,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109399,studies,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109400,",",O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109401,variations,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109402,of,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109403,MEC,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109404,exfoliation,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109405,were,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109406,associated,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109407,with,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109408,variations,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109409,in,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109410,milk,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109411,yield,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109412,and,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109413,changes,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109414,in,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109415,mammary,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109416,epithelium,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109417,integrity,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109418,.,O,3811.0,"In most of these studies , variations of MEC exfoliation were associated with variations in milk yield and changes in mammary epithelium integrity ."
109780,Finally,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109781,",",O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109782,our,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109783,results,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109784,confirm,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109785,the,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109786,protective,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109787,effect,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109788,of,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109789,a,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109790,daily,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109791,water,B-AG.01.z,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109792,intake,B-X,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109793,of,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109794,1,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109795,-,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109796,2,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109797, ,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109798,L,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109799,",",O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109800,but,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109801,unfortunately,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109802,this,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109803,quantity,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109804,is,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109805,usually,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109806,consumed,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109807,by,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109808,about,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109809,a,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109810,quarter,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109811,of,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109812,the,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109813,sample,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
109814,.,O,3822.0,"Finally , our results confirm the protective effect of a daily water intake of 1 - 2   L , but unfortunately this quantity is usually consumed by about a quarter of the sample ."
110156,Anthocyanins,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110157,are,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110158,water,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110159,-,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110160,soluble,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110161,flavonoids,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110162,",",O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110163,and,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110164,are,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110165,responsible,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110166,for,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110167,red,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110168,",",O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110169,violet,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110170,",",O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110171,and,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110172,blue,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110173,colours,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110174,in,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110175,fruits,B-AG.01.h.01,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110176,",",O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110177,vegetables,B-AG.01.h.02,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110178,",",O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110179,and,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110180,grains,B-AG.01.i,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110181,.,O,3838.0,"Anthocyanins are water - soluble flavonoids , and are responsible for red , violet , and blue colours in fruits , vegetables , and grains ."
110214,As,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110215,such,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110216,",",O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110217,whole,B-AG.01,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110218,grain,I-AG.01,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110219,functional,I-AG.01,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110220,foods,I-AG.01,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110221,made,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110222,with,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110223,coloured,B-AG.01.i,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110224,grains,I-AG.01.i,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110225,are,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110226,promising,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110227,new,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110228,products,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
110229,.,O,3840.0,"As such , whole grain functional foods made with coloured grains are promising new products ."
111111,The,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111112,recent,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111113,isolation,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111114,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111115,a,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111116,larger,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111117,number,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111118,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111119,novel,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111120,presumably,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111121,viral,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111122,DNAs,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111123,from,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111124,serum,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111125,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111126,meat,B-AG.01.d,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111127,and,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111128,dairy,B-AG.01.e,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111129,products,I-AG.01.e,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111130,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111131,healthy,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111132,dairy,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111133,cows,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111134,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111135,at,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111136,least,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111137,part,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111138,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111139,them,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111140,infectious,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111141,for,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111142,human,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111143,cells,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111144,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111145,deserves,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111146,further,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111147,investigation,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111148,.,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111239,Water,B-AG.01.z,3876.0,Water used for food processing was simultaneously sampled .
111240,used,O,3876.0,Water used for food processing was simultaneously sampled .
111241,for,O,3876.0,Water used for food processing was simultaneously sampled .
111242,food,O,3876.0,Water used for food processing was simultaneously sampled .
111243,processing,O,3876.0,Water used for food processing was simultaneously sampled .
111244,was,O,3876.0,Water used for food processing was simultaneously sampled .
111245,simultaneously,O,3876.0,Water used for food processing was simultaneously sampled .
111246,sampled,O,3876.0,Water used for food processing was simultaneously sampled .
111247,.,O,3876.0,Water used for food processing was simultaneously sampled .
111288,The,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111289,As,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111290,concentration,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111291,exceeded,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111292,10,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111293,μg,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111294,/,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111295,L,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111296,in,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111297,74,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111298,%,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111299,of,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111300,the,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111301,water,B-AG.01.z,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111302,samples,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111303,taken,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111304,from,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111305,SMEs,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111306,.,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111411,The,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111412,effect,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111413,of,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111414,vegetable,B-AG.01.h,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111415,and,I-AG.01.h,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111416,fruit,I-AG.01.h,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111417,consumption,B-X,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111418,on,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111419,breast,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111420,cancer,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111421,risk,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111422,is,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111423,controversial,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111424,.,O,3885.0,The effect of vegetable and fruit consumption on breast cancer risk is controversial .
111671,The,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111672,aim,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111673,of,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111674,this,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111675,study,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111676,was,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111677,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111678,investigate,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111679,if,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111680,grape,B-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111681,or,I-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111682,apple,I-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111683,juices,I-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111684,are,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111685,able,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111686,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111687,protect,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111688,bone,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111689,tissue,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111690,of,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111691,rats,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111692,exposed,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111693,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111694,cadmium,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111695,.,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111696,For,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111697,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111698,purpose,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111699,",",O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111700,histopathological,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111701,analysis,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111702,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111703,immunohistochemistry,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111704,for,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111705,RUNX-2,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111706,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111707,RANK,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111708,-,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111709,L,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111710,were,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111711,investigated,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111712,in,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111713,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111714,setting,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111715,.,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111795,Cadmium,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111796,and,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111797,grape,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111798,juice,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111799,and,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111800,cadmium,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111801,and,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111802,apple,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111803,juice,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111804,groups,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111805,received,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111806,a,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111807,single,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111808,i.p,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
111809,.,O,3902.0,Cadmium and grape juice and cadmium and apple juice groups received a single i.p .
112245,Both,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112246,ethanol,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112247,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112248,wine,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112249,treatments,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112250,reduced,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112251,the,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112252,incidence,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112253,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112254,lung,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112255,Clara,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112256,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112257,cell,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112258,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112259,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112260,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112261,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112262,10,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112263,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112264,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112265,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112266,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112267,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112268,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112269,reduced,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112270,the,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112271,frequency,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112272,(,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112273,number,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112274,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112275,specific,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112276,tumours,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112277,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112278,number,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112279,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112280,tumour,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112281,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112282,bearing,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112283,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112284,),O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112285,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112286,both,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112287,Clara,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112288,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112289,cell,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112290,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112291,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112292,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112293,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112294,10,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112295,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112296,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112297,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112298,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112299,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112300,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112301,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112302,alveolar,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112303,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112304,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112305,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112306,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112307,20,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112308,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112309,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112310,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112311,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112312,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112313,.,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112704,From,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112705,1984,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112706,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112707,1988,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112708,a,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112709,population,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112710,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112711,based,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112712,case,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112713,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112714,control,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112715,study,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112716,was,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112717,carried,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112718,out,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112719,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112720,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112721,Netherlands,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112722,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112723,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112724,collaboration,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112725,with,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112726,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112727,International,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112728,Agency,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112729,for,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112730,Research,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112731,on,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112732,Cancer,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112733,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112734,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112735,examine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112736,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112737,possible,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112738,relationship,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112739,between,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112740,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112741,habitual,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112742,lifetime,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112743,consumption,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112744,of,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112745,alcohol,B-AG.01.y.01,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112746,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112747,coffee,B-AG.01.ad,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112748,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112749,tea,B-AG.01.ac,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112750,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112751,exocrine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112752,pancreatic,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112753,carcinoma,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112754,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112755,176,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112756,cases,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112757,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112758,487,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112759,controls,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112760,.,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
113296,These,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113297,associations,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113298,are,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113299,possibly,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113300,because,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113301,of,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113302,the,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113303,high,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113304,fructose,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113305,:,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113306,glucose,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113307,ratios,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113308,",",O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113309,and,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113310,fructose,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113311,malabsorption,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113312,.,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113422,Strawberries,B-AG.01.h.01.b,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113423,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113424,a,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113425,rich,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113426,source,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113427,of,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113428,phytochemicals,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113429,(,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113430,ellagic,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113431,acid,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113432,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113433,anthocyanins,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113434,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113435,quercetin,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113436,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113437,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113438,catechin,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113439,),O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113440,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113441,vitamins,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113442,(,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113443,ascorbic,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113444,acid,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113445,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113446,folic,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113447,acid,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113448,),O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113449,",",O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113450,have,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113451,been,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113452,highly,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113453,ranked,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113454,among,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113455,dietary,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113456,sources,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113457,of,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113458,polyphenols,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113459,and,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113460,antioxidant,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113461,capacity,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113462,.,O,3953.0,"Strawberries , a rich source of phytochemicals ( ellagic acid , anthocyanins , quercetin , and catechin ) and vitamins ( ascorbic acid and folic acid ) , have been highly ranked among dietary sources of polyphenols and antioxidant capacity ."
113562,Mechanistic,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113563,studies,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113564,have,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113565,elucidated,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113566,specific,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113567,biochemical,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113568,pathways,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113569,that,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113570,might,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113571,confer,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113572,these,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113573,protective,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113574,effects,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113575,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113576,strawberries,B-AG.01.h.01.b,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113577,:,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113578,upregulation,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113579,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113580,endothelial,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113581,nitric,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113582,oxide,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113583,synthase,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113584,(,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113585,eNOS,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113586,),O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113587,activity,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113588,",",O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113589,downregulation,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113590,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113591,NF,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113592,-,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113593,kB,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113594,activity,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113595,and,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113596,subsequent,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113597,inflammation,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113598,",",O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113599,or,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113600,inhibitions,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113601,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113602,carbohydrate,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113603,digestive,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113604,enzymes,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113605,.,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113714,Parathyroid,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113715,hormone,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113716,-,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113717,related,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113718,protein,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113719,derived,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113720,from,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113721,the,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113722,mammary,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113723,gland,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113724,is,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113725,assumed,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113726,to,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113727,play,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113728,a,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113729,role,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113730,in,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113731,maintaining,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113732,the,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113733,maternal,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113734,calcium,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113735,homeostasis,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113736,and,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113737,calcium,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113738,transport,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113739,from,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113740,blood,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113741,to,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113742,milk,B-AG.01.e,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113743,.,O,3962.0,Parathyroid hormone - related protein derived from the mammary gland is assumed to play a role in maintaining the maternal calcium homeostasis and calcium transport from blood to milk .
113838,We,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113839,measured,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113840,the,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113841,PTHrP,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113842,concentrations,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113843,in,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113844,normal,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113845,liquid,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113846,milk,B-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113847,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113848,processed,B-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113849,milk,I-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113850,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113851,milk,B-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113852,drinks,I-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113853,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113854,formulated,B-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113855,milk,I-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113856,powders,I-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113857,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113858,and,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113859,skim,B-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113860,milk,I-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113861,powder,I-AG.01.e,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113862,by,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113863,using,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113864,the,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113865,appropriate,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113866,combination,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113867,of,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113868,pretreatment,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113869,(,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113870,acidification,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113871,),O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113872,and,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113873,diluent,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113874,(,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113875,plasma,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113876,treated,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113877,with,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113878,protease,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113879,inhibitors,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113880,),O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113881,.,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
114017,In,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114018,some,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114019,countries,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114020,(,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114021,eg,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114022,",",O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114023,United,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114024,States,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114025,",",O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114026,Canada,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114027,),O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114028,",",O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114029,the,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114030,gluten,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114031,-,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114032,free,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114033,diet,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114034,is,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114035,completely,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114036,devoid,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114037,of,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114038,gluten,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114039,and,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114040,is,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114041,based,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114042,on,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114043,foods,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114044,such,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114045,as,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114046,rice,B-AG.01.i,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114047,and,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114048,corn,B-AG.01.i,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114049,that,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114050,are,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114051,naturally,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114052,gluten,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114053,free,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114054,.,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114262,Milk,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114263,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114264,cheese,B-AG.01.e.02,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114265,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114266,yogurt,B-AG.01.e,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114267,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114268,and,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114269,other,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114270,dairy,B-AG.01.e,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114271,products,I-AG.01.e,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114272,have,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114273,long,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114274,been,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114275,known,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114276,to,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114277,provide,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114278,good,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114279,nutrition,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114280,.,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114633,Dietary,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114634,patterns,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114635,were,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114636,:,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114637,low,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114638,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114639,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114640,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114641,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114642,32·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114643,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114644,",",O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114645,moderate,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114646,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114647,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114648,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114649,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114650,42·1,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114651,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114652,and,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114653,high,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114654,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114655,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114656,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114657,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114658,26·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114659,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114660,.,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
115755,After,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115756,adjustment,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115757,for,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115758,age,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115759,and,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115760,total,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115761,energy,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115762,intake,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115763,",",O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115764,intake,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115765,of,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115766,trans,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115767,isomers,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115768,was,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115769,directly,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115770,related,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115771,to,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115772,risk,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115773,of,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115774,CHD,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115775,(,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115776,relative,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115777,risk,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115778,for,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115779,highest,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115780,vs,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115781,lowest,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115782,quintile,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115783,1.50,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115784,[,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115785,95,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115786,%,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115787,Cl,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115788,1.12,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115789,-,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115790,2.00,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115791,],O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115792,",",O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115793,p,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115794,for,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115795,trend,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115796,=,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115797,0.001,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115798,),O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115799,.,O,4033.0,"After adjustment for age and total energy intake , intake of trans isomers was directly related to risk of CHD ( relative risk for highest vs lowest quintile 1.50 [ 95 % Cl 1.12 - 2.00 ] , p for trend = 0.001 ) ."
115912,These,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115913,findings,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115914,support,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115915,the,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115916,hypothesis,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115917,that,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115918,consumption,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115919,of,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115920,partially,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115921,hydrogenated,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115922,vegetable,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115923,oils,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115924,may,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115925,contribute,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115926,to,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115927,occurrence,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115928,of,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115929,CHD,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115930,.,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
116227,The,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116228,validity,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116229,of,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116230,ancient,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116231,medicine,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116232,is,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116233,now,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116234,being,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116235,evaluated,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116236,critically,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116237,in,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116238,cell,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116239,-,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116240,free,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116241,systems,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116242,",",O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116243,animal,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116244,models,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116245,",",O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116246,and,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116247,human,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116248,populations,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116249,.,O,4051.0,"The validity of ancient medicine is now being evaluated critically in cell - free systems , animal models , and human populations ."
116439,Rats,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116440,receiving,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116441,garlic,B-AG.01.h.02.e,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116442,orally,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116443,and,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116444,intraperitoneally,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116445,also,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116446,showed,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116447,a,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116448,significant,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116449,reduction,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116450,in,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116451,triglyceride,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116452,levels,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116453,(,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116454,38,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116455,%,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116456,),O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116457,.,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
117078,Contrary,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117079,to,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117080,expectations,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117081,",",O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117082,epidemiologic,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117083,studies,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117084,and,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117085,clinical,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117086,trials,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117087,suggest,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117088,that,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117089,regular,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117090,nut,B-AG.01.h.01.f,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117091,consumption,B-X,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117092,is,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117093,unlikely,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117094,to,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117095,contribute,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117096,to,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117097,obesity,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117098,and,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117099,may,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117100,even,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117101,help,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117102,in,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117103,weight,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117104,loss,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117105,.,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117199,Dietary,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117200,histories,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117201,concerned,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117202,the,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117203,frequency,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117204,of,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117205,consumption,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117206,per,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117207,week,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117208,of,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117209,29,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117210,selected,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117211,food,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117212,items,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117213,(,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117214,including,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117215,the,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117216,major,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117217,sources,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117218,of,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117219,starches,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117220,",",O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117221,proteins,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117222,",",O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117223,fats,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117224,",",O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117225,fibres,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117226,",",O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117227,vitamins,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117228,A,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117229,and,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117230,C,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117231,",",O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117232,nitrates,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117233,and,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117234,nitrites,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117235,in,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117236,the,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117237,Italian,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117238,diet,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117239,),O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117240,and,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117241,subjective,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117242,scores,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117243,for,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117244,condiments,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117245,and,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117246,salt,B-AG.01.l.01,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117247,intake,B-X,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117248,.,O,4090.0,"Dietary histories concerned the frequency of consumption per week of 29 selected food items ( including the major sources of starches , proteins , fats , fibres , vitamins A and C , nitrates and nitrites in the Italian diet ) and subjective scores for condiments and salt intake ."
117595,Direct,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117596,effects,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117597,in,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117598,the,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117599,gastrointestinal,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117600,tract,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117601,include,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117602,prevention,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117603,of,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117604,constipation,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117605,and,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117606,possibly,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117607,colon,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117608,cancer,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117609,.,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117695,Histamine,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117696,release,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117697,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117698,HR,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117699,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117700,studies,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117701,were,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117702,performed,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117703,in,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117704,40,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117705,birch,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117706,pollen,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117707,-,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117708,allergic,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117709,patients,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117710,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117711,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117712,case,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117713,history,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117714,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117715,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117716,SPT,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117717,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117718,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117719,birch,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117720,pollen,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117721,-,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117722,specific,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117723,serum,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117724,IgE,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117725,:,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117726,RAST,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117727,>,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117728,or,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117729,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117730,3,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117731,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117732,with,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117733,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117734,n,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117735,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117736,20,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117737,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117738,A,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117739,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117740,and,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117741,without,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117742,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117743,n,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117744,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117745,20,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117746,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117747,B,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117748,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117749,fruit,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117750,hypersensitivity,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117751,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117752,and,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117753,10,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117754,nonatopic,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117755,volunteers,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117756,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117757,C,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117758,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117759,.,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117760,Several,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117761,fruit,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117762,allergens,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117763,were,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117764,used,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117765,and,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117766,characterized,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117767,by,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117768,protein,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117769,determination,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117770,and,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117771,immunoblot,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117772,techniques,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117773,.,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117774,Dose,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117775,-,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117776,dependent,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117777,HR,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117778,(,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117779,apple,B-AG.01.h.01.c,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117780,peel,I-AG.01.h.01.c,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117781,=,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117782,apple,B-AG.01.h.01.c,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117783,pulp,I-AG.01.h.01.c,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117784,>,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117785,peach,B-AG.01.h.01.e,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117786,=,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117787,cherry,B-AG.01.h.01.e,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117788,),O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117789,was,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117790,demonstrated,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117791,in,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117792,both,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117793,allergic,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117794,groups,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117795,",",O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117796,but,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117797,to,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117798,a,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117799,higher,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117800,extent,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117801,in,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117802,patients,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117803,with,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117804,fruit,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117805,allergy,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117806,(,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117807,P,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117808,<,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117809,0.01,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117810,),O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117811,.,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117849,We,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117850,conclude,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117851,that,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117852,fruit,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117853,-,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117854,related,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117855,symptoms,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117856,require,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117857,not,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117858,only,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117859,high,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117860,specific,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117861,serum,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117862,IgE,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117863,",",O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117864,but,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117865,a,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117866,strong,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117867,cellular,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117868,sensitization,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117869,to,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117870,birch,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117871,pollen,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117872,allergens,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117873,together,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117874,with,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117875,an,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117876,increased,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117877,cellular,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117878,reactivity,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117879,to,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117880,fruit,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117881,allergens,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117882,.,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117896,Some,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117897,studies,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117898,showed,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117899,that,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117900,cadmium,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117901,(,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117902,Cd,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117903,),O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117904,was,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117905,among,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117906,the,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117907,most,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117908,significant,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117909,hazards,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117910,in,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117911,kitchen,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117912,garden,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117913,soils,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117914,and,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117915,prolonged,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117916,exposure,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117917,to,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117918,this,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117919,metal,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117920,could,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117921,cause,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117922,deleterious,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117923,health,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117924,effects,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117925,in,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117926,humans,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117927,.,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117986,Using,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117987,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117988,UBM,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117989,protocol,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117990,(,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117991,unified,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117992,BARGE,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117993,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117994,method,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117995,),O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117996,",",O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117997,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117998,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117999,of,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118000,Cd,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118001,was,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118002,measured,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118003,in,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118004,raw,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118005,/,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118006,cooked,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118007,vegetables,B-AG.01.h.02,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118008,.,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118090,Cooking,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118091,by,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118092,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118093,steaming,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118094,process,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118095,generally,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118096,increased,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118097,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118098,bioaccessibility,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118099,of,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118100,Cd,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118101,in,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118102,French,B-AG.01.h.02.g,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118103,bean,I-AG.01.h.02.g,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118104,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118105,carrot,B-AG.01.h.02.a,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118106,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118107,and,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118108,leek,B-AG.01.h.02.e,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118109,.,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118636,The,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118637,analysis,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118638,of,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118639,food,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118640,patterns,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118641,can,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118642,contribute,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118643,to,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118644,the,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118645,understanding,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118646,of,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118647,the,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118648,association,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118649,between,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118650,eating,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118651,habits,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118652,and,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118653,anthropometric,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118654,indicators,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118655,.,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
